Tabbacin kisa na bioweapon: sama da takaddun kimiyya 1,000 sun faɗi haka. Wannan ba rashin gaskiya ba ne na gwamnati- kamfanoni. Waɗannan laifukan yaƙi ne na Yamma. Tashin Rediyon Sinoland 220125

2022-01-25
| No Comments

YANZU A HARSHE 22 DABAN DABAN. DANNA KASASHEN KWUSULUN HAGU "FURSSARA" DOMIN NEMAN NAKU!

Da Jeff J. Brown

Hoton da ke sama: Dukkanmu a cikin tattalin arzikin jari-hujja na duniya muna fama da yakin ilimin halitta. Waɗannan laifukan yaƙi ne kuma hujjar kimiyya tana da yawa. 

A nan, yana ɗaukar daƙiƙa guda kawai…

Goyi bayan sa'o'i da yawa na bincike da labarai akan CRRS ta hanyar FundRazr! FundRazr kuma yana karɓar katunan banki, PayPal, tare da maimaituwa ko gudummawar lokaci ɗaya

https://fundrazr.com/CRRS_2021_fundraiser?ref=ab_78aX23

Goyi bayan duk aikina mai wahala, bidiyo, podcasts da hirarraki akan CRRS ta hanyar PayPal! Hakanan ana iya amfani da katunan banki ta hanyar tashar PayPal, tare da gudummawar da ake bayarwa akai-akai ko sau ɗaya,

https://www.paypal.me/ChinaRisingRadioSino

Idan ka fi son Patreon don ci gaba da tallafawa, zaɓi zaɓinka, CRRS ko China Tech News Flash!

https://www.patreon.com/China_Rising_Radio_Sinoland

https://www.patreon.com/China_Tech_News_Flash

Ko ta Wechat (hagu) da Alipay (dama),

Na gode, Jeff

Shekaru goma sha shida a kan tituna, ina zaune da aiki tare da mutanen China , Jeff

Sauke manhajar SoundCloud (kuma a ƙasan wannan shafin), Brighteon, iVoox, RuVid , da kuma yadda ake tallata su a iTunes , Stitcher Radio da Reason.fm (hanyoyin haɗin da ke ƙasa),

Tashar Bidiyo ta Brighteon: https://www.brighteon.com/channels/jeffjbrown

MUHIMMAN SANARWA: techofascism yana nan! StumbleUpon (yanzu Mix) da Reddit sun cire ni. Facebook, Twitter da YouTube suna yi mani sharhi sosai. Lokaci ne kawai kafin su cire min dandamali kuma. Da fatan za a fara amfani da Brighteon don bidiyo na, sannan ku haɗa da ni ta wasu kafofin watsa labarun da aka jera a ƙasa, musamman VK, Telegram, Parler da WeChat, waɗanda ba sa cikin na'urar farfagandar MSM ta Yamma (BLPM).

Babu mai gani. Rubutu kawai.

Labarin tushe: Ina biyan kuɗi zuwa ga wasiƙar labarai ta The Titanic Lifeboat Academy kuma ina goyon bayan aikinsu mai kyau tare da gudummawa. Ina fatan kai ma za ka yi…

https://titaniclifeboatacademy.org/19-articles/techno-socio-milieu/1621-covid-19-vaccines-scientific-proof-of-lethality

 

Sama da Nazarin Kimiyya Dubu Daya Ya Tabbatar da Cewa Cutar COVID-19 Alurar riga kafi suna da haɗari, kuma duk waɗanda ke tura wannan Ajandar Suna Aikata Laifin Babban Laifi a Ofishin Jama'a. 

Sama da watanni 12 daga tura COVID 19 na gaggawa na amfani da rigakafin gwaji, nazarin kimiyya a cikin dubunnan, da rahotannin korafe-korafen aikata laifuka na hari da kisan kai daga haramtacciyar amfani da gubar sinadarai da aka yi wa jami'an 'yan sanda a duk fadin kasar, tabbatar da kai hari kan jama'ar Burtaniya da ba su ji ba. Kimiyyar da ba za a iya warwarewa ba ta nuna cewa rigakafin COVID 19 ba shi da aminci kuma ba shi da tasiri wajen iyakance watsawa ko kamuwa da cuta daga SARS-CoV-2, ƙwayoyin cuta na coronavirus.

Farfagandar karya ta "aminci da inganci", wanda jami'an gwamnati suka fitar wadanda a yanzu ke ci gaba da tura wannan allurar, keta hakkin aiki ne. Ma'aikacin gwamnati yana ƙarƙashin, kuma yana sane da, wani aikin da ya rataya a wuyansa na hana mutuwa ko mummunan rauni wanda ya taso kawai ta hanyar ayyukan ma'aikata.

Mutane da yawa sun karya wannan doka kuma, ta hanyar yin hakan, suna haifar da haɗarin mutuwa ko mummunan rauni, ta hanyar ci gaba da yin komai game da haɗarin da aka tabbatar da ke tattare da allurar COVID 19. Wasu daga cikin waɗannan haɗarin sun haɗa da toshewar jini, myocarditis, pericarditis, thrombosis, thrombocytopenia, anaphylaxis, Bell's palsy, Guillain-Barre, ciwon daji har da mutuwa, da sauransu.

Duk waɗannan an tabbatar da su a cikin bayanan kimiyya-da-gwamnati da suka tattara daga Hukumar Lafiya da Tsaro ta Burtaniya kan COVID 19 game da lalacewar rigakafin.

An canza kalmar “alurar rigakafi” kwanan nan don haɗa wannan ba bisa ƙa'ida ba, gwajin likitanci ba bisa ka'ida ba don sauƙaƙe amfani da fasahar mRNA wanda ba alurar riga kafi ba, wanda ya ƙunshi nano-metamaterials masu guba na halitta masu alaƙa da ikon tattara bayanan birni na 5G.

Ƙarfe nanoparticulates an san su a kimiyya don zama genotoxic - guba wanda kuma zai iya haifar da haifuwa. Hatsarin da ke tattare da wadanda abin ya shafa a nan gaba kadan daga wannan batu na likitanci an san yanzu. Duk da haka, har yanzu ba a gano tsawon lokacin da wannan makami ke kashewa ba saboda illar da yake da shi a kan tsarin garkuwar jiki, yana haifar da Ciwon Immunodeficiency Syndrome (AIDS).

Yanzu za mu iya tabbatar da takaddun bayanan tsaro na sirri na 2017, wanda ke nuna kisan da aka yi niyyar kashe sama da miliyan 55 a duk faɗin Burtaniya nan da 2025 ta amfani da wannan makami na sinadarai.

Hukumar Kula da Magunguna da Kula da Kiwon Lafiya (MHRA) ta riga ta yi gargaɗi game da ɗimbin ɗimbin halayen da ake sa ran kafin aikewa—tabbatar da yanayin da aka riga aka tsara na aikata laifuka da laifuffukan ɗabi'a na jama'a a da da yanzu.

  1. Tashin jini na jijiyoyin jini bayan COVID-19 a cikin Burtaniya: nazarin ƙungiyoyi masu yawa: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/
  2. thrombocytopenia na rigakafi da aka haifar da rigakafin rigakafi tare da yaduwar coagulation na intravascular da mutuwa bayan rigakafin ChAdOx1 nCoV-19: https://www.sciencedirect.com/science/article/pii/S1052305721003414
  3. Cutar jini mai saurin mutuwa bayan COVID-19: https://pubmed.ncbi.nlm.nih.gov/33928772/
  4. Myocarditis bayan rigakafin mRNA daga SARS-CoV-2, jerin shari'o'i: https://www.sciencedirect.com/science/article/pii/S2666602221000409
  5. Laifukan uku na m thromboembolism a cikin mata bayan allurar rigakafin COVID-19: https://www.sciencedirect.com/science/article/pii/S2213333X21003929
  6. M thrombosis na bishiyar jijiyoyin jini bayan allurar rigakafin COVID-19: https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988
  7. Rahoton shari'ar Amurka game da thrombosis na sinus venous tare da thrombocytopenia bayan alurar riga kafi tare da Ad26.COV2.S (da covid-19), Maris 2 zuwa Afrilu 21, 2020: https://pubmed.ncbi.nlm.nih.gov/33929487/
  8. Portal vein thrombosis mai alaƙa da maganin ChAdOx1 nCov-19: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/
  9. Gudanar da thrombosis na jijiyoyin jini da splanchnic da ke hade da thrombocytopenia a cikin batutuwan da aka riga aka yi wa alurar riga kafi tare da Vaxzevria (AstraZeneca): bayanin matsayi na Societyungiyar Italiyanci don Nazarin Hemostasis da Thrombosis (SISET): https://pubmed.ncbi.nlm.nih.gov/33871350/
  10. Alurar rigakafin rigakafin thrombotic thrombocytopenia da thrombosis na sinus thrombosis bayan allurar rigakafi tare da COVID-19; nazari na tsari: https://www.sciencedirect.com/science/article/pii/S0022510X21003014
  11. Thrombosis tare da ciwo na thrombocytopenia mai alaƙa da rigakafin COVID-19: https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381
  12. thrombosis da thrombocytopenia da ke haifar da rigakafin alurar rigakafin Covid-19: sharhi kan wani muhimmin matsala na asibiti mai amfani: https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505
  13. Thrombosis tare da ciwo na thrombocytopenia da ke hade da COVID-19 rigakafin vector viral: https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904
  14. COVID-19 rigakafin rigakafi-jawo rigakafin thrombotic thrombocytopenia: dalilin da ya fito na thrombosis na jijiyoyin jijiya: https://www.sciencedirect.com/science/article/pii/S1665268121000557
  15. Matsayin platelets a cikin coagulopathy mai alaƙa da COVID-19 da rigakafin thrombotic na rigakafi thrombocytopenia (covid): https://www.sciencedirect.com/science/article/pii/S1050173821000967
  16. Tushen rigakafin autoimmunity na abubuwan thrombotic bayan rigakafin COVID-19: https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160
  17. Cerebral venous sinus thrombosis bayan alurar riga kafi: ƙwarewar Burtaniya: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext
  18. Thrombotic rigakafi thrombocytopenia wanda SARS-CoV-2 ya haifar da rigakafin: https://www.nejm.org/doi/full/10.1056/nejme2106315
  19. Myocarditis bayan yin rigakafi da rigakafin COVID-19 mRNA a cikin membobin sojojin Amurka. Wannan labarin ya ba da rahoton cewa a cikin "marasa lafiya maza 23, ciki har da 22 a baya ma'aikatan soja lafiya, an gano myocarditis a cikin kwanaki 4 bayan karbar maganin": https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601
  20. Thrombosis da thrombocytopenia bayan alurar riga kafi tare da ChAdOx1 nCoV-19: https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article
  21. Ƙungiyar myocarditis tare da BNT162b2 manzon RNA maganin alurar riga kafi a cikin jerin yara: https://pubmed.ncbi.nlm.nih.gov/34374740/
  22. Thrombotic thrombocytopenia bayan alurar riga kafi tare da ChAdOx1 nCov-19: https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?query=recirc_curatedRelated_article
  23. Abubuwan da aka gano bayan mutuwa a cikin thrombocytopenia da ke haifar da alurar rigakafi (covid-19): https://haematologica.org/article/view/haematol.2021.279075
  24. Thrombocytopenia, gami da thrombocytopenia na rigakafi bayan an karɓi allurar COVID-19 mRNA da aka ruwaito zuwa Tsarin Bayar da Batun Alurar rigakafin Alurar (VAERS): https://www.sciencedirect.com/science/article/pii/S0264410X21005247
  25. Myocarditis mai saurin kamuwa da cuta a cikin samari bakwai bayan Pfizer-BioNTech COVID-19 rigakafin: https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478
  26. Aphasia kwanaki bakwai bayan kashi na biyu na rigakafin mRNA na tushen SARS-CoV-2. Brain MRI ya bayyana zubar da jini na intracerebral (ICBH) a cikin lobe na hagu na hagu a cikin wani mutum mai shekaru 52. https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005
  27. Kwatanta cututtukan thrombotic da ke haifar da alurar rigakafi tsakanin ChAdOx1 nCoV-19 da Ad26.COV.2.S: https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895
  28. Hasashe a bayan lokuta masu wuya na thrombosis tare da ciwo na thrombocytopenia bayan rigakafin SARS-CoV-2: https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315
  29. Jini da zubar da jini bayan BNT162b2 da ChAdOx1 nCoV-19 rigakafin: nazarin bayanan Turai: https://www.sciencedirect.com/science/article/pii/S0896841121000937
  30. Ciwon jini na jini bayan BNT162b2 mRNA SARS-CoV-2: https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098
  31. Rashin wadatar adrenal na farko da ke da alaƙa da thrombotic na rigakafi thrombocytopenia wanda rigakafin Oxford-AstraZeneca ChAdOx1 nCoV-19 (VITT) ya haifar: https://www.sciencedirect.com/science/article/pii/S0953620521002363
  32. Myocarditis da pericarditis bayan allurar rigakafi tare da COVID-19 mRNA: shawarwari masu amfani ga masu ba da kulawa: https://www.sciencedirect.com/science/article/pii/S0828282X21006243
  33. "Portal vein thrombosis yana faruwa bayan kashi na farko na rigakafin SARS-CoV-2 mRNA a cikin mara lafiya tare da ciwon antiphospholipid": https://www.sciencedirect.com/science/article/pii/S2666572721000389
  34. Sakamakon farko na jiyya na bivalirudin don thrombotic thrombocytopenia da thrombosis sinus thrombosis na cerebral venous bayan alurar riga kafi tare da Ad26.COV2.S: https://www.sciencedirect.com/science/article/pii/S0196064421003425
  35. Myocarditis, pericarditis da cardiomyopathy bayan COVID-19 rigakafin: https://www.sciencedirect.com/science/article/pii/S1443950621011562
  36. Hanyoyi na immunothrombosis a cikin maganin alurar rigakafin thrombotic thrombocytopenia (VITT) idan aka kwatanta da kamuwa da cuta ta SARS-CoV-2 na halitta: https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706
  37. Prothrombotic rigakafi thrombocytopenia bayan COVID-19 alurar riga kafi: https://www.sciencedirect.com/science/article/pii/S0006497121009411
  38. Thrombotic thrombocytopenia da ke haifar da alurar rigakafi: babi mai duhu na labarin nasara: https://www.sciencedirect.com/science/article/pii/S2589936821000256
  39. Cerebral venous sinus thrombosis mara kyau ga anti-PF4 antibody ba tare da thrombocytopenia ba bayan allurar rigakafi tare da rigakafin COVID-19 a cikin wani tsoho ɗan Indiya wanda ba shi da haɗin gwiwa wanda aka yi wa maganin rigakafin heparin-warfarin na al'ada: https://www.sciencedirect.com/science/article/pii/S1871402121002046
  40. Thrombosis bayan rigakafin COVID-19: yuwuwar hanyar haɗi zuwa hanyoyin ACE: https://www.sciencedirect.com/science/article/pii/S0049384821004369
  41. Cerebral venous sinus thrombosis a cikin yawan jama'ar Amurka bayan rigakafin SARS-CoV-2 tare da adenovirus da kuma bayan COVID-19: https://www.sciencedirect.com/science/article/pii/S0735109721051949
  42. Wani lamari da ba kasafai ba na wani namiji dan Asiya mai matsakaicin shekaru tare da thrombosis na jijiyoyin jini bayan AstraZeneca COVID-19 rigakafin: https://www.sciencedirect.com/science/article/pii/S0735675721005714
  43. Cerebral venous sinus thrombosis da thrombocytopenia bayan COVID-19 alurar riga kafi: rahoton lokuta biyu a cikin United Kingdom: https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X
  44. Immune thrombocytopenic purpura bayan allurar rigakafin COVID-19 (ChAdOx1 nCov-19): https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963.
  45. Kwayoyin rigakafin Antiphospholipid da haɗarin thrombophilia bayan rigakafin COVID-19: bambaro da ke karya bayan raƙumi?: https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ
  46. thrombocytopenia da ke haifar da allurar rigakafi, wani lamari ne mai wuya amma mai tsananin zafi na abokantaka a cikin yaƙi da cutar ta COVID-19: Menene pathogenesis?: https://www.sciencedirect.com/science/article/pii/S0953620521002314
  47. Shawarwari-maganin warkewa na ad-hoc FACME ƙwararrun ƙungiyar ma'aikata kan kula da jijiyar jijiyoyin jijiya mai alaƙa da rigakafin COVID-19: https://www.sciencedirect.com/science/article/pii/S0213485321000839
  48. Thrombocytopenia da intracranial venous sinus thrombosis bayan bayyanar da "alurar AstraZeneca COVID-19": https://pubmed.ncbi.nlm.nih.gov/33918932/
  49. Thrombocytopenia yana bin Pfizer da Moderna SARS-CoV-2 rigakafin: https://pubmed.ncbi.nlm.nih.gov/33606296/
  50. thrombocytopenia mai tsanani kuma mai saurin kamuwa da cuta yana faruwa bayan rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33854395/
  51. Kurjin Purpuric da thrombocytopenia bayan mRNA-1273 (Na zamani) rigakafin COVID-19: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/
  52. Alurar rigakafin COVID-19: bayani kan abin da ya faru na jijiyoyi da jijiyoyin jini ta amfani da bayanai daga VigiBase: https://pubmed.ncbi.nlm.nih.gov/33863748/
  53. Ciwon jijiyoyi na cerebral da ke da alaƙa da rigakafin covid-19 a Jamus: https://onlinelibrary.wiley.com/doi/10.1002/ana.26172
  54. Ciwon jini na jini bayan BNT162b2 mRNA rigakafin BNT162b2 akan SARS-CoV-2: taron swan baki: https://pubmed.ncbi.nlm.nih.gov/34133027/
  55. Muhimmancin sanin thrombosis na jijiyoyi na cerebral bayan rigakafin rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34001390/
  56. Thrombosis tare da thrombocytopenia bayan alurar rigakafin RNA manzo -1273: https://pubmed.ncbi.nlm.nih.gov/34181446/
  57. Jinin jini da zub da jini bayan BNT162b2 da ChAdOx1 nCoV-19 rigakafin: nazarin bayanan Turai: https://pubmed.ncbi.nlm.nih.gov/34174723/
  58. Kashi na farko na ChAdOx1 da BNT162b2 COVID-19 alurar rigakafi da thrombocytopenic, thromboembolic, da abubuwan da suka faru na jini a Scotland: https://www.nature.com/articles/s41591-021-01408-4
  59. Ƙarfafawar thrombocytopenia na rigakafi bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34075578/
  60. Rahoton farko na labarin de novo iTTP mai alaƙa da maganin rigakafin COVID-19 na tushen COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34105244/
  61. PF4 immunoassays a cikin maganin alurar rigakafin thrombotic thrombocytopenia: https://www.nejm.org/doi/full/10.1056/NEJMc2106383
  62. Epitopes na antibody a cikin thrombocytopenia na rigakafi da ke haifar da rigakafin rigakafi: https://www.nature.com/articles/s41586-021-03744-4
  63. Myocarditis tare da rigakafin COVID-19 mRNA: https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135
  64. Myocarditis da pericarditis bayan rigakafin COVID-19: https://jamanetwork.com/journals/jama/fullarticle/2782900
  65. Myocarditis na ɗan lokaci yana da alaƙa da rigakafin COVID-19: https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891.
  66. Alurar rigakafin COVID-19 Haɗe da Myocarditis a cikin Matasa: https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf
  67. Myocarditis mai tsanani bayan gudanar da maganin BNT162b2 daga COVID-19: https://pubmed.ncbi.nlm.nih.gov/33994339/
  68. Ƙungiyar ɗan lokaci tsakanin rigakafin COVID-19 Ad26.COV2.S da myocarditis mai tsanani: rahoton shari'a da nazarin wallafe-wallafe: https://www.sciencedirect.com/science/article/pii/S1553838921005789
  69. Myocarditis mai haifar da rigakafin COVID-19: rahoton shari'a tare da bitar wallafe-wallafe: https://www.sciencedirect.com/science/article/pii/S1871402121002253
  70. Ƙungiya mai yuwuwa tsakanin rigakafin COVID-19 da myocarditis: binciken asibiti da CMR: https://www.sciencedirect.com/science/article/pii/S1936878X2100485X
  71. Maimaituwar myocarditis na ɗan lokaci mai alaƙa da karɓar rigakafin cutar mRNA na coronavirus 2019 (COVID-19) a cikin saurayi: https://www.sciencedirect.com/science/article/pii/S002234762100617X
  72. Cikakkun myocarditis da kumburin ƙwayar cuta na ɗan lokaci mai alaƙa da BNT162b2 COVID-19 mRNA rigakafin a cikin marasa lafiya biyu: https://www.sciencedirect.com/science/article/pii/S0167527321012286.
  73. Myocarditis mai tsanani bayan gudanar da maganin BNT162b2: https://www.sciencedirect.com/science/article/pii/S2214250921001530
  74. Lymphohistocytic myocarditis bayan alurar riga kafi tare da COVID-19 Ad26.COV2.S viral vector: https://www.sciencedirect.com/science/article/pii/S2352906721001573
  75. Myocarditis bayan allurar rigakafi tare da BNT162b2 a cikin namiji mai lafiya: https://www.sciencedirect.com/science/article/pii/S0735675721005362
  76. Myocarditis mai tsanani bayan allurar Comirnaty (Pfizer) a cikin namiji mai lafiya tare da kamuwa da cutar SARS-CoV-2 na baya: https://www.sciencedirect.com/science/article/pii/S1930043321005549
  77. Myopericarditis bayan Pfizer mRNA COVID-19 alurar riga kafi a cikin samari: https://www.sciencedirect.com/science/article/pii/S002234762100665X
  78. Pericarditis bayan gudanar da maganin BNT162b2 mRNA COVID-19 mRNA: https://www.sciencedirect.com/science/article/pii/S1885585721002218
  79. Myocarditis mai tsanani bayan alurar riga kafi tare da SARS-CoV-2 mRNA-1273 mRNA: https://www.sciencedirect.com/science/article/pii/S2589790X21001931
  80. Dangantaka na ɗan lokaci tsakanin kashi na biyu na BNT162b2 mRNA Covid-19 maganin rigakafi da shigar zuciya cikin majiyyaci tare da kamuwa da cutar SARS-COV-2 na baya: https://www.sciencedirect.com/science/article/pii/S2352906721000622
  81. Myopericarditis bayan alurar riga kafi tare da COVID-19 mRNA a cikin matasa masu shekaru 12 zuwa 18: https://www.sciencedirect.com/science/article/pii/S0022347621007368
  82. Myocarditis mai tsanani bayan rigakafin SARS-CoV-2 a cikin wani mutum mai shekaru 24: https://www.sciencedirect.com/science/article/pii/S0870255121003243
  83. Muhimmiyar bayanai akan myopericarditis bayan yin allurar rigakafi tare da Pfizer COVID-19 mRNA a cikin samari: https://www.sciencedirect.com/science/article/pii/S0022347621007496
  84. Jerin marasa lafiya tare da myocarditis bayan alurar riga kafi da SARS-CoV-2 tare da mRNA-1279 da BNT162b2: https://www.sciencedirect.com/science/article/pii/S1936878X21004861
  85. Takotsubo cardiomyopathy bayan alurar riga kafi tare da mRNA COVID-19: https://www.sciencedirect.com/science/article/pii/S1443950621011331
  86. COVID-19 rigakafin mRNA da myocarditis: https://pubmed.ncbi.nlm.nih.gov/34268277/
  87. Alurar rigakafin COVID-19 da myocarditis: https://pubmed.ncbi.nlm.nih.gov/34399967/
  88. Epidemiology da fasali na asibiti na myocarditis / pericarditis kafin gabatarwar rigakafin COVID-19 mRNA a cikin yaran Koriya: binciken da yawa https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resourc e/en/covidwho-1360706.
  89. Alurar rigakafin COVID-19 da myocarditis: https://pubmed.ncbi.nlm.nih.gov/34246566/
  90. Myocarditis da sauran rikice-rikice na zuciya na COVID-19 mRNA na tushen COVID-19 https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp lications-na-da-mrna-tushen-covid-19-alurar rigakafi https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-complications-of-the-mrna-based-covid-19-vaccines
  91. Myocarditis, pericarditis, da cardiomyopathy bayan COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34340927/
  92. Myocarditis tare da rigakafin covid-19 mRNA: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135
  93. Ƙungiyar myocarditis tare da maganin COVID-19 mRNA a cikin yara: https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-co vid-19-vaccine-in-children/
  94. Ƙungiyar myocarditis tare da COVID-19 messenger RNA rigakafin BNT162b2 a cikin jerin yara: https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052
  95. Myocarditis bayan yin rigakafi da rigakafin COVID-19 mRNA a cikin membobin sojojin Amurka: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C
  96. Myocarditis yana faruwa bayan rigakafi tare da COVID-19 na tushen COVID-19 na mRNA: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600
  97. Myocarditis bayan yin rigakafi da Covid-19 mRNA: https://www.nejm.org/doi/full/10.1056/NEJMc2109975
  98. Marasa lafiya masu fama da myocarditis bayan allurar rigakafin COVID-19 mRNA: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602
  99. Myocarditis hade da allurar rigakafi tare da COVID-19 mRNA: https://pubs.rsna.org/doi/10.1148/radiol.2021211430
  100. Alamun Cutar Myocarditis a cikin Matasa 7 bayan Pfizer-BioNTech COVID-19 Alurar rigakafin: https://pediatrics.aappublications.org/content/148/3/e2021052478
  101. Abubuwan binciken hoton maganadisu na zuciya da jijiyoyin jini a cikin matasa marasa lafiya da ke da myocarditis mai tsanani bayan COVID-19 mRNA rigakafin: jerin shari'o'i: https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4
  102. Jagorar Asibiti ga Matasa masu fama da Myocarditis da Pericarditis bayan Alurar rigakafin COVID-19 mRNA: https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis
  103. Hoton zuciya na myocarditis mai tsanani bayan alurar riga kafi tare da COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34402228/
  104. Rahoton shari'ar: m myocarditis bayan kashi na biyu na rigakafin mRNA-1273 SARS-CoV-2 mRNA: https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567
  105. Myocarditis / pericarditis hade da maganin COVID-19: https://science.gc.ca/eic/site/063.nsf/eng/h_98291.html
  106. Raunin zuciya na wucin gadi a cikin samari masu karɓar maganin BNT162b2 mRNA COVID-19: https://journals.lww.com/pidj/Abstract/9000/Transient_Cardiac_Injury_in_Adolesce nts_Receiving.95800.aspx
  107. Perimyocarditis a cikin samari bayan Pfizer-BioNTech COVID-19 rigakafin: https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543
  108. Sabuwar dandamalin rigakafin mRNA na COVID-19 da myocarditis: alamu ga yuwuwar tsarin tushen: https://pubmed.ncbi.nlm.nih.gov/34312010/
  109. Mummunan rauni na zuciya bayan allurar COVID-19: rahoton shari'a da bitar shaidar yanzu daga bayanan Tsarin Bayar da Rahoton Abubuwan Alurar rigakafin Alurar: https://pubmed.ncbi.nlm.nih.gov/34219532/
  110. Kasance faɗakarwa ga haɗarin mummunan al'amuran zuciya da jijiyoyin jini bayan rigakafin COVID-19: https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033
  111. Myocarditis mai alaƙa da rigakafin COVID-19: echocardiographic, cardiac tomography, and Magnetic resonance Hoto: https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236
  112. Ƙididdiga mai zurfi na shari'ar myocarditis da aka zaci bayan kashi na biyu na rigakafin mRNA na COVID-19: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038
  113. Faɗuwar myocarditis mai tsanani-kamar myocarditis bayan rigakafin COVID-19: kawai daidaituwar haɗari ko kuma mai alaƙa da allurar rigakafin cutar myocarditis?: https://pubmed.ncbi.nlm.nih.gov/34333695/
  114. Maimaituwar myocarditis na ɗan lokaci mai alaƙa da karɓar rigakafin cutar mRNA na coronavirus 2019 (COVID-19) a cikin saurayi: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/
  115. Myocarditis bayan rigakafin SARS-CoV-2: maganin alurar riga kafi?: https://pubmed.ncbi.nlm.nih.gov/34118375/
  116. Myocarditis mai iyakacin kai wanda ke nunawa tare da ciwon kirji da girman ST-segment a cikin samari bayan alurar riga kafi tare da maganin BNT162b2 mRNA: https://pubmed.ncbi.nlm.nih.gov/34180390/
  117. Myopericarditis a cikin wani saurayi mai koshin lafiya a baya bayan rigakafin COVID-19: Rahoton shari'a: https://pubmed.ncbi.nlm.nih.gov/34133825/
  118. Biopsy-tabbatar da lymphocytic myocarditis bayan farko COVID-19 mRNA alurar riga kafi a cikin wani mutum mai shekaru 40: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34487236/
  119. Hanyoyi daga samfurin murine na COVID-19 mRNA rigakafin myopericarditis: na iya haifar da allurar rigakafi ta cikin hanji ta bazata ta haifar da myopericarditis https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059
  120. Gabatarwar da ba a saba ba na m perimyocarditis bayan rigakafin SARS-COV-2 mRNA-1237 na zamani: https://pubmed.ncbi.nlm.nih.gov/34447639/
  121. Perimyocarditis bayan kashi na farko na mRNA-1273 SARS-CoV-2 (na zamani) rigakafin mRNA-1273 a cikin saurayi mai lafiya: rahoton shari'ar: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02183
  122. Myocarditis mai tsanani bayan kashi na biyu na rigakafin SARS-CoV-2: rashin tausayi ko alaƙa mai haɗari: https://pubmed.ncbi.nlm.nih.gov/34236331/
  123. Rhabdomyolysis da fasciitis wanda rigakafin COVID-19 mRNA ya jawo: https://pubmed.ncbi.nlm.nih.gov/34435250/
  124. Rhabdomyolysis da aka haifar da COVID-19: rahoton shari'ar tare da bitar littattafai: https://pubmed.ncbi.nlm.nih.gov/34186348/.
  125. GM1 ganglioside antibody da COVID-19 mai alaƙa da cutar Guillain Barre: rahoton shari'a, bita na tsari, da abubuwan da ke haifar da ci gaban rigakafin: https://www.sciencedirect.com/science/article/pii/S2666354621000065
  126. Ciwon Guillain-Barré bayan AstraZeneca COVID-19 alurar riga kafi: dalili ko haɗin kai: https://www.sciencedirect.com/science/article/pii/S0303846721004169
  127. Sensory Guillain-Barré ciwo bayan ChAdOx1 nCov-19 maganin alurar riga kafi: rahoton lokuta biyu da nazarin wallafe-wallafe: https://www.sciencedirect.com/science/article/pii/S0165572821002186
  128. Ciwon Guillain-Barré bayan kashi na farko na rigakafin SARS-CoV-2: abin da ya faru na ɗan lokaci, ba ƙungiyar da ke da alaƙa ba: https://www.sciencedirect.com/science/article/pii/S2214250921000998.
  129. Ciwon Guillain-Barré yana nunawa azaman diplegia na fuska bayan allurar rigakafi tare da COVID-19: rahoton shari'a: https://www.sciencedirect.com/science/article/pii/S0736467921006442
  130. Ciwon Guillain-Barré bayan allurar farko ta ChAdOx1 nCoV-19: rahoton farko: https://www.sciencedirect.com/science/article/pii/S0035378721005853.
  131. Magungunan SARS-CoV-2 ba su da aminci ga waɗanda ke da ciwo na Guillain-Barre bayan allurar: https://www.sciencedirect.com/science/article/pii/S2049080121005343
  132. Mummunan ciwon hauka mai saurin kamuwa da cutar ta biyo bayan allurar COVID-19 tare da amsa mai ban mamaki ga methylprednisolone: rahoton shari'a: https://www.sciencedirect.com/science/article/pii/S2049080121007536
  133. Ciwon jijiyar fuska biyo bayan gudanar da allurar COVID-19 mRNA: nazarin bayanan rahoton kai: https://www.sciencedirect.com/science/article/pii/S1201971221007049
  134. Alamomin jijiya da sauye-sauyen neuroimaging masu alaƙa da rigakafin COVID-19: sanadi ko daidaituwa: https://www.sciencedirect.com/science/article/pii/S0899707121003557.
  135. Sabon-farko matsayin farfadiya bayan allurar ChAdOx1 nCoV-19: https://www.sciencedirect.com/science/article/pii/S0165572821001569
  136. M myelitis mai tsanani da kuma ChAdOx1 nCoV-19 maganin alurar riga kafi: daidaituwa ko haɗin kai: https://www.sciencedirect.com/science/article/pii/S0165572821002137
  137. Bell's palsy da rigakafin SARS-CoV-2: labari mai buɗewa: https://www.sciencedirect.com/science/article/pii/S1473309921002735
  138. Cutar sankarau ta Bell bayan kashi na biyu na allurar Pfizer COVID-19 a cikin mara lafiya da ke da tarihin ciwon gurguwar Bell: https://www.sciencedirect.com/science/article/pii/S266635462100020X
  139. Babban-farko na tsakiya serous retinopathy bayan rigakafi tare da COVID-19 mRNA rigakafin:. https://www.sciencedirect.com/science/article/pii/S2451993621001456.
  140. Bell's palsy bayan COVID-19 alurar riga kafi: rahoton shari'ar: https://www.sciencedirect.com/science/article/pii/S217358082100122X.
  141. Kwarewar asibiti na ilimi yana kimanta haɗarin COVID-19 mRNA rigakafin ta amfani da tarihin rashin lafiyar mara lafiya: https://www.sciencedirect.com/science/article/pii/S2213219821007972
  142. Alurar rigakafin COVID-19 da aka haifar da axillary da pectoral lymphadenopathy a cikin PET: https://www.sciencedirect.com/science/article/pii/S1930043321002612
  143. vasculitis mai alaƙa da ANCA bayan Pfizer-BioNTech COVID-19 rigakafin: https://www.sciencedirect.com/science/article/pii/S0272638621007423
  144. Halayen ƙwayoyin cuta na ƙarshe bayan gudanar da allurar rigakafin mRNA na COVID-19: https://www.sciencedirect.com/science/article/pii/S2213219821007996
  145. Rhabdomyolysis da COVID-19 ya haifar da rigakafin: rahoton shari'a tare da bitar wallafe-wallafe: https://www.sciencedirect.com/science/article/pii/S1871402121001880
  146. Abubuwan da suka dace na asibiti da cututtukan fata na halayen fata ga rigakafin COVID-19, gami da V-REPP: binciken tushen rajista: https://www.sciencedirect.com/science/article/pii/S0190962221024427
  147. Thrombosis tare da ciwon thrombocytopenia mai alaƙa da rigakafin COVID-19:. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381.
  148. Anaphylaxis mai alaƙa da rigakafin COVID-19: sanarwa daga Kwamitin Anaphylaxis na Ƙungiyar Allergy ta Duniya:. https://www.sciencedirect.com/science/article/pii/S1939455121000119.
  149. Cerebral venous sinus thrombosis mara kyau ga anti-PF4 antibody ba tare da thrombocytopenia ba bayan rigakafi tare da maganin COVID-19 a cikin tsofaffi, namijin Indiya wanda ba ya haɗa da maganin rigakafi na heparin-warfarin na al'ada:. https://www.sciencedirect.com/science/article/pii/S1871402121002046.
  150. Myocarditis mai tsanani bayan gudanar da rigakafin BNT162b2 daga COVID-19:. https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X
  151. Jinin jini da zub da jini bayan BNT162b2 da ChAdOx1 nCoV-19 rigakafin: nazarin bayanan Turai:. https://www.sciencedirect.com/science/article/pii/S0896841121000937.
  152. rigakafin thrombocytopenia hade da Pfizer-BioNTech's COVID-19 BNT162b2 mRNA rigakafin:. https://www.sciencedirect.com/science/article/pii/S2214250921002018.
  153. Barkewar miyagun ƙwayoyi bayan kashi na biyu na rigakafin COVID-19 mRNA-1273 (Moderna): Rahoton shari'a: https://www.sciencedirect.com/science/article/pii/S1876034121001878.
  154. Magungunan tushen COVID-19 RNA da haɗarin cutar prion: https://scivisionpub.com/pdfs/covid19rna-based-vaccines-and-the-risk-of-prion-dis sauƙi-1503.pdf
  155. Wannan binciken ya lura cewa mata masu juna biyu 115 sun rasa jariransu, daga cikin 827 da suka shiga wani bincike kan amincin rigakafin cutar ta covid-19: https://www.nejm.org/doi/full/10.1056/NEJMoa2104983.
  156. Abubuwan ƙazanta masu alaƙa da tsari a cikin rigakafin ChAdOx1 nCov-19: https://www.researchsquare.com/article/rs-477964/v1
  157. Maganin COVID-19 mRNA yana haifar da kumburin CNS: jerin shari'o'i: https://link.springer.com/article/10.1007/s00415-021-10780-7
  158. Abubuwan rashin lafiyar jiki, gami da anaphylaxis, bayan sun karɓi kashi na farko na rigakafin Pfizer-BioNTech COVID-19: https://pubmed.ncbi.nlm.nih.gov/33475702/
  159. Halayen rashin lafiyan ga rigakafin COVID-19 na farko: yuwuwar rawar polyethylene glycol: https://pubmed.ncbi.nlm.nih.gov/33320974/
  160. Alurar riga kafi na Pfizer yana haifar da damuwa: https://pubmed.ncbi.nlm.nih.gov/33384356/
  161. Rashin lafiyar jiki, gami da anaphylaxis, bayan an karɓi kashi na farko na rigakafin Pfizer-BioNTech COVID-19 - Amurka, Disamba 14-23, 2020: https://pubmed.ncbi.nlm.nih.gov/33444297/
  162. Rashin lafiyar jiki, gami da anaphylaxis, bayan an karɓi kashi na farko na rigakafin COVID-19 na zamani - Amurka, Disamba 21, 2020-Janairu 10, 2021: https://pubmed.ncbi.nlm.nih.gov/33507892/
  163. Rahotanni na anaphylaxis bayan rigakafin cutar coronavirus 2019, Koriya ta Kudu, Fabrairu 26-Afrilu 30, 2021: https://pubmed.ncbi.nlm.nih.gov/34414880/
  164. Rahotanni na anaphylaxis bayan karbar maganin rigakafin COVID-19 mRNA a cikin US-Dec 14, 2020-Jan 18, 2021: https://pubmed.ncbi.nlm.nih.gov/33576785/
  165. Ayyukan rigakafi da haɗarin anaphylaxis: na yanzu, cikakken sabuntawa na bayanan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34269740/
  166. Dangantaka tsakanin rashin lafiyar da ta kasance da kuma halayen anaphylactic biyo bayan gudanar da maganin COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34215453/
  167. Anaphylaxis Haɗe da COVID-19 mRNA Alurar rigakafi: Hanyar zuwa Binciken Allergy: https://pubmed.ncbi.nlm.nih.gov/33932618/
  168. Mummunan Maganganun Allergic bayan COVID-19 Alurar riga kafi tare da Pfizer / BioNTech Vaccine a Biritaniya da Amurka: Matsayin Matsayi na Ƙungiyoyin Allergy na Jamus: Ƙungiyar Likitocin Jamus na Allergologists (AeDA), Ƙungiyar Jama'a don Allergology da Clinical Immunology (DGAKI) da Society for Pediatric Allergology da GP Allergology https://pubmed.ncbi.nlm.nih.gov/33643776/
  169. Halayen rashin lafiyan da anaphylaxis ga allurar COVID-19 na tushen LNP: https://pubmed.ncbi.nlm.nih.gov/33571463/
  170. An ba da rahoton mummunan tasirin orofacial daga allurar COVID-19: sananne da wanda ba a sani ba: https://pubmed.ncbi.nlm.nih.gov/33527524/
  171. Mummunan illar cututtukan da ake samu na rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34518015/
  172. Rahoto mai ban mamaki game da anaphylaxis biyo bayan alluran rigakafin COVID-19 mRNA (Pfizer-BioNTech) a Japan: rahoton watan farko: https://pubmed.ncbi.nlm.nih.gov/34347278/
  173. Alurar rigakafin COVID-19 suna ƙara haɗarin anaphylaxis: https://pubmed.ncbi.nlm.nih.gov/33685103/
  174. Biphasic anaphylaxis bayan fallasa zuwa kashi na farko na Pfizer-BioNTech COVID-19 mRNA maganin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34050949/
  175. Abubuwan da ke haifar da Allergenic na rigakafin mRNA-1273 don COVID-19: yuwuwar shigar da polyethylene glycol da kunnawa mai matsakaicin IgG: https://pubmed.ncbi.nlm.nih.gov/33657648/
  176. Polyethylene glycol (PEG) shine sanadin anaphylaxis ga Pfizer / BioNTech mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/33825239/
  177. Mummunan rashin lafiyan ga allurar COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/33683290/
  178. Rashin lafiyar polyethylene glycole na mai karɓar rigakafin SARS CoV2: rahoton shari'ar saurayi mai karɓa da gudanar da bayyanar da SARS-CoV2 a gaba: https://pubmed.ncbi.nlm.nih.gov/33919151/
  179. Matsakaicin ƙimar anaphylaxis bayan allurar rigakafi tare da Pfizer BNT162b2 rigakafin mRNA akan COVID-19 a cikin ma'aikatan kiwon lafiya na Japan; nazari na biyu na bayanan aminci na farko bayan amincewa: https://pubmed.ncbi.nlm.nih.gov/34128049/
  180. Halayen rashin lafiyan da kuma abubuwan da suka faru masu banƙyama masu alaƙa da gudanar da allurar tushen mRNA. Kwarewar tsarin kiwon lafiya: https://pubmed.ncbi.nlm.nih.gov/34474708/
  181. Halayen rashin lafiyan ga allurar COVID-19: bayanin Ƙungiyar Al'ummar Belgian na Allergy da Clinical Immunology (BelSACI): https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447
  182. .Alaji mai tsaka-tsaki na IgE zuwa polyethylene glycol (PEG) a matsayin sanadin anaphylaxis zuwa rigakafin mRNA na COVID-19: https://pubmed.ncbi.nlm.nih.gov/34318537/
  183. Alamun rashin lafiyar bayan COVID-19 alurar riga kafi: sanya haɗarin cikin hangen nesa: https://pubmed.ncbi.nlm.nih.gov/34463751/
  184. Halin anaphylactic zuwa rigakafin COVID-19 mRNA: kira don ƙarin karatu: https://pubmed.ncbi.nlm.nih.gov/33846043/ 188.
  185. Hadarin rashin lafiyan mai tsanani ga allurar COVID-19 tsakanin marasa lafiya da ke fama da cutar fata: shawarwari masu amfani. Bayanin matsayi na ETFAD tare da masana na waje: https://pubmed.ncbi.nlm.nih.gov/33752263/
  186. Alurar rigakafin COVID-19 da mutuwa: algorithm na haddasawa bisa ga tantance cancantar WHO: https://pubmed.ncbi.nlm.nih.gov/34073536/
  187. Zubar da jini mai saurin mutuwa bayan maganin COVID-19: https://pubmed.ncbi.nlm.nih.gov/33928772/
  188. Jerin shari'o'in halayen fata ga rigakafin COVID-19 a cikin Sashen Nazarin fata a Jami'ar Loma Linda: https://pubmed.ncbi.nlm.nih.gov/34423106/
  189. Abubuwan halayen fata sun ba da rahoton bayan Moderna da Pfizer's COVID-19 alurar riga kafi: binciken da ya danganci rajista na lokuta 414: https://pubmed.ncbi.nlm.nih.gov/33838206/
  190. Abubuwan da suka dace na asibiti da cututtukan fata na halayen fata ga rigakafin COVID-19, gami da V-REPP: binciken tushen rajista: https://pubmed.ncbi.nlm.nih.gov/34517079/
  191. Halayen fata bayan allurar rigakafin SARS-COV-2: nazarin ɓangaren ɓangaren Mutanen Espanya na ƙasa baki ɗaya na shari'o'i 405: https://pubmed.ncbi.nlm.nih.gov/34254291/
  192. Kwayar cutar Varicella zoster da kwayar cutar ta herpes simplex bayan allurar rigakafin COVID-19: bita na shari'o'i 40 a cikin rajistar cututtukan fata na duniya: https://pubmed.ncbi.nlm.nih.gov/34487581/
  193. Thrombosis na rigakafi da thrombocytopenia (VITT) masu alaƙa da maganin COVID-19: shawarwarin bincike da magani don sabon ciwo: https://pubmed.ncbi.nlm.nih.gov/33987882/
  194. Gwajin dakin gwaje-gwaje don zargin COVID-19 da ke haifar da thrombotic (na rigakafi) thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34138513/
  195. Zubar da jini na intracerebral saboda thrombosis tare da ciwo na thrombocytopenia bayan rigakafin COVID-19: shari'ar farko mai mutuwa a Koriya: https://pubmed.ncbi.nlm.nih.gov/34402235/
  196. Hadarin thrombocytopenia da thromboembolism bayan rigakafin covid-19 da ingantattun gwaje-gwajen SARS-CoV-2: nazarin jerin shari'o'in sarrafa kai: https://pubmed.ncbi.nlm.nih.gov/34446426/
  197. Alurar rigakafin thrombotic thrombocytopenia da thrombosis na sinus thrombosis na cerebral venous bayan rigakafin covid-19; nazari na tsari: https://pubmed.ncbi.nlm.nih.gov/34365148/.
  198. Abubuwan da ke faruwa na jijiyoyin jijiya da tsoka bayan alurar riga kafi tare da COVID-19: nazari na yau da kullun da meta-bincike na gwaji na asibiti: https://pubmed.ncbi.nlm.nih.gov/34452064/.
  199. Wani lamari da ba kasafai ba na thrombosis na jijiyoyi na cerebral da kuma yaduwa coagulation na cikin jini na dan lokaci hade da gudanar da maganin COVID-19: https://pubmed.ncbi.nlm.nih.gov/33917902/
  200. Rashin wadatar adrenal na farko da ke da alaƙa da thrombotic na rigakafi thrombocytopenia wanda Oxford-AstraZeneca ChAdOx1 nCoV-19 (VITT) ya haifar: https://pubmed.ncbi.nlm.nih.gov/34256983/
  201. M ƙwanƙwasa jijiyar jijiyoyin jini da bugun jini mai alaƙa da maganin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34247246/.
  202. Thromboaspiration jiko da fibrinolysis ga portomesenteric thrombosis bayan gudanar da maganin AstraZeneca COVID-19: https://pubmed.ncbi.nlm.nih.gov/34132839/
  203. Matar 'yar shekara 59 mai zurfin jini mai zurfi da thromboembolism na huhu kwanaki 7 bayan kashi na farko na Pfizer-BioNTech BNT162b2 mRNA rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34117206/
  204. Ciwon jijiyoyi na cerebral da thrombocytopenia da ke haifar da alurar riga kafi.a. Oxford-AstraZeneca COVID-19: damar da aka rasa don saurin dawowa kan gwaninta: https://pubmed.ncbi.nlm.nih.gov/34033927/
  205. Myocarditis da sauran rikice-rikice na zuciya da jijiyoyin jini na mRNA na tushen COVID-19: https://pubmed.ncbi.nlm.nih.gov/34277198/
  206. Pericarditis bayan gudanar da maganin COVID-19 mRNA BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34364831/
  207. Bayyanar da ba a saba gani ba na m pericarditis bayan allurar rigakafin SARS-COV-2 mRNA-1237 na zamani: https://pubmed.ncbi.nlm.nih.gov/34447639/
  208. Rahoton shari'ar: m myocarditis bayan kashi na biyu na SARS-CoV-2 mRNA-1273 rigakafin mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34514306/
  209. Barkewar cutar ta hanyar rigakafi ko cutar da ta fara kwanan nan a cikin batutuwa 27 bayan rigakafin mRNA/DNA akan SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33946748/
  210. Hanyoyi daga samfurin murine na myopericarditis wanda aka haifar da rigakafin COVID-19 mRNA: na iya haifar da allurar rigakafi ta cikin hanji ta bazata ta haifar da myopericarditis: https://pubmed.ncbi.nlm.nih.gov/34453510/
  211. Immune thrombocytopenia a cikin shekaru 22 na rigakafin Covid-19: https://pubmed.ncbi.nlm.nih.gov/33476455/
  212. propylthiouracil-induced neutrophil anti-cytoplasmic antibody-hade vasculitis bayan COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34451967/
  213. Thrombocytopenia na rigakafi na biyu (ITP) mai alaƙa da ChAdOx1 Covid-19 rigakafin: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34377889/
  214. Thrombosis tare da ciwon thrombocytopenia (TTS) yana bin AstraZeneca ChAdOx1 nCoV-19 (AZD1222) rigakafin COVID-19: nazarin fa'ida ga mutane <60 shekaru a Ostiraliya: https://pubmed.ncbi.nlm.nih.gov/34272095/
  215. Ƙungiyar rigakafin COVID-19 da ɓacin rai na fuska: Nazarin sarrafa shari'a: https://pubmed.ncbi.nlm.nih.gov/34165512/
  216. Ƙungiyar tsakanin allurar COVID-19 da palsy na Bell: https://pubmed.ncbi.nlm.nih.gov/34411533/
  217. Bell's palsy bayan COVID-19 alurar riga kafi: https://pubmed.ncbi.nlm.nih.gov/33611630/
  218. Acute transverse myelitis (ATM): nazarin asibiti na marasa lafiya 43 tare da ATM mai alaƙa da COVID-19 da munanan abubuwa guda 3 na ATM ɗin bayan allurar rigakafi tare da rigakafin ChAdOx1 nCoV-19 (AZD1222): https://pubmed.ncbi.nlm.nih.gov/33981305/
  219. Ciwon Bell bayan awanni 24 na rigakafin mRNA-1273 SARS-CoV-2 mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34336436/
  220. Ciwon jijiyar fuskar fuska na jere bayan allurai na farko da na biyu na rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34281950/.
  221. Transverse myelitis ta hanyar rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34458035/
  222. Ciwon jijiyar fuskar fuska bayan allurar rigakafi tare da BNT162b2 (COVID-19): https://pubmed.ncbi.nlm.nih.gov/33734623/
  223. M abducens palsy jijiyoyi bayan COVID-19 alurar riga kafi: https://pubmed.ncbi.nlm.nih.gov/34044114/.
  224. Ciwon jijiyar fuska bayan gudanar da rigakafin COVID-19 mRNA: nazarin bayanan rahoton kai: https://pubmed.ncbi.nlm.nih.gov/34492394/
  225. Paralysis na oculomotor na wucin gadi bayan gudanar da maganin alurar riga kafi na RNA-1273 don SARS-CoV-2 diplopia bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34369471/
  226. Bell's palsy bayan Ad26.COV2.S COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34014316/
  227. Bell's palsy bayan COVID-19 alurar riga kafi: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34330676/
  228. Halin m polyradiculoneuropathy na demyelinating tare da palsy na fuska biyu biyo bayan allurar ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34272622/
  229. Ciwon Guilian Barré bayan allurar rigakafi tare da mRNA-1273 akan COVID-19: https://pubmed.ncbi.nlm.nih.gov/34477091/
  230. Mummunan ciwon fuska a matsayin mai yuwuwar rikitarwa na rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33975372/.
  231. Bell's palsy bayan COVID-19 alurar riga kafi tare da babban maganin rigakafi a cikin CSF: https://pubmed.ncbi.nlm.nih.gov/34322761/.
  232. Parsonage-Turner ciwo mai alaƙa da SARS-CoV-2 ko SARS-CoV-2 rigakafin. Sharhi akan: "Amyotrophy neuralgic da kamuwa da cutar COVID-19: 2 lokuta na ciwon ƙwayar cuta na kashin baya" ta Coll et al. Articular Spine 2021; 88: 10519: https://pubmed.ncbi.nlm.nih.gov/34139321/.
  233. Bell's palsy bayan kashi ɗaya na rigakafin mRNA. SARS-CoV-2: rahoton shari'a: https://pubmed.ncbi.nlm.nih.gov/34032902/.
  234. Autoimmune hepatitis yana tasowa bayan rigakafin cutar coronavirus 2019 (COVID-19): sanadin ko wanda aka azabtar?: https://pubmed.ncbi.nlm.nih.gov/33862041/
  235. Autoimmune hepatitis ya haifar da allurar rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34332438/
  236. Mummunan ciwon hanta mai kama da ciwon hanta tare da maganin antimitochondrial na yau da kullun bayan allurar rigakafin COVID-19 mRNA: sabon mahallin asibiti: https://pubmed.ncbi.nlm.nih.gov/34293683/.
  237. Autoimmune hepatitis bayan rigakafin COVID: https://pubmed.ncbi.nlm.nih.gov/34225251/
  238. Wani sabon labari na bambance-bambancen diplegia na bifacial na ciwo na Guillain-Barré bayan alurar riga kafi tare da Janssen COVID-19: https://pubmed.ncbi.nlm.nih.gov/34449715/
  239. Kwatanta al'amuran thrombotic da ke haifar da alurar rigakafi tsakanin ChAdOx1 nCoV-19 da Ad26.COV.2.S: https://pubmed.ncbi.nlm.nih.gov/34139631/.
  240. Mafi kyawun thrombophthalmic vein thrombosis, bugun jini na ischemic da thrombocytopenia na rigakafi bayan alurar riga kafi tare da ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/33864750/
  241. Ganewa da kuma kula da thrombosis na sinus na cerebral venous tare da maganin rigakafi-jawowar rigakafin thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/33914590/
  242. Ciwon thrombosis na sinus bayan allurar rigakafi tare da ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34420802/
  243. Cerebral venous sinus thrombosis biyo bayan allurar rigakafin SARS-CoV-2: nazarin lamuran da aka ruwaito ga Hukumar Kula da Magunguna ta Turai: https://pubmed.ncbi.nlm.nih.gov/34293217/
  244. Hadarin thrombocytopenia da thromboembolism bayan rigakafin covid-19 da ingantattun gwaje-gwajen SARS-CoV-2: nazarin jerin shari'o'in sarrafa kai: https://pubmed.ncbi.nlm.nih.gov/34446426/
  245. Jinin jini da zub da jini bayan BNT162b2 da ChAdOx1 nCoV-19 rigakafin: nazarin bayanan Turai: https://pubmed.ncbi.nlm.nih.gov/34174723/
  246. Abubuwan da suka faru na jijiya, thromboembolism mai jijiya, thrombocytopenia da zub da jini bayan alurar riga kafi tare da Oxford-AstraZeneca ChAdOx1-S a Denmark da Norway: Nazarin ƙungiyar jama'a: https://pubmed.ncbi.nlm.nih.gov/33952445/
  247. Kashi na farko na ChAdOx1 da BNT162b2 COVID-19 alurar rigakafi da thrombocytopenic, thromboembolic da abubuwan da suka faru na jini a Scotland: https://pubmed.ncbi.nlm.nih.gov/34108714/
  248. Cutar sankarau mai alaƙa da maganin COVID-19 a Jamus: https://pubmed.ncbi.nlm.nih.gov/34288044/
  249. Mugun rauni na cerebral bayan alurar riga kafi tare da ChAdOx1 nCov-19: bambance-bambancen bala'i na thrombocytopenia na rigakafi da ke haifar da rigakafin rigakafi: https://pubmed.ncbi.nlm.nih.gov/34341358/
  250. Celiac artery da splenic artery thrombosis mai rikitarwa ta hanyar infarction na splenic kwanaki 7 bayan kashi na farko na rigakafin Oxford, alaƙar dalili ko daidaituwa: https://pubmed.ncbi.nlm.nih.gov/34261633/.
  251. Rashin wadatar adrenal na farko da ke da alaƙa da Oxford-AstraZeneca ChAdOx1 nCoV-19 (VITT) allurar rigakafin thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34256983/
  252. Thrombocytopenia bayan COVID-19 alurar riga kafi: https://pubmed.ncbi.nlm.nih.gov/34332437/.
  253. Cerebral venous sinus thrombosis hade da thrombocytopenia bayan COVID-19 alurar riga kafi: https://pubmed.ncbi.nlm.nih.gov/33845870/.
  254. Thrombosis tare da ciwon thrombocytopenia bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34236343/
  255. Myocardial infarction a cikin sa'o'i 24 bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34364657/.
  256. Babban macular neuroretinopathy na biyu bayan rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34287612/
  257. thrombosis na sinus na tsakiya tare da zubar jini na subarachnoid bayan rigakafin COVID-19 mRNA: waɗannan rahotannin sun zo daidai ne kawai: https://pubmed.ncbi.nlm.nih.gov/34478433/
  258. Zubar da jini na intracerebral saboda thrombosis tare da ciwo na thrombocytopenia bayan rigakafin COVID-19: shari'ar farko mai mutuwa a Koriya: https://pubmed.ncbi.nlm.nih.gov/34402235/
  259. Cerebral venous sinus thrombosis mara kyau ga anti-PF4 antibody ba tare da thrombocytopenia ba bayan allurar rigakafi tare da rigakafin COVID-19 a cikin wani tsoho ɗan Indiya wanda ba shi da lafiya wanda aka yi wa maganin rigakafin heparin-warfarin na al'ada: https://pubmed.ncbi.nlm.nih.gov/34186376/
  260. Ciwon thrombosis na sinus na cerebral makonni 2 bayan kashi na farko na rigakafin SARS-CoV-2 mRNA: https://pubmed.ncbi.nlm.nih.gov/34101024/
  261. Shari'ar thrombocytopenia da yawa da thrombosis bayan allurar rigakafi tare da ChAdOx1 nCoV-19 akan SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34137813/
  262. thrombocytopenia da ke haifar da alurar riga kafi: hanyar da ba ta dace ba tsakanin thrombosis da allurar rigakafin SARS-CoV-2 na tushen adenovirus: https://pubmed.ncbi.nlm.nih.gov/34191218/
  263. Babban bugun jini na ischemic yana bayyana thrombocytopenia na rigakafi na rigakafi wanda ChAdOx1 nCov-19 ke haifar da rigakafin: tasiri akan dabarun sake farfadowa: https://pubmed.ncbi.nlm.nih.gov/34175640/
  264. Sabon-farko matsayin farfadiya bayan allurar ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34153802/
  265. Thrombosis tare da ciwo na thrombocytopenia da ke hade da COVID-19 rigakafin vector viral: https://pubmed.ncbi.nlm.nih.gov/34092488/
  266. Cutar kumburin huhu, harin ischemic na wucin gadi, da thrombocytopenia bayan rigakafin Johnson & Johnson COVID-19: https://pubmed.ncbi.nlm.nih.gov/34261635/
  267. Thromboaspiration jiko da fibrinolysis ga portomesenteric thrombosis bayan gudanar da maganin AstraZeneca COVID-19: https://pubmed.ncbi.nlm.nih.gov/34132839/.
  268. Ciwon HIT na kwatsam: maye gurbin gwiwa, kamuwa da cuta, da daidaitawa tare da thrombocytopenia na rigakafi da ke haifar da rigakafi: https://pubmed.ncbi.nlm.nih.gov/34144250/
  269. Zurfafa thrombosis (DVT) yana faruwa jim kaɗan bayan kashi na biyu na rigakafin SARS-CoV-2 mRNA: https://pubmed.ncbi.nlm.nih.gov/33687691/
  270. Procoagulant antibody mediated platelets a cikin rigakafin thrombotic thrombocytopenia hade da rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34011137/.
  271. Alurar rigakafin thrombocytopenia na rigakafi wanda ke haifar da mummunan nau'in thrombosis na jijiyoyin jini tare da yawan mace-mace: jerin shari'o'in: https://pubmed.ncbi.nlm.nih.gov/34393988/.
  272. Procoagulant microparticles: yuwuwar hanyar haɗi tsakanin allurar rigakafin rigakafin thrombocytopenia (VITT) da ƙwayar cuta ta sinus venous: https://pubmed.ncbi.nlm.nih.gov/34129181/.
  273. Atypical thrombosis hade da maganin alurar riga kafi VaxZevria® (AstraZeneca): bayanai daga cibiyar sadarwa ta Faransa na cibiyoyin magunguna na yanki: https://pubmed.ncbi.nlm.nih.gov/34083026/.
  274. M ƙwanƙwasa jijiyar jijiyoyin jini da bugun jini mai alaƙa da maganin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34247246/.
  275. Thrombosis da thrombocytopenia da ke haifar da allurar rigakafi tare da zubar jini na adrenal biyu: https://pubmed.ncbi.nlm.nih.gov/34235757/.
  276. Palmar digital vein thrombosis bayan Oxford-AstraZeneca COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34473841/.
  277. Cutaneous thrombosis hade da cutaneous necrosis bin Oxford-AstraZeneca COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34189756/
  278. Cerebral venous thrombosis biyo bayan allurar COVID-19: https://pubmed.ncbi.nlm.nih.gov/34045111/.
  279. Lipschütz ulcers bayan AstraZeneca COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34366434/.
  280. Amyotrophic Neuralgia na biyu zuwa rigakafin Vaxzevri (AstraZeneca) COVID-19: https://pubmed.ncbi.nlm.nih.gov/34330677/
  281. Thrombosis tare da thrombocytopenia bayan rigakafin Messenger RNA-1273: https://pubmed.ncbi.nlm.nih.gov/34181446/
  282. Jinin jini na intracerebral kwana goma sha biyu bayan alurar riga kafi tare da ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34477089/
  283. Thrombotic thrombocytopenia bayan alurar riga kafi tare da COVID-19: don neman hanyar da ke ƙasa: https://pubmed.ncbi.nlm.nih.gov/34071883/
  284. Coronavirus (COVID-19) Alurar rigakafin thrombotic thrombocytopenia (VITT): https://pubmed.ncbi.nlm.nih.gov/34033367/
  285. Kwatanta mummunan halayen ƙwayoyi a tsakanin alluran rigakafin COVID-19 guda huɗu a Turai ta amfani da bayanan EudraVigilance: Thrombosis a cikin wuraren da ba a saba gani ba: https://pubmed.ncbi.nlm.nih.gov/34375510/
  286. Immunoglobulin adjuvant don rigakafin rigakafin thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34107198/
  287. Mummunan alurar riga kafi da aka haifar da thrombocytopenia thrombocytopenia biyo bayan allurar rigakafi tare da COVID-19: rahoton shari'ar autopsy da bita na wallafe-wallafe: https://pubmed.ncbi.nlm.nih.gov/34355379/.
  288. Wani lamari na m huhu embolism bayan rigakafi tare da SARS-CoV-2 mRNA: https://pubmed.ncbi.nlm.nih.gov/34452028/
  289. La'akari da neurosurgical game da decompressive craniectomy don intracerebral hemorrhage bayan SARS-CoV-2 alurar riga kafi a cikin thrombocytopenia-VITT alurar riga kafi: https://pubmed.ncbi.nlm.nih.gov/34202817/
  290. Thrombosis da SARS-CoV-2 rigakafi: rigakafin rigakafin thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34237213/.
  291. An samu thrombotic thrombocytopenic thrombocytopenic purpura: cuta mai saurin kamuwa da alurar rigakafin BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34105247/.
  292. Kamfanonin rigakafi, rigakafi na asali da NETosis a cikin ChAdOx1 da ke haifar da thrombocytopenia alurar rigakafi: https://pubmed.ncbi.nlm.nih.gov/34405870/.
  293. Sensory Guillain-Barré ciwo yana biye da maganin ChAdOx1 nCov-19: rahoton lokuta biyu da nazarin wallafe-wallafe: https://pubmed.ncbi.nlm.nih.gov/34416410/.
  294. Vogt-Koyanagi-Harada ciwo bayan COVID-19 da ChAdOx1 nCoV-19 (AZD1222) rigakafin: https://pubmed.ncbi.nlm.nih.gov/34462013/.
  295. Sake kunna cutar Vogt-Koyanagi-Harada karkashin kulawa fiye da shekaru 6, bayan rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34224024/.
  296. Bayan-alurar rigakafi encephalitis bayan ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34324214/
  297. Alamomin jijiya da sauye-sauyen neuroimaging masu alaƙa da rigakafin COVID-19: sanadi ko daidaituwa?: https://pubmed.ncbi.nlm.nih.gov/34507266/
  298. Mutuwar ƙwayar cuta ta jini bayan SARS-COV-2 a cikin mara lafiya tare da myeloma da yawa: https://pubmed.ncbi.nlm.nih.gov/34459725/
  299. Polyarthralgia da ciwo na myalgia bayan alurar riga kafi tare da ChAdOx1 nCOV-19: https://pubmed.ncbi.nlm.nih.gov/34463066/
  300. Laifukan uku na subacute thyroiditis bayan rigakafin SARS-CoV-2: cututtukan ASIA bayan allurar rigakafi: https://pubmed.ncbi.nlm.nih.gov/34043800/.
  301. Diplegia na fuska: bambance-bambancen da ba a saba gani ba na cutar Guillain-Barré da maganin Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34447646/
  302. Ƙungiya tsakanin allurar ChAdOx1 nCoV-19 da yanayin zubar jini: babban binciken ƙungiyar jama'a: https://pubmed.ncbi.nlm.nih.gov/34479760/.
  303. myocarditis mai cike da kumburi da kumburin tsarin jiki na ɗan lokaci mai alaƙa da BNT162b2 COVID-19 mRNA rigakafin a cikin marasa lafiya biyu: https://pubmed.ncbi.nlm.nih.gov/34416319/.
  304. Mummunan illa da aka bayar da rahoton bayan rigakafin COVID-19 a cikin wani babban asibitin kulawa, wanda ya ta'allaka kan thrombosis sinus thrombosis (CVST): https://pubmed.ncbi.nlm.nih.gov/34092166/
  305. Ƙaddamarwa da haɓakar lupus erythematosus erythematosus na ƙananan cuta bayan rigakafin mRNA- ko adenoviral vector na tushen SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34291477/
  306. Petechiae da bawon yatsu bayan rigakafi tare da BTN162b2 messenger RNA (mRNA) rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34513435/
  307. Kwayar cutar Hepatitis C ta sake kunnawa bayan rigakafin COVID-19: rahoton shari'a: https://pubmed.ncbi.nlm.nih.gov/34512037/
  308. Keratolysis na rigakafi mai tsaka-tsaki bayan yin rigakafi tare da SARS-CoV-2 recombinant vector vector: https://pubmed.ncbi.nlm.nih.gov/34483273/.
  309. thrombocytopenic purpura na rigakafin rigakafi bayan Pfizer-BioNTech COVID-19 a cikin wata tsohuwa: https://pubmed.ncbi.nlm.nih.gov/34513446/
  310. Kunna platelet da daidaitawa a cikin thrombosis tare da ciwo na thrombocytopenia mai alaƙa da maganin ChAdO × 1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34474550/
  311. Arthritis mai amsawa bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34033732/.
  312. Laifukan guda biyu na cutar Graves bayan rigakafin SARS-CoV-2: ciwo na autoimmune / kumburi wanda adjuvants ya jawo: https://pubmed.ncbi.nlm.nih.gov/33858208/
  313. Mummunan koma baya da raunin rigakafi bayan rigakafin COVID-19 a cikin majiyyaci mai sclerosis da yawa da aka yi wa rituximab: https://pubmed.ncbi.nlm.nih.gov/34015240/
  314. Yaɗuwar ƙayyadaddun ƙayyadaddun ƙwayar ƙwayar cuta bayan allurar rigakafi tare da ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34482558/
  315. Maganin COVID-19 mRNA yana haifar da kumburin CNS: jerin shari'o'i: https://pubmed.ncbi.nlm.nih.gov/34480607/
  316. Thymic hyperplasia bayan Covid-19 na tushen rigakafin mRNA tare da Covid-19: https://pubmed.ncbi.nlm.nih.gov/34462647/
  317. Cutar sankarau mai saurin yaduwa bayan allurar rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34325334/
  318. Tolosa-Hunt ciwo yana faruwa bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34513398/
  319. Ciwon ƙwayar cuta ta tsarin capillary extravasation bayan allurar rigakafi tare da ChAdOx1 nCOV-19 (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34362727/
  320. Thrombocytopenia mai tsaka-tsaki na rigakafi da ke hade da maganin Ad26.COV2.S (Janssen; Johnson & Johnson): https://pubmed.ncbi.nlm.nih.gov/34469919/.
  321. Thrombocytopenia na wucin gadi tare da glycoprotein-takamaiman platelet autoantibodies bayan alurar riga kafi tare da Ad26.COV2.S: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34516272/.
  322. Mummunan ciwon hauka mai saurin kamuwa da cutar ta biyo bayan allurar COVID-19 tare da amsa mai ban mamaki ga methylprednisolone: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34512961/
  323. Raunin zuciya na wucin gadi a cikin samari masu karɓar maganin BNT162b2 mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34077949/
  324. Autoimmune hepatitis yana tasowa bayan maganin ChAdOx1 nCoV-19 (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34171435/
  325. Mummunan koma baya na sclerosis da yawa bayan rigakafin COVID-19: rahoton shari'a: https://pubmed.ncbi.nlm.nih.gov/34447349/
  326. Lymphohistocytic myocarditis bayan alurar riga kafi tare da COVID-19 viral vector Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34514078/
  327. Hemophagocytic lymphohistocytosis bayan alurar riga kafi tare da ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34406660/.
  328. IgA vasculitis a cikin manya mara lafiya bayan alurar riga kafi tare da ChadOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34509658/
  329. Shari'ar leukocytoclastic vasculitis bayan alurar riga kafi tare da rigakafin SARS-CoV2: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34196469/.
  330. Faruwa / fashewar psoriasis bayan cutar Corona Virus ChAdOx1 nCoV-19 (Oxford-AstraZeneca / Covichield): rahoton lokuta biyu: https://pubmed.ncbi.nlm.nih.gov/34350668/
  331. Cutar Hailey-Hailey ta tsananta bayan rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34436620/
  332. Supraclavicular lymphadenopathy bayan COVID-19 alurar riga kafi a Koriya: jeri-bi-bi-bi-biyu ta ultrasonography: https://pubmed.ncbi.nlm.nih.gov/34116295/.
  333. Alurar rigakafin COVID-19, thrombocytopenia na rigakafi na rigakafi, jaundice, hyperviscosity: damuwa a lokuta tare da matsalolin hanta: https://pubmed.ncbi.nlm.nih.gov/34509271/.
  334. Rahoton na Kasa da Kasa na Kasa da Kasa da Kasa da Kasa na Kasa da Kasa da Kasa. https://pubmed.ncbi.nlm.nih.gov/34462996/
  335. Immune thrombocytopenia bayan alurar riga kafi yayin cutar ta COVID-19: https://pubmed.ncbi.nlm.nih.gov/34435486/
  336. COVID-19: ya kamata a yi la'akari da darussa daga bala'in Yaren mutanen Norway a cikin shirin ƙaddamar da rigakafin a cikin ƙasashe masu tasowa / masu tasowa: https://pubmed.ncbi.nlm.nih.gov/34435142/
  337. Rituximab wanda ya haifar da m lympholysis da pancytopenia bayan allurar rigakafi tare da COVID-19: https://pubmed.ncbi.nlm.nih.gov/34429981/
  338. Excerbation na plaque psoriasis bayan COVID-19 inactivate mRNA da BNT162b2 alluran rigakafi: rahoton lokuta biyu: https://pubmed.ncbi.nlm.nih.gov/34427024/
  339. Cutar cututtukan huhun da ke haifar da alurar riga kafi: wani abin da ba kasafai ake samu ba ga rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34510014/.
  340. Halayen cututtukan fata na Vesiculobullous da aka jawo ta hanyar rigakafin COVID-19 mRNA: rahoton shari'o'i huɗu da bitar wallafe-wallafe: https://pubmed.ncbi.nlm.nih.gov/34236711/
  341. Thrombocytopenia da ke haifar da rigakafi tare da ciwon kai mai tsanani: https://pubmed.ncbi.nlm.nih.gov/34525282/
  342. Mugun perimyocarditis bayan kashi na farko na maganin COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34515024/
  343. Rhabdomyolysis da fasciitis wanda COVID-19 mRNA ke haifar da shi: https://pubmed.ncbi.nlm.nih.gov/34435250/.
  344. Mummunan illar cututtukan fata na COVID-19: jerin shari'o'i da bita na wallafe-wallafe: https://pubmed.ncbi.nlm.nih.gov/34363637/
  345. Immune thrombocytopenia hade da Pfizer-BioNTech COVID-19 mRNA alurar riga kafi BNT162b2: https://www.sciencedirect.com/science/article/pii/S2214250921002018
  346. Thrombocytopenia na rigakafi na biyu wanda ake iya danganta shi ga rigakafin COVID-19: https://casereports.bmj.com/content/14/5/e242220.abstract.
  347. Immune thrombocytopenia bin Pfizer-BioNTech BNT162b2 mRNA COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34155844/
  348. Sabbin bincike na idiopathic thrombocytopenia bayan gudanar da maganin rigakafin COVID-19: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/.
  349. Idiopathic thrombocytopenic purpura da rigakafin zamani na Covid-19: https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext.
  350. Thrombocytopenia bayan Pfizer da Moderna rigakafin SARS - CoV-2: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/.
  351. Immune thrombocytopenic purpura da mummunan rauni na hanta bayan rigakafin COVID-19: https://casereports.bmj.com/content/14/7/e242678.
  352. Tarin madaidaicin-matsakaici da yanayin cututtukan cututtukan jini na autoimmune bayan rigakafin SARS-CoV-2: https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic
  353. Petechial rash da ke hade da rigakafin CoronaVac: rahoton farko na illar cututtukan fata kafin sakamako na 3: https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794
  354. Magungunan COVID-19 suna haifar da hemolysis mai tsanani a cikin haemoglobinuria na nocturnal paroxysmal: https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in
  355. Cutar sankarau mai alaƙa da maganin COVID-19 a Jamus: https://pubmed.ncbi.nlm.nih.gov/34288044/.
  356. Cerebral venous sinus thrombosis bayan COVID-19 alurar riga kafi: Neurological da radiological management: https://pubmed.ncbi.nlm.nih.gov/34327553/.
  357. Tashin jini na jijiyoyin jini da thrombocytopenia bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/33878469/.
  358. Cerebral venous sinus thrombosis da thrombocytopenia bayan COVID-19 alurar riga kafi: rahoton lokuta biyu a cikin United Kingdom: https://pubmed.ncbi.nlm.nih.gov/33857630/.
  359. Cutar sankarau ta cerebral thrombosis ta hanyar rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34090750/.
  360. Carotid artery rigakafi thrombosis haifar da adenovirus-vectored COVID-19 rigakafin: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34312301/.
  361. Cerebral venous sinus thrombosis hade da maganin alurar rigakafin thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34333995/
  362. Matsayin platelets a cikin coagulopathy mai alaƙa da COVID-19 da thrombocytopenia na rigakafi da ke haifar da rigakafi: https://pubmed.ncbi.nlm.nih.gov/34455073/
  363. Ciwon jini na jini bayan maganin BNT162b2 mRNA SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34111775/.
  364. Cerebral venous thrombosis bayan COVID-19 alurar riga kafi: https://pubmed.ncbi.nlm.nih.gov/34045111/
  365. Mutuwar ƙwayar cuta ta sinus thrombosis bayan COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/33983464/
  366. Cerebral venous sinus thrombosis a cikin yawan jama'ar Amurka, Bayan rigakafin SARS-CoV-2 tare da adenovirus da bayan COVID-19: https://pubmed.ncbi.nlm.nih.gov/34116145/
  367. Ciwon jini na jini bayan COVID-19 alurar riga kafi: shine haɗarin thrombosis ya karu ta hanyar gudanar da maganin alurar riga kafi: https://pubmed.ncbi.nlm.nih.gov/34286453/.
  368. Thrombosis na sinus na tsakiya tare da zubar jini na subarachnoid bayan rigakafin COVID-19 mRNA: waɗannan rahotannin sun yi karo da juna kawai: https://pubmed.ncbi.nlm.nih.gov/34478433/
  369. Cerebral venous sinus thrombosis bayan ChAdOx1 nCov-19 alurar riga kafi tare da ɓarna na farko na kwakwalwa MRI: https://pubmed.ncbi.nlm.nih.gov/34244448/
  370. Sakamakon farko na jiyya na bivalirudin don thrombotic thrombocytopenia da thrombosis sinus thrombosis na cerebral venous bayan alurar riga kafi tare da Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34226070/
  371. Cerebral venous sinus thrombosis hade da thrombocytopenia bayan allurar rigakafin ta COVID-19: https://pubmed.ncbi.nlm.nih.gov/33845870/.
  372. Ciwon thrombosis na sinus na cerebral makonni 2 bayan kashi na farko na rigakafin SARS-CoV-2 mRNA: https://pubmed.ncbi.nlm.nih.gov/34101024/.
  373. Alurar rigakafin thrombocytopenia na rigakafi wanda ke haifar da mummunan nau'in thrombosis na jijiyoyin jini tare da yawan mace-mace: jerin shari'o'in: https://pubmed.ncbi.nlm.nih.gov/34393988/.
  374. Adenovirus hulɗa tare da platelets da coagulation da maganin alurar rigakafi da ke da alaƙa da ciwon thrombocytopenia thrombosis: https://pubmed.ncbi.nlm.nih.gov/34407607/.
  375. Ciwon kai wanda aka danganta ga COVID-19 (SARS-CoV-2 coronavirus) rigakafin cutar tare da rigakafin ChAdOx1 nCoV-19 (AZD1222): nazarin ƙungiyoyin sa ido da yawa: https://pubmed.ncbi.nlm.nih.gov/34313952/
  376. Mummunan illa da aka bayar da rahoton bayan rigakafin COVID-19 a cikin babban asibitin kulawa, mai da hankali kan thrombosis na sinus venous (CVST): https://pubmed.ncbi.nlm.nih.gov/34092166/
  377. Cerebral venous sinus thrombosis biyo bayan allurar rigakafin SARS-CoV-2: nazarin lamuran da aka ruwaito ga Hukumar Kula da Magunguna ta Turai: https://pubmed.ncbi.nlm.nih.gov/34293217/
  378. Wani lamari da ba kasafai ba na wani namiji dan Asiya mai matsakaicin shekaru tare da thrombosis na jijiyoyin jini bayan COVID-19 AstraZeneca rigakafin: https://pubmed.ncbi.nlm.nih.gov/34274191/
  379. Cerebral venous sinus thrombosis mara kyau ga anti-PF4 antibody ba tare da thrombocytopenia ba bayan allurar rigakafi tare da rigakafin COVID-19 a cikin wani tsoho ɗan Indiya wanda ba shi da lafiya wanda aka yi wa maganin rigakafin heparin-warfarin na al'ada: https://pubmed.ncbi.nlm.nih.gov/34186376/
  380. Abubuwan da suka faru na jijiya, thromboembolism mai jijiya, thrombocytopenia da zub da jini bayan alurar riga kafi tare da Oxford-AstraZeneca ChAdOx1-S a Denmark da Norway: Nazarin ƙungiyar jama'a: https://pubmed.ncbi.nlm.nih.gov/33952445/
  381. Procoagulant microparticles: yuwuwar hanyar haɗi tsakanin allurar rigakafin rigakafin thrombocytopenia (VITT) da ƙwayar cuta ta sinus venous: https://pubmed.ncbi.nlm.nih.gov/34129181/
  382. Rahoton shari'ar S. na thrombosis na sinus na cerebral venous tare da thrombocytopenia bayan alurar riga kafi tare da Ad26.COV2.S, Maris 2-Afrilu 21, 2021: https://pubmed.ncbi.nlm.nih.gov/33929487/.
  383. Mugun rauni na cerebral bayan alurar riga kafi tare da ChAdOx1 nCov-19: bambance-bambancen bala'i na thrombocytopenia na rigakafi da ke haifar da rigakafin rigakafi: https://pubmed.ncbi.nlm.nih.gov/34341358/
  384. Babban bugun jini na ischemic yana bayyana thrombocytopenia na rigakafi na rigakafi wanda ChAdOx1 nCov-19 ke haifar da rigakafin: tasiri akan dabarun sake farfadowa: https://pubmed.ncbi.nlm.nih.gov/34175640/
  385. Alurar rigakafin thrombotic na rigakafi na thrombocytopenia (VITT): sabon mahallin asibiti tare da gabatarwar asibiti iri-iri: https://pubmed.ncbi.nlm.nih.gov/34159588/.
  386. Hoto da binciken hematologic a cikin thrombosis da thrombocytopenia bayan alurar riga kafi tare da ChAdOx1 nCoV-19 (AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34402666/
  387. Tushen autoimmunity na abubuwan thrombotic bayan alurar riga kafi tare da COVID-19: https://pubmed.ncbi.nlm.nih.gov/34508917/
  388. Cerebral venous sinus thrombosis bayan alurar riga kafi: ƙwarewar Burtaniya: https://pubmed.ncbi.nlm.nih.gov/34370974/
  389. Babban ƙwanƙwasa jijiyar jijiyoyin jini da ƙwanƙwasa jijiyar jijiya a matsayin ƙarshen rikitarwa na COVID-19: rahoton shari'a: https://pubmed.ncbi.nlm.nih.gov/34373991/
  390. Ostiraliya da New Zealand tsarin kula da ganewar asali da kuma kula da maganin rigakafi da aka haifar da thrombosis na rigakafi da thrombocytopenia na rigakafi: https://pubmed.ncbi.nlm.nih.gov/34490632/
  391. Nazarin lura don gano yawan thrombocytopenia da anti-PF4 / polyanion antibodies a cikin ma'aikatan kiwon lafiya na Norwegian bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/33909350/
  392. Acute transverse myelitis (ATM): nazarin asibiti na marasa lafiya 43 tare da ATM mai alaƙa da COVID-19 da munanan abubuwan da suka faru na ATM na bayan allurar rigakafin ChAdOx3 nCoV-1 (AZD19): https://pubmed.ncbi.nlm.nih.gov/33981305/.
  393. Halin m polyradiculoneuropathy na demyelinating tare da palsy na fuska biyu bayan ChAdOx1 nCoV-19 rigakafin:. https://pubmed.ncbi.nlm.nih.gov/34272622/
  394. Thrombocytopenia tare da matsanancin bugun jini na ischemic da zubar jini a cikin mara lafiya kwanan nan an yi masa allurar rigakafin cutar ta COVID-19 ta adenoviral vector:. https://pubmed.ncbi.nlm.nih.gov/33877737/
  395. Hasashen da aka lura da faruwar al'amuran thromboembolic tsakanin Koreans da aka yi wa alurar rigakafin ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34254476/
  396. Kashi na farko na ChAdOx1 da BNT162b2 COVID-19 alurar rigakafi da thrombocytopenic, thromboembolic, da abubuwan da suka faru na jini a Scotland: https://pubmed.ncbi.nlm.nih.gov/34108714/
  397. ChAdOx1 nCoV-19 mai alaƙa da thrombocytopenia: lokuta uku na thrombocytopenia na rigakafi bayan allurai 107,720 na allurar ChAdOx1 a Thailand: https://pubmed.ncbi.nlm.nih.gov/34483267/.
  398. Cutar kumburin huhu, harin ischemic na wucin gadi, da thrombocytopenia bayan rigakafin Johnson & Johnson COVID-19: https://pubmed.ncbi.nlm.nih.gov/34261635/
  399. La'akari da neurosurgical game da decompressive craniectomy don intracerebral hemorrhage bayan SARS-CoV-2 allurar rigakafin thrombotic thrombocytopenia-VITT: https://pubmed.ncbi.nlm.nih.gov/34202817/
  400. Babban bugun jini na jini bayan allurar rigakafin ChAdOx1 nCoV-19: rahoton shari'a: https://pubmed.ncbi.nlm.nih.gov/34273119/
  401. Polyarthralgia da ciwo na myalgia bayan alurar riga kafi tare da ChAdOx1 nCOV-19: https://pubmed.ncbi.nlm.nih.gov/34463066/
  402. Wani lamari da ba kasafai ba na thrombosis da thrombocytopenia na babban ophthalmic jijiya bayan ChAdOx1 nCoV-19 allurar rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34276917/
  403. Thrombosis da matsanancin ciwo na numfashi na Coronavirus 2 alluran rigakafi: rigakafin rigakafin thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34237213/.
  404. thrombocytopenia na rigakafi na thrombotic (VITT): https://pubmed.ncbi.nlm.nih.gov/34268278/.
  405. Limb ischemia da thrombosis na huhu na huhu bayan maganin ChAdOx1 nCoV-19 (Oxford-AstraZeneca): shari'ar thrombocytopenia na rigakafi da aka haifar da rigakafi: https://pubmed.ncbi.nlm.nih.gov/33990339/.
  406. Ƙungiya tsakanin allurar ChAdOx1 nCoV-19 da yanayin zubar jini: babban binciken ƙungiyar jama'a: https://pubmed.ncbi.nlm.nih.gov/34479760/.
  407. Thrombocytopenia na biyu bayan rigakafin SARS-CoV-2: rahoton shari'ar jini da hematoma bayan ƙaramin tiyata na baka: https://pubmed.ncbi.nlm.nih.gov/34314875/.
  408. Thromboembolism na jini da ƙananan thrombocytopenia bayan alurar riga kafi tare da ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34384129/
  409. Mummunan tashin hankali na ChadOx1-nCoV-19-induced thrombotic thrombocytopenia ciwo bayan nasarar farkawa ta farko tare da immunoglobulins na ciki: dalili don saka idanu matakan immunoglobulin G: https://pubmed.ncbi.nlm.nih.gov/34382387/
  410. Shari'ar vasculitis mai alaƙa da ANCA bayan AZD1222 (Oxford-AstraZeneca) rigakafin SARS-CoV-2: wanda aka azabtar ko kuma sanadin?: https://pubmed.ncbi.nlm.nih.gov/34416184/.
  411. Zubar da jini na intracerebral hade da maganin alurar rigakafin thrombotic thrombocytopenia bayan ChAdOx1 nCOVID-19 a cikin mace mai ciki: https://pubmed.ncbi.nlm.nih.gov/34261297/
  412. Babban thrombocytopenia na thrombotic na rigakafi da ke haifar da rigakafin rigakafi: https://pubmed.ncbi.nlm.nih.gov/34261296/
  413. Ciwon Nephrotic bayan ChAdOx1 nCoV-19 rigakafin SARScoV-2: https://pubmed.ncbi.nlm.nih.gov/34250318/.
  414. Halin da ke haifar da rigakafin rigakafi da rigakafin thrombotic thrombocytopenia tare da babban thrombosis na arteriovenous: https://pubmed.ncbi.nlm.nih.gov/34059191/
  415. Cutaneous thrombosis hade da cutaneous necrosis bin Oxford-AstraZeneca COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34189756/
  416. Thrombocytopenia a cikin matashi mai ciwon sikila anemia bayan COVID-19 alurar riga kafi: https://pubmed.ncbi.nlm.nih.gov/34331506/
  417. Thrombocytopenia da ke haifar da rigakafi tare da ciwon kai mai tsanani: https://pubmed.ncbi.nlm.nih.gov/34525282/
  418. Myocarditis da ke da alaƙa da rigakafin SARS-CoV-2 mRNA a cikin yara masu shekaru 12 zuwa 17: ƙididdigar ƙira na bayanan ƙasa: https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1
  419. COVID-19 mRNA rigakafi da haɓaka na CMR-tabbataccen mypericarditis: https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09.
  420. Mummunan anemia hemolytic autoimmune bayan an sami rigakafin SARS-CoV-2 mRNA: https://onlinelibrary.wiley.com/doi/10.1111/trf.16672
  421. Allurar rigakafin cutar coronavirus 2019 (COVID-19) na mRNA na iya haifar da m myopericarditis a cikin ƙirar linzamin kwamfuta: https://t.co/j0IEM8cMXI
  422. Rahoton myocarditis m abubuwan da suka faru a cikin US Vaccine Adverse Event Reporting System. (VAERS) a cikin haɗin gwiwa tare da COVID-19 ilimin halittu masu allura: https://pubmed.ncbi.nlm.nih.gov/34601006/
  423. Wannan binciken ya kammala da cewa: "An danganta allurar rigakafin da wuce haddi na myocarditis (abubuwa 1 zuwa 5 a cikin mutane 100,000). https://www.nejm.org/doi/full/10.1056/NEJMoa2110475
  424. Uveitis na biyu bayan allurar rigakafin COVID-19: rahoton shari'a: https://www.sciencedirect.com/science/article/pii/S1201971221007797
  425. Myocarditis da ke da alaƙa da rigakafin SARS-CoV-2 mRNA a cikin yara masu shekaru 12 zuwa 17: ƙididdigar ƙira na bayanan ƙasa: https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1.
  426. Hepatitis mai tsaka-tsaki na rigakafi tare da maganin Moderna ba ya zama daidaituwa amma an tabbatar da shi: https://www.sciencedirect.com/science/article/pii/S0168827821020936
  427. Bincike mai zurfi ya nuna daidaitattun sauye-sauye na pathophysiologic bayan allurar rigakafin COVID-19: https://www.nature.com/articles/s41421-021-00329-3
  428. Hemorrhage na Lobar tare da fashewar ventricular jim kadan bayan kashi na farko na rigakafin SARS-CoV-2 na tushen mRNA: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/
  429. Alurar rigakafin Mrna COVID suna ƙara haɓaka alamun kumburin endothelial da haɗarin Ciwon Cutar Cutar Cutar Cutar Cutar Cutar Corona kamar yadda aka auna ta gwajin zuciya na PULS: taka tsantsan: https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712
  430. ChAdOx1 yana hulɗa tare da CAR da PF4 tare da abubuwan da ke haifar da thrombosis tare da ciwo na thrombocytopenia:https://www.science.org/doi/10.1126/sciadv.abl8213
  431. Mummunan maganin rigakafi da ke haifar da rigakafi na thrombotic na rigakafi thrombocytopenia (VITT) bayan sanarwar 26.COV2.S: shari'ar farko da aka rubuta a wajen Amurka: https://pubmed.ncbi.nlm.nih.gov/34626338/
  432. Rashin lafiyar thrombocytopenic na prothrombotic mai kama da heparin-induced thrombocytopenia bayan rigakafin coronavirus-19: https://europepmc.org/article/PPR/PPR304469 435.
  433. VITT (alurar rigakafin thrombotic thrombocytopenia) bayan alurar riga kafi tare da ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34731555/
  434. Alurar rigakafin thrombotic thrombocytopenia (VITT): sabon mahallin asibiti tare da gabatarwar asibiti iri-iri: https://pubmed.ncbi.nlm.nih.gov/34159588/
  435. Maganin m bugun jini na ischemic mai alaƙa da ChAdOx1 nCoV-19 allurar rigakafin thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34461442/
  436. Spectrum na rikice-rikicen jijiyoyin jiki bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34719776/.
  437. Cerebral venous sinus thrombosis bayan alurar riga kafi: ƙwarewar Burtaniya: https://pubmed.ncbi.nlm.nih.gov/34370974/
  438. Jijiyoyin jijiyoyin jijiya/jini na sinus thrombosis tare da ciwon thrombocytopenia bayan COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34373413/
  439. Portal vein thrombosis saboda maganin alurar rigakafin thrombotic na rigakafi na thrombocytopenia (VITT) bayan allurar rigakafin Covid tare da ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34598301/
  440. Hematuria, kumburin kurji da ciwon kai bayan Oxford AstraZeneca ChAdOx1 nCoV-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34620638/
  441. Ciwon zuciya na zuciya da thrombosis na azygos bayan allurar rigakafin ChAdOx1 nCoV-19 a cikin majinyacin hemodialysis: https://pubmed.ncbi.nlm.nih.gov/34650896/
  442. Takotsubo (danniya) cardiomyopathy bayan alurar riga kafi tare da ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34625447/
  443. Amsar ban dariya ta haifar da rigakafin Prime-Boost tare da ChAdOx1 nCoV-19 da kuma BNT162b2 mRNA a cikin mara lafiya tare da sclerosis mai yawa da ake yi da teriflunomide: https://pubmed.ncbi.nlm.nih.gov/34696248/
  444. Ciwon Guillain-Barré bayan ChAdOx1 nCoV-19 rigakafin COVID-19: jerin shari'o'i: https://pubmed.ncbi.nlm.nih.gov/34548920/
  445. Maganganun rigakafin rigakafin thrombotic thrombocytopenia (VITT) wanda ke haifar da rigakafi tare da jinkirin musayar plasma warkewa (TPE): https://pubmed.ncbi.nlm.nih.gov/34672380/.
  446. Halin da ba kasafai ba na COVID-19 wanda ke da alaƙa da allurar rigakafi na intracranial hemorrhage tare da venous sinus thrombosis: https://pubmed.ncbi.nlm.nih.gov/34556531/.
  447. Jinkirta ciwon kai bayan allurar COVID-19: alamar gargadi don maganin thrombosis na jijiyoyin jijiya: https://pubmed.ncbi.nlm.nih.gov/34535076/.
  448. Siffofin asibiti na thrombocytopenia da ke haifar da alurar rigakafi da thrombosis na rigakafi: https://pubmed.ncbi.nlm.nih.gov/34379914/.
  449. Masu tsinkayar mace-mace a cikin thrombotic thrombocytopenia bayan allurar COVID-19 na adenoviral: makin FAPIC: https://pubmed.ncbi.nlm.nih.gov/34545400/
  450. Ischemic bugun jini a matsayin gabatar da fasalin rigakafin thrombotic thrombocytopenia wanda aka haifar da rigakafin ChAdOx1-nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34035134/
  451. Nazarin lura a cikin asibiti game da cututtukan jijiyoyin jiki a cikin marasa lafiya kwanan nan da aka yi musu rigakafin COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34688190/
  452. Jiyya na Endovascular don maganin alurar rigakafin ƙwayar cuta ta sinus thrombosis da thrombocytopenia bayan alurar riga kafi tare da ChAdOx1 nCoV-19: rahoton lokuta uku: https://pubmed.ncbi.nlm.nih.gov/34782400/
  453. Abubuwan da ke faruwa na zuciya da jijiyoyin jini, neurological, da na huhu bayan alurar riga kafi tare da BNT162b2, ChAdOx1 nCoV-19, da Ad26.COV2.S: nazarin bayanan Turai: https://pubmed.ncbi.nlm.nih.gov/34710832/
  454. Cerebral venous thrombosis tasowa bayan alurar riga kafi. COVID-19: VITT, VATT, TTS da ƙari: https://pubmed.ncbi.nlm.nih.gov/34695859/
  455. Ciwon jini na jini da kuma myeloproliferative neoplasms: bincike na tsakiya uku na lokuta 74 a jere: https://pubmed.ncbi.nlm.nih.gov/34453762/.
  456. Abubuwan da za a iya haifar da thrombocytopenia da/ko zubar jini ta hanyar allurar BNT162b2, Pfizer-BioNTech: https://pubmed.ncbi.nlm.nih.gov/34660652/.
  457. Shafukan da yawa na thrombosis na arterial a cikin majiyyaci mai shekaru 35 bayan alurar riga kafi tare da ChAdOx1 (AstraZeneca), wanda ke buƙatar gaggawa na femoral da carotid thrombectomy: https://pubmed.ncbi.nlm.nih.gov/34644642/
  458. Jerin shari'o'in da aka haifar da thrombotic thrombocytopenia a cikin asibitin koyarwa na London: https://pubmed.ncbi.nlm.nih.gov/34694650/
  459. Matsalolin Neuro-ophthalmic tare da thrombocytopenia da thrombosis da rigakafin ChAdOx1 nCoV-19 ya haifar: https://pubmed.ncbi.nlm.nih.gov/34726934/
  460. Abubuwan da suka faru na Thrombotic bayan rigakafin COVID-19 a cikin shekaru sama da 50: sakamakon binciken tushen yawan jama'a a Italiya: https://pubmed.ncbi.nlm.nih.gov/34835237/
  461. Zubar da jini na intracerebral hade da maganin alurar rigakafin thrombotic thrombocytopenia bayan ChAdOx1 nCOVID-19 a cikin mace mai ciki: https://pubmed.ncbi.nlm.nih.gov/34261297/
  462. Abubuwan da suka shafi shekaru- da jima'i na ƙayyadaddun abubuwan da suka faru na ƙwayar cuta ta sinus thrombosis mai alaƙa da Ad26.COV2.S COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34724036/.
  463. Necrosis na al'aura tare da thrombosis na fata bayan allurar rigakafin COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34839563/
  464. Cerebral venous sinus thrombosis bayan mRNA na tushen COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34783932/.
  465. COVID-19 allurar rigakafin rigakafin cututtukan cututtukan jini tare da thrombocytopenia thrombosis (VITT) da inuwar launin toka a cikin samuwar thrombus: https://pubmed.ncbi.nlm.nih.gov/34624910/
  466. Myositis mai kumburi bayan alurar riga kafi tare da ChAdOx1: https://pubmed.ncbi.nlm.nih.gov/34585145/
  467. Mummunan ST-segment dagawa myocardial infarction na biyu zuwa rigakafi-jawo rigakafin thrombosis tare da thrombocytopenia (VITT): https://pubmed.ncbi.nlm.nih.gov/34580132/.
  468. Wani lamari da ba kasafai ba na COVID-19 wanda ke haifar da thrombotic thrombocytopenia (VITT) wanda ke shafar venosplanchnic da bugun jini na huhu daga babban asibitin gundumar Burtaniya: https://pubmed.ncbi.nlm.nih.gov/34535492/
  469. thrombocytopenia thrombotic thrombocytopenia wanda ke haifar da rigakafin COVID-19: jerin shari'o'i: https://pubmed.ncbi.nlm.nih.gov/34527501/
  470. Thrombosis tare da ciwo na thrombocytopenia (TTS) bayan alurar riga kafi tare da AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19: bincike mai fa'ida ga mutane <60% ƙididdigar fa'ida ga mutane <60 shekaru a Ostiraliya: https://pubmed.ncbi.nlm.nih.gov/34272095/
  471. Immune thrombocytopenia bayan allurar rigakafi tare da Vaxzevria ChadOx1-S (AstraZeneca), Victoria, Ostiraliya: https://pubmed.ncbi.nlm.nih.gov/34756770/
  472. Halaye da sakamakon marasa lafiya tare da thrombosis na sinus thrombosis a cikin thrombotic na rigakafi thrombocytopenia wanda rigakafin SARS-CoV-2 ya haifar: https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622
  473. Nazarin shari'ar thrombosis da ciwon thrombocytopenia bayan gudanar da maganin AstraZeneca COVID-19: https://pubmed.ncbi.nlm.nih.gov/34781321/
  474. Thrombosis tare da Ciwon Thrombocytopenia Haɗe da Alurar COVID-19: https://pubmed.ncbi.nlm.nih.gov/34062319/
  475. Cerebral venous sinus thrombosis bayan allurar rigakafi tare da ChAdOx1: shari'ar farko ta tabbataccen thrombosis tare da ciwo na thrombocytopenia a Indiya: https://pubmed.ncbi.nlm.nih.gov/34706921/
  476. Cutar sankarau mai alaƙa da maganin rigakafi ta COVID-19 tare da ciwo na thrombocytopenia (TTS): nazari na yau da kullun da bincike na hoc: https://pubmed.ncbi.nlm.nih.gov/34698582/.
  477. Rahoton shari'ar na thrombocytopenia na rigakafi bayan alurar riga kafi tare da ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34751013/.
  478. m transverse myelitis bayan COVID-19 alurar riga kafi: https://pubmed.ncbi.nlm.nih.gov/34684047/.
  479. Damuwa game da mummunan tasirin thrombocytopenia da thrombosis bayan allurar rigakafi na adenovirus-vectored COVID-19: https://pubmed.ncbi.nlm.nih.gov/34541935/
  480. Babban bugun jini na jini bayan ChAdOx1 nCoV-19 rigakafin: rahoton shari'a: https://pubmed.ncbi.nlm.nih.gov/34273119/
  481. Cerebral venous sinus thrombosis bayan COVID-19 rigakafin: neurologic da radiologic management: https://pubmed.ncbi.nlm.nih.gov/34327553/.
  482. Thrombocytopenia tare da mummunan bugun jini na ischemic da zubar jini a cikin majiyyaci kwanan nan da aka yi wa alurar riga kafi na adenoviral vector COVID-19: https://pubmed.ncbi.nlm.nih.gov/33877737/
  483. Zubar da jini na intracerebral da thrombocytopenia bayan AstraZeneca COVID-19 maganin alurar riga kafi: na asibiti da ƙalubalen bincike na thrombocytopenia da ke haifar da alurar rigakafi: https://pubmed.ncbi.nlm.nih.gov/34646685/
  484. Karancin canjin cuta tare da mummunan rauni na koda bayan Oxford-AstraZeneca COVID-19 rigakafin: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34242687/.
  485. Rahoton shari'ar: thrombosis na sinus na cerebral a cikin marasa lafiya biyu tare da maganin AstraZeneca SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34609603/
  486. Rahoton shari'ar: Pityriasis rosea-kamar kurji bayan alurar riga kafi tare da COVID-19: https://pubmed.ncbi.nlm.nih.gov/34557507/
  487. Faɗakarwar myelitis mai tsayi mai tsayi bayan ChAdOx1 nCOV-19 rigakafin: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34641797/.
  488. M eosinophilic pneumonia mai alaƙa da maganin rigakafin COVID-19 AZD1222: https://pubmed.ncbi.nlm.nih.gov/34812326/.
  489. Thrombocytopenia, gami da thrombocytopenia na rigakafi bayan an karɓi allurar COVID-19 mRNA da aka ruwaito zuwa Tsarin Bayar da Batun Alurar rigakafin Alurar (VAERS): https://pubmed.ncbi.nlm.nih.gov/34006408/
  490. Shari'ar vasculitis mai alaƙa da ANCA bayan AZD1222 (Oxford-AstraZeneca) rigakafin SARS-CoV-2: wanda aka azabtar ko kuma sanadin?: https://pubmed.ncbi.nlm.nih.gov/34416184/
  491. Alurar rigakafin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan hai da kuma cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan da kuma cututtukan cututtukan da ke haifar da kamuwa da cutar sankara na coronavirus 2. https://pubmed.ncbi.nlm.nih.gov/34664303/.
  492. Thrombosis a cikin cututtukan jijiya na gefe da thrombotic thrombocytopenia biyo bayan allurar COVID-19 na adenoviral: https://pubmed.ncbi.nlm.nih.gov/34649281/.
  493. Sabuwar kamuwa da cutar thrombocytopenia na rigakafi a cikin majiyyaci mai ciki bayan cutar coronavirus 2019 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34420249/
  494. Cerebral venous sinus thrombosis da thrombotic abubuwan da suka faru bayan rigakafin COVID-19 na tushen vector: nazari na yau da kullun da meta-bincike: https://pubmed.ncbi.nlm.nih.gov/34610990/.
  495. Ciwon Sweet bayan Oxford-AstraZeneca COVID-19 (AZD1222) a cikin wata tsohuwa: https://pubmed.ncbi.nlm.nih.gov/34590397/
  496. Rashin ji na ji ba zato ba tsammani bayan COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34670143/.
  497. Yaɗuwar munanan abubuwan da suka faru a tsakanin ƙwararrun kiwon lafiya bayan sun karɓi kashi na farko na rigakafin cutar Coronavirus na ChAdOx1 nCoV-19 (Covichield) a Togo, Maris 2021: https://pubmed.ncbi.nlm.nih.gov/34819146/.
  498. M hemichorea-hemibalismus bayan COVID-19 (AZD1222) rigakafin: https://pubmed.ncbi.nlm.nih.gov/34581453/
  499. Maimaituwar alopecia areata bayan rigakafin covid-19: rahoton lokuta uku a Italiya: https://pubmed.ncbi.nlm.nih.gov/34741583/
  500. Shingles-kamar raunin fata bayan alurar riga kafi tare da AstraZeneca don COVID-19: rahoton shari'a: https://pubmed.ncbi.nlm.nih.gov/34631069/
  501. Thrombosis bayan rigakafin COVID-19: yuwuwar hanyar haɗi zuwa hanyoyin ACE: https://pubmed.ncbi.nlm.nih.gov/34479129/
  502. Thrombocytopenia a cikin matashi mai ciwon sikila anemia bayan COVID-19 alurar riga kafi: https://pubmed.ncbi.nlm.nih.gov/34331506/
  503. Leukocytoclastic vasculitis a matsayin bayyanar cutaneous bayyanar cututtuka na ChAdOx1 corona virus nCoV-19 (recombinant): https://pubmed.ncbi.nlm.nih.gov/34546608/
  504. Ciwon ciki da zubar jini na adrenal na gefe biyu daga thrombotic thrombocytopenia na rigakafi wanda rigakafin COVID-19 ya jawo: https://pubmed.ncbi.nlm.nih.gov/34546343/
  505. Tsawon lokaci mai tsayi myelitis na mahaifa bayan allurar rigakafin cutar COVID-19 da ba a kunna ba: https://pubmed.ncbi.nlm.nih.gov/34849183/
  506. Ƙaddamar da ƙwayar cuta na leukocytoclastic vasculitis bayan maganin ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34853744/.
  507. Halin necrolysis na epidermal mai guba bayan alurar riga kafi tare da ChAdOx1 nCoV-19 (AZD1222): https://pubmed.ncbi.nlm.nih.gov/34751429/.
  508. Abubuwan da ba su dace ba bayan allurar COVID-19: https://pubmed.ncbi.nlm.nih.gov/34559576/
  509. Bacin rai bayan ChAdOx1-S / nCoV-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34608345/.
  510. Thromboembolism na jini da ƙananan thrombocytopenia bayan allurar ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34384129/.
  511. vasculitis mai alaƙa da ANCA mai maimaitawa bayan Oxford AstraZeneca ChAdOx1-S COVID-19 rigakafin: jerin shari'o'in marasa lafiya biyu: https://pubmed.ncbi.nlm.nih.gov/34755433/
  512. Babban thrombosis na arteries da allurar rigakafin ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34839830/
  513. Halin da ba a sani ba na lymphadenopathy na supraclavicular bayan allurar rigakafi tare da COVID-19: ƙididdigar ƙididdiga da binciken duban dan tayi: https://pubmed.ncbi.nlm.nih.gov/34667486/
  514. Cutaneous lymphocytic vasculitis bayan gudanar da kashi na biyu na AZD1222 (Oxford-AstraZeneca) Mummunan ciwo na numfashi na coronavirus 2: dama ko dalili: https://pubmed.ncbi.nlm.nih.gov/34726187/.
  515. Kin amincewa da alluran pancreas bayan allurar ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34781027/
  516. Fahimtar haɗarin thrombosis tare da ciwo na thrombocytopenia biyo bayan rigakafin Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34595694/
  517. Halayen cuttaneous na 35,229 allurai na COVID-19 Sinovac da AstraZeneca maganin COVID-19: nazari mai zuwa a cikin ma'aikatan kiwon lafiya: https://pubmed.ncbi.nlm.nih.gov/34661934/
  518. Sharhi game da thrombosis bayan alurar riga kafi: jerin jagoran furotin na iya zama alhakin thrombosis da thrombocytopenia-mai shiga tsakani: https://pubmed.ncbi.nlm.nih.gov/34788138
  519. Eosinophilic dermatosis bayan AstraZeneca COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34753210/.
  520. Tsananin thrombocytopenia na rigakafi bayan rigakafin COVID-19: rahoton shari'o'i hudu da bitar wallafe-wallafe: https://pubmed.ncbi.nlm.nih.gov/34653943/.
  521. Komawar thrombocytopenia na rigakafi bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34591991/
  522. Thrombosis a cikin pre- da kuma bayan allurar rigakafin COVID-19; https://pubmed.ncbi.nlm.nih.gov/34650382/
  523. Dubi rawar da ke tattare da immunohistochemistry na bayan mutuwa a cikin fahimtar cututtukan cututtukan cututtukan kumburi na cutar COVID-19 da abubuwan da suka faru na cututtukan thrombotic masu alaƙa da alurar rigakafi: bita na labari: https://pubmed.ncbi.nlm.nih.gov/34769454/
  524. Alurar rigakafin COVID-19 a cikin marasa lafiya tare da cututtukan hypercoagulability: hangen nesa na asibiti: https://pubmed.ncbi.nlm.nih.gov/34786893/
  525. Thrombocytopenia da ke hade da maganin alurar rigakafi da thrombosis: venous endothelopathy wanda ke haifar da haɗin micro-macrothrombosis na jijiyar: https://pubmed.ncbi.nlm.nih.gov/34833382/
  526. Thrombosis da thrombocytopenia ciwo yana haifar da keɓancewar alamar carotid occlusion bayan COVID-19 Ad26.COV2.S (Janssen): https://pubmed.ncbi.nlm.nih.gov/34670287/
  527. Bambance-bambancen da ba a saba gani ba na thrombosis mai zurfi mai zurfi bayan rigakafin COVID-19 na zamani: rahoton shari'a: https://pubmed.ncbi.nlm.nih.gov/34790811/
  528. Immunoglobulins mai girma mai girma kai tsaye tare da magani kai tsaye tare da masu hana thrombin yana da mahimmanci don rayuwa a cikin rigakafin rigakafin thrombotic thrombocytopenia Sars-Covid-19-vector adenoviral VITT tare da venous thrombosis na cerebral sinus da portal vein: https://pubmed.ncbi.nlm.nih.gov/34023956/.
  529. Samuwar Thrombosis bayan COVID-19 alurar rigakafin rigakafi: labarin bita: https://pubmed.ncbi.nlm.nih.gov/34629931/
  530. Hoto da binciken hematologic a cikin thrombosis da thrombocytopenia bayan alurar riga kafi tare da ChAdOx1 nCoV-19 (AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34402666/
  531. Spectrum na binciken neuroimaging a cikin allurar bayan-CoVID-19: jerin shari'o'i da bita na wallafe-wallafe: https://pubmed.ncbi.nlm.nih.gov/34842783/
  532. Cerebral venous sinus thrombosis, huhu embolism, da thrombocytopenia bayan COVID-19 alurar riga kafi a cikin wani mutumin Taiwan: rahoton shari'a da bitar wallafe-wallafe: https://pubmed.ncbi.nlm.nih.gov/34630307/
  533. Mutuwar ƙwayar cuta ta sinus thrombosis bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/33983464/
  534. Tushen autoimmune na abubuwan thrombotic bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34508917/.
  535. Sabuwar thrombosis na portal thrombosis a cikin cirrhosis: thrombophilia yana tsananta ta hanyar alurar riga kafi ko COVID-19: https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext.
  536. Hotunan rigakafin thrombotic thrombocytopenia wanda Oxford / AstraZeneca® COVID-19 ya haifar: https://pubmed.ncbi.nlm.nih.gov/33962903/.
  537. Cerebral venous sinus thrombosis bayan alurar riga kafi tare da COVID-19 mRNA na BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34796065/.
  538. Haɗarin urticaria/angioedema bayan BNT162b2 mRNA rigakafin COVID-19 a cikin ma'aikatan kiwon lafiya waɗanda ke ɗaukar masu hana ACE: https://pubmed.ncbi.nlm.nih.gov/34579248/
  539. Wani lamari na bayyanar asibiti mai sauƙi wanda ba a saba gani ba na COVID-19 wanda ke haifar da rigakafin thrombotic thrombocytopenia tare da splanchnic vein thrombosis: https://pubmed.ncbi.nlm.nih.gov/34843991/
  540. Ciwon thrombosis na sinus na cerebral bayan allurar rigakafi tare da Pfizer-BioNTech COVID-19 (BNT162b2): https://pubmed.ncbi.nlm.nih.gov/34595867/
  541. Shari'ar idiopathic thrombocytopenic purpura bayan ƙarar adadin maganin COVID-19 BNT162b2 (Pfizer-Biontech): https://pubmed.ncbi.nlm.nih.gov/34820240/
  542. Alurar rigakafin rigakafin thrombotic na rigakafi na thrombocytopenia (VITT): hanyoyin da aka yi niyya tare da inhibitors na tyrosine kinase na Bruton: https://pubmed.ncbi.nlm.nih.gov/33851389/
  543. Thrombotic thrombocytopenic purpura bayan alurar riga kafi tare da Ad26.COV2-S: https://pubmed.ncbi.nlm.nih.gov/33980419/
  544. Abubuwan da ke faruwa na Thromboembolic a cikin ƙananan mata da aka fallasa ga Pfizer-BioNTech ko Moderna COVID-19: https://pubmed.ncbi.nlm.nih.gov/34264151/
  545. Haɗarin haɗari na al'amuran thrombotic bayan COVID-19 alurar riga kafi tare da Oxford-AstraZeneca a cikin mata masu karɓar isrogen: https://pubmed.ncbi.nlm.nih.gov/34734086/
  546. Thrombosis bayan adenovirus-vectored COVID-19 alurar riga kafi: damuwa ga cututtukan da ke ciki: https://pubmed.ncbi.nlm.nih.gov/34755555/
  547. Adenovirus hulɗa tare da platelets da coagulation da maganin alurar riga kafi na thrombotic thrombocytopenia ciwo: https://pubmed.ncbi.nlm.nih.gov/34407607/
  548. Thrombotic thrombocytopenic purpura: sabuwar barazana bayan COVID bnt162b2 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34264514/.
  549. Wurin da ba a sani ba na thrombosis mai zurfi bayan allurar rigakafin cutar coronavirus mRNA-2019 coronavirus (COVID-19): https://pubmed.ncbi.nlm.nih.gov/34840204/
  550. Abubuwan da ke haifar da cututtukan jijiyoyi na rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34750810/
  551. Coagulopathies bayan rigakafin SARS-CoV-2 na iya samuwa daga haɗuwar tasirin furotin na SARS-CoV-2 da hanyoyin siginar vector mai kunna adenovirus: https://pubmed.ncbi.nlm.nih.gov/34639132/
  552. Keɓancewar kumburin huhu bayan allurar COVID: rahoton shari'o'i 2 da bita na rikice-rikice na huhu na huhu da bibiya: https://pubmed.ncbi.nlm.nih.gov/34804412/
  553. Rufewar jijiya ta tsakiya bayan allurar rigakafi tare da SARS-CoV-2 mRNA: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34571653/.
  554. Rahoton shari'a mai rikitarwa na dogon lokaci na rigakafin thrombotic na rigakafi na thrombocytopenia A: https://pubmed.ncbi.nlm.nih.gov/34835275/.
  555. Zurfafa thrombosis bayan alurar riga kafi tare da Ad26.COV2.S a cikin manya maza: https://pubmed.ncbi.nlm.nih.gov/34659839/.
  556. Cututtukan autoimmune na jijiyoyi bayan rigakafin SARS-CoV-2: jerin shari'o'i: https://pubmed.ncbi.nlm.nih.gov/34668274/.
  557. Anemia mai tsanani autoimmune hemolytic autoimmune anemia bayan karbar maganin SARS-CoV-2 mRNA: https://pubmed.ncbi.nlm.nih.gov/34549821/
  558. Faɗuwar bambance-bambancen COVID-19 tsakanin masu karɓar rigakafin ChAdOx1 nCoV-19 (sake haɗawa): https://pubmed.ncbi.nlm.nih.gov/34528522/
  559. Yawaitar thrombocytopenia, anti-platelet factor 4 antibodies, da haɓakar D-dimer a cikin Thais bayan alurar riga kafi tare da ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34568726/
  560. Annobar cutar myocarditis/pericarditis mai tsanani a cikin samari na Hong Kong bayan rigakafin hadin gwiwa: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/644 5179.
  561. Myocarditis bayan cutar coronavirus na 2019 rigakafin mRNA: jerin shari'o'i da ƙaddara adadin abin da ya faru: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408
  562. Myocarditis da pericarditis bayan rigakafin COVID-19: rashin daidaito a cikin shekaru da nau'in rigakafin: https://www.mdpi.com/2075-4426/11/11/1106
  563. Epidemiology da fasali na asibiti na myocarditis/pericarditis kafin gabatar da rigakafin COVID-19 mRNA a cikin yaran Koriya: binciken da yawa: https://pubmed.ncbi.nlm.nih.gov/34402230/
  564. Bayar da haske kan rigakafin cutar myocarditis da pericarditis a cikin COVID-19 da masu karɓar rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34696294/
  565. Myocarditis Yana bin mRNA COVID-19 Allurar: https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_ mRNA_COVID_19_Vaccine.9.aspx.
  566. Myocarditis yana bin BNT162b2 mRNA rigakafin mRNA Covid-19 a cikin Isra'ila: https://pubmed.ncbi.nlm.nih.gov/34614328/.
  567. Myocarditis, pericarditis, da cardiomyopathy bayan rigakafin COVID-19: https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext
  568. Myocarditis da sauran matsalolin cututtukan zuciya na COVID-19 mRNA na tushen COVID-19: https://pubmed.ncbi.nlm.nih.gov/34277198/
  569. Ƙungiya mai yuwuwa Tsakanin COVID-19 Alurar riga kafi da Myocarditis: Bincike na asibiti da CMR: https://pubmed.ncbi.nlm.nih.gov/34246586/
  570. Ciwon Hankali na Myocarditis da Alurar COVID-19: https://pubmed.ncbi.nlm.nih.gov/34856634/.
  571. Myocarditis mai tsanani mai alaƙa da maganin COVID-19: zebra ko unicorn?: https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext.
  572. Myocardial infarction da myocarditis bayan rigakafin COVID-19: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/
  573. Myocarditis bayan rigakafin Covid-19 a cikin babbar ƙungiyar kiwon lafiya: https://www.nejm.org/doi/10.1056/NEJMoa2110737
  574. Ƙungiyar myocarditis tare da COVID-19 manzo RNA BNT162b2 maganin rigakafi a cikin jerin yara: https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052
  575. Zaton asibiti na myocarditis na ɗan lokaci yana da alaƙa da rigakafin COVID-19 a cikin matasa da matasa: https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
  576. STEMI mimicry: myocarditis mai hankali a cikin majiyyaci matashi bayan COVID-19 mRNA alurar riga kafi:. https://pubmed.ncbi.nlm.nih.gov/34756746/
  577. Myocarditis da pericarditis a cikin haɗin gwiwa tare da rigakafin COVID-19 mRNA: lokuta daga cibiyar kula da magunguna na yanki: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/
  578. Myocarditis bayan COVID-19 mRNA rigakafin: https://pubmed.ncbi.nlm.nih.gov/34546329/.
  579. Marasa lafiya masu fama da myocarditis bayan COVID-19 rigakafin mRNA:. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602.
  580. Myocarditis bayan rigakafin COVID-19: jerin shari'o'i: https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub.
  581. Myocarditis mai alaƙa da rigakafin COVID-19 a cikin samari: https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357
  582. Binciken Myocarditis akan hoton maganadisu na zuciya bayan allurar rigakafin COVID-19 mRNA a cikin samari:. https://pubmed.ncbi.nlm.nih.gov/34704459/
  583. Myocarditis bayan rigakafin COVID-19: nazarin hoton maganadisu: https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6 421640.
  584. Myocarditis mai tsanani bayan gudanar da kashi na biyu na maganin BNT162b2 COVID-19: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/
  585. Myocarditis bayan rigakafin COVID-19: https://www.sciencedirect.com/science/article/pii/S2352906721001603
  586. Rahoton shari'ar: mai yiwuwa myocarditis bayan rigakafin mRNA na Covid-19 a cikin mara lafiya tare da arrhythmogenic na hagu na ventricular cardiomyopathy: https://pubmed.ncbi.nlm.nih.gov/34712717/.
  587. Myocarditis mai tsanani bayan gudanar da maganin BNT162b2 daga COVID-19: https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administration-bnt162b2-S188558572100133X.
  588. Myocarditis mai alaƙa da rigakafin COVID-19 mRNA: https://pubs.rsna.org/doi/10.1148/radiol.2021211430
  589. Myocarditis mai tsanani bayan rigakafin COVID-19: rahoton shari'a: https://www.sciencedirect.com/science/article/pii/S0248866321007098
  590. Mummunan myopericarditis bayan rigakafin COVID-19 a cikin samari:. https://pubmed.ncbi.nlm.nih.gov/34589238/.
  591. Perimyocarditis a cikin samari bayan Pfizer-BioNTech COVID-19 rigakafin: https://academic.oup.com/jpids/article/10/10/962/6329543.
  592. Babban myocarditis mai alaƙa da rigakafin COVID-19: https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196.
  593. Myocarditis mai alaƙa da rigakafin COVID-19: echocardiographic, CT na zuciya, da binciken MRI:. https://pubmed.ncbi.nlm.nih.gov/34428917/.
  594. Myocarditis mai saurin kamuwa da cuta a cikin samari 7 bayan Pfizer-BioNTech COVID-19 rigakafin:. https://pubmed.ncbi.nlm.nih.gov/34088762/.
  595. Myocarditis da pericarditis a cikin samari bayan allurai na farko da na biyu na rigakafin COVID-19 mRNA:. https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/64 42104.
  596. Alurar rigakafin COVID 19 ga matasa. Abubuwan da ke da alaƙa da myocarditis da pericarditis: https://www.mdpi.com/2036-7503/13/3/61.
  597. Hoton zuciya na myocarditis mai tsanani bayan alurar riga kafi tare da COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34402228/
  598. Myocarditis na ɗan lokaci yana da alaƙa da rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34133885/
  599. Mummunan rauni na myocardial bayan rigakafin COVID-19: rahoton shari'a da bitar shaidar yanzu daga bayanan tsarin ba da rahoton abubuwan da suka faru na rigakafin cutar: https://pubmed.ncbi.nlm.nih.gov/34219532/
  600. Babban myocarditis mai alaƙa da rigakafin COVID-19: rahoton wani lamari: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/
  601. Myocarditis bayan allurar rigakafi tare da COVID-19 messenger RNA: jerin shari'ar Jafananci: https://pubmed.ncbi.nlm.nih.gov/34840235/.
  602. Myocarditis a cikin tsarin rigakafin COVID-19 na kwanan nan: https://pubmed.ncbi.nlm.nih.gov/34712497/.
  603. Myocarditis mai tsanani bayan kashi na biyu na rigakafin COVID-19 mRNA: rahoton lokuta biyu: https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext.
  604. Yawaitar thrombocytopenia, antiplatelet factor 4 antibodies, da haɓakar D-dimer a cikin Thais bayan alurar riga kafi tare da ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34568726/
  605. Annobar cutar myocarditis/pericarditis mai tsanani a cikin samari na Hong Kong bayan rigakafin hadin gwiwa: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179
  1. Myocarditis bayan cutar coronavirus na 2019 rigakafin mRNA: jerin shari'o'i da ƙayyadaddun adadin abin da ya faru: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408.
  2. Myocarditis da pericarditis bayan rigakafin COVID-19: rashin daidaito a cikin shekaru da nau'in rigakafin: https://www.mdpi.com/2075-4426/11/11/1106
  3. Epidemiology da fasali na asibiti na myocarditis/pericarditis kafin gabatar da rigakafin COVID-19 mRNA a cikin yaran Koriya: binciken da yawa: https://pubmed.ncbi.nlm.nih.gov/34402230/
  4. Bayar da haske kan rigakafin cutar myocarditis da pericarditis a cikin COVID-19 da masu karɓar rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34696294/
  5. Yada ciwon prothrombotic bayan gudanar da maganin ChAdOx1 nCoV-19: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34615534/
  6. Laifukan uku na m thromboembolism na jijiyoyi a cikin mata bayan rigakafin coronavirus 2019: https://pubmed.ncbi.nlm.nih.gov/34352418/
  7. Siffofin asibiti da na ilimin halitta na ƙwayar cuta ta sinus thrombosis na cerebral venous bayan allurar rigakafi tare da ChAdOx1 nCov-19; https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340.
  8. Alurar rigakafin COV2-S na iya bayyana thrombophilia na gado: babban thrombosis na jijiyar jijiyoyin jini a cikin saurayi mai ƙididdige adadin platelet: https://pubmed.ncbi.nlm.nih.gov/34632750/
  9. Abubuwan da aka gano bayan mutuwa a cikin thrombocytopenia da ke haifar da alurar rigakafi: https://haematologica.org/article/view/haematol.2021.279075
  10. thrombosis da ke haifar da rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34802488/.
  11. Kumburi da kunna platelet bayan allurar COVID-19: yuwuwar hanyoyin da ke haifar da rigakafin rigakafin thrombocytopenia da thrombosis: https://pubmed.ncbi.nlm.nih.gov/34887867/.
  12. Halin anaphylaptoid da thrombosis na jijiyoyin jini masu alaƙa da maganin COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34863404/.
  13. Alurar rigakafi da ke haifar da thrombosis na jijiyoyin bugun jini da thrombocytopenia. Oxford-AstraZeneca COVID-19: damar da aka rasa don saurin dawowa kan gwaninta: https://www.sciencedirect.com/science/article/pii/S235255682100093X
  14. Faɗuwar ƙwayar cuta ta splenic saboda thrombosis na arterial bayan allurar rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34876440/
  15. Zurfafa thrombosis fiye da makonni biyu bayan COVID-19 alurar riga kafi: https://pubmed.ncbi.nlm.nih.gov/33928773/
  16. Rahoton shari'ar: Dauki kallo na biyu: Cutar sankarau mai alaƙa da maganin alurar riga kafi na Covid-19 da ciwon thrombocytopenia na thrombotic: https://pubmed.ncbi.nlm.nih.gov/34880826/
  17. Bayani akan ChAdOx1 nCoV-19 maganin rigakafin thrombotic thrombocytopenia wanda ke haifar da rigakafi: https://pubmed.ncbi.nlm.nih.gov/34587242/
  18. Canji a cikin dankowar jini bayan rigakafin COVID-19: kimantawa ga mutanen da ke fama da rashin lafiya na rayuwa: https://pubmed.ncbi.nlm.nih.gov/34868465/
  19. Gudanar da majiyyaci tare da rashin lafiyan gaɓoɓin gaɓoɓin mahaifa bayan SARS-CoV-2 da aka haifar da thrombosis da thrombocytopenia (VITT): https://pubmed.ncbi.nlm.nih.gov/34097311/
  20. bugun jini na thalamic na biyu: shari'ar COVID-19 (VITT) rigakafin rigakafin thrombotic thrombocytopenia ko daidaituwa saboda dalilai masu haɗari: https://pubmed.ncbi.nlm.nih.gov/34820232/.
  21. Thrombocytopenia da splanchnic thrombosis bayan alurar riga kafi tare da Ad26.COV2.S an yi nasarar magance shi tare da transjugular intrahepatic portosystemic shunt da thrombectomy: https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258
  22. Abubuwan da ke faruwa na mummunan bugun jini bayan allurar rigakafin coronavirus a Indonesia: jerin shari'o'in: https://pubmed.ncbi.nlm.nih.gov/34579636/
  23. Nasarar maganin alurar rigakafin thrombotic thrombocytopenia na rigakafin rigakafi a cikin majinyata mai shekaru 26: https://pubmed.ncbi.nlm.nih.gov/34614491/
  24. Rahoton shari'ar: maganin rigakafin rigakafin rigakafin thrombotic thrombocytopenia a cikin mara lafiya tare da ciwon daji na pancreatic bayan alurar riga kafi tare da manzo RNA-1273: https://pubmed.ncbi.nlm.nih.gov/34790684/
  25. Idiopathic idiopathic waje jugular jijiya thrombophlebitis bayan rigakafin cutar coronavirus (COVID-19): https://pubmed.ncbi.nlm.nih.gov/33624509/.
  26. Squamous cell carcinoma na huhu tare da hemoptysis bayan allurar rigakafi tare da tozinameran (BNT162b2, Pfizer-BioNTech): https://pubmed.ncbi.nlm.nih.gov/34612003/
  27. Alurar rigakafin thrombotic thrombocytopenia bayan Ad26.COV2.S alurar riga kafi a cikin mutumin da ke nunawa a matsayin m thromboembolism venous: https://pubmed.ncbi.nlm.nih.gov/34096082/
  28. Myocarditis mai alaƙa da rigakafin COVID-19 a cikin yara maza uku: https://pubmed.ncbi.nlm.nih.gov/34851078/.
  29. Abubuwan da aka gano na maganadisu na zuciya da jijiyoyin jini a cikin matasa marasa lafiya da ke da myocarditis mai tsanani bayan rigakafin COVID-19 mRNA: jerin shari'o'i: https://pubmed.ncbi.nlm.nih.gov/34496880/
  30. Perimyocarditis bayan alurar riga kafi tare da COVID-19: https://pubmed.ncbi.nlm.nih.gov/34866957/
  31. Annobar cutar myocarditis/pericarditis mai tsanani a cikin samari na Hong Kong bayan rigakafin hadin gwiwa: https://pubmed.ncbi.nlm.nih.gov/34849657/.
  32. Myocarditis-mutuwar kwatsam bayan BNT162b2 COVID-19 rigakafin mRNA a Koriya: rahoton shari'ar yana mai da hankali kan binciken tarihi: https://pubmed.ncbi.nlm.nih.gov/34664804/
  33. Myocarditis mai tsanani bayan allurar rigakafin COVID-19 mRNA a cikin manya masu shekaru 18 ko sama da haka: https://pubmed.ncbi.nlm.nih.gov/34605853/
  34. Maimaituwar myocarditis na ɗan lokaci mai alaƙa da karɓar maganin rigakafin cutar mRNA na coronavirus na 2019 (COVID-19) a cikin namiji matashi: https://pubmed.ncbi.nlm.nih.gov/34166671/
  35. Matashi namiji mai ciwon myocarditis bayan mRNA-1273 cutar coronavirus-2019 (COVID-19) rigakafin mRNA: https://pubmed.ncbi.nlm.nih.gov/34744118/
  36. Myocarditis mai tsanani bayan rigakafin SARS-CoV-2 a cikin namiji mai shekaru 24: https://pubmed.ncbi.nlm.nih.gov/34334935/.
  37. Hotunan Ga-DOTATOC na dijital na PET na ƙwayoyin kumburi suna kutsawa cikin myocarditis bayan alurar riga kafi tare da COVID-19: https://pubmed.ncbi.nlm.nih.gov/34746968/
  38. Faɗuwar myocarditis mai tsanani-kamar myocarditis bayan alurar riga kafi tare da COVID-19: kawai daidaituwar haɗari ko kuma mai alaƙa da allurar rigakafin cutar myocarditis? https://pubmed.ncbi.nlm.nih.gov/34333695/.
  39. Myocarditis mai iyakacin kai wanda ke nunawa tare da ciwon kirji da girman ST-segment a cikin samari bayan alurar riga kafi tare da maganin BNT162b2 mRNA: https://pubmed.ncbi.nlm.nih.gov/34180390/
  40. Myocarditis Bayan Yin rigakafi da COVID-19 mRNA Alurar rigakafin a cikin Membobin Sojojin Amurka: https://pubmed.ncbi.nlm.nih.gov/34185045/
  41. Myocarditis bayan allurar BNT162b2 a cikin namiji mai lafiya: https://pubmed.ncbi.nlm.nih.gov/34229940/
  42. Myopericarditis a cikin wani saurayi mai koshin lafiya a baya bayan rigakafin COVID-19: Rahoton shari'a: https://pubmed.ncbi.nlm.nih.gov/34133825/
  43. Myocarditis mai tsanani bayan SARS-CoV-2 mRNA-1273 rigakafin mRNA: https://pubmed.ncbi.nlm.nih.gov/34308326/.
  44. Ciwon ƙirji tare da ingantaccen haɓakar bugun jini na electrocardiogram bayan allurar rigakafin COVID-19 da Moderna kera: https://pubmed.ncbi.nlm.nih.gov/34866106/
  45. Biopsy-tabbatar da lymphocytic myocarditis bayan rigakafin farko da COVID-19 mRNA a cikin wani mutum mai shekaru 40: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34487236/
  46. Multimodality Hoto da histopathology a cikin wani saurayi da ke gabatar da cikakken myocarditis lymphocytic da cardiogenic girgiza bayan alurar riga kafi tare da mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34848416/
  47. Rahoton wani lamari na myopericarditis bayan yin allurar rigakafi tare da BNT162b2 COVID-19 mRNA a cikin wani saurayi dan Koriya: https://pubmed.ncbi.nlm.nih.gov/34636504/
  48. Myocarditis mai tsanani bayan rigakafin Comirnaty a cikin namiji mai lafiya tare da kamuwa da cutar SARS-CoV-2 na baya: https://pubmed.ncbi.nlm.nih.gov/34367386/
  49. Myocarditis mai tsanani a cikin matashi kwana biyu bayan alurar riga kafi tare da Pfizer: https://pubmed.ncbi.nlm.nih.gov/34709227/
  50. Rahoton shari'ar: m fulminant myocarditis da cardiogenic shock bayan manzo RNA coronavirus alurar riga kafi a cikin 2019 na buƙatar farfaɗowar zuciya na waje: https://pubmed.ncbi.nlm.nih.gov/34778411/
  51. Myocarditis mai tsanani bayan rigakafin cutar coronavirus na 2019: https://pubmed.ncbi.nlm.nih.gov/34734821/
  52. Jerin marasa lafiya tare da myocarditis bayan alurar riga kafi da SARS-CoV-2 tare da mRNA-1279 da BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34246585/
  53. Myopericarditis bayan Pfizer messenger ribonucleic acid coronavirus cutar rigakafin cutar a cikin matasa: https://pubmed.ncbi.nlm.nih.gov/34228985/
  54. Bayan allurar rigakafin kumburin kumburi a cikin manya ba tare da shaidar kamuwa da cutar SARS-CoV-2 da ta gabata ba: https://pubmed.ncbi.nlm.nih.gov/34852213/
  55. Myocarditis mai tsanani da aka bayyana bayan alurar riga kafi tare da 2019 mRNA na cutar coronavirus: https://pubmed.ncbi.nlm.nih.gov/34866122/
  56. Rashin aiki na systolic biventricular a cikin myocarditis mai tsanani bayan rigakafin SARS-CoV-2 mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34601566/
  57. Myocarditis yana bin rigakafin COVID-19: Nazarin MRI: https://pubmed.ncbi.nlm.nih.gov/34739045/.
  58. Myocarditis mai tsanani bayan rigakafin COVID-19: rahoton shari'ar: https://docs.google.com/document/d/1Hc4bh_qNbZ7UVm5BLxkRdMPnnI9zcCsl/e
  59. Ƙungiyar myocarditis tare da COVID-19 manzon RNA BNT162b2 rigakafin COVID-19 a cikin jerin yara: https://pubmed.ncbi.nlm.nih.gov/34374740/
  60. Zaton asibiti na myocarditis na ɗan lokaci yana da alaƙa da rigakafin COVID-19 a cikin matasa da matasa: https://pubmed.ncbi.nlm.nih.gov/34865500/
  61. Myocarditis bayan allurar rigakafi tare da Covid-19 a cikin babbar ƙungiyar kiwon lafiya: https://pubmed.ncbi.nlm.nih.gov/34614329/
  62. Alurar rigakafin AstraZeneca COVID-19 da cutar Guillain-Barré a cikin Tasmania: hanyar haɗi: https://pubmed.ncbi.nlm.nih.gov/34560365/
  63. COVID-19, Guillain-Barré da alluran rigakafin haɗari: https://pubmed.ncbi.nlm.nih.gov/34108736/.
  64. Ciwon Guillain-Barré bayan kashi na farko na rigakafin Pfizer-BioNTech COVID-19: rahoton shari'a da sake duba lamuran da aka ruwaito: https://pubmed.ncbi.nlm.nih.gov/34796417/.
  65. Ciwon Guillain-Barre bayan maganin BNT162b2 COVID-19: https://link.springer.com/article/10.1007%2Fs10072-021-05523-5.
  66. COVID-19 allurar adenovirus da cutar Guillain-Barré tare da palsy na fuska: https://onlinelibrary.wiley.com/doi/10.1002/ana.26258.
  67. Ƙungiyar karɓa ta Ad26.COV2.S COVID-19 rigakafin cutar Guillain-Barre, Fabrairu-Yuli 2021: https://jamanetwork.com/journals/jama/fullarticle/2785009
  68. Wani shari'ar Guillain-Barré ciwo bayan Pfizer COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34567447/
  69. Ciwon Guillain-Barré mai alaƙa da rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34648420/.
  70. Adadin ciwon Guillain-Barré mai maimaitawa bayan COVID-19 BNT162b2 rigakafin mRNA: https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708
  71. Ciwon Guillain-Barre bayan rigakafin COVID-19 a cikin samari: https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext.
  72. Ciwon Guillain-Barre bayan ChAdOx1-S / nCoV-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34114256/.
  73. Ciwon Guillain-Barre bayan COVID-19 mRNA-1273 rigakafin: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34767184/.
  74. Ciwon Guillain-Barre ya biyo bayan rigakafin SARS-CoV-2 a cikin marasa lafiya 19: https://pubmed.ncbi.nlm.nih.gov/34644738/.
  75. Ciwon Guillain-Barre yana nunawa tare da diplegia na fuska bayan allurar rigakafin COVID-19 a cikin marasa lafiya biyu: https://pubmed.ncbi.nlm.nih.gov/34649856/
  76. Wani shari'ar da ba kasafai ba na cutar Guillain-Barré bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34671572/
  77. Rikicin jijiya na COVID-19: Ciwon Guillain-Barre bayan Pfizer COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/33758714/
  78. Alurar rigakafin COVID-19 da ke haifar da ciwo na Guillain-Barre, wani sakamako mai ban mamaki wanda ba a saba gani ba: https://pubmed.ncbi.nlm.nih.gov/34484780/
  79. Ciwon Guillain-Barre bayan kashi na farko na rigakafin COVID-19: rahoton shari'a; https://pubmed.ncbi.nlm.nih.gov/34779385/.
  80. Miller Fisher ciwo bayan Pfizer COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34817727/.
  81. Miller Fisher ciwo bayan 2019 BNT162b2 mRNA coronavirus rigakafin: https://pubmed.ncbi.nlm.nih.gov/34789193/.
  82. Rauni na fuska biyu tare da bambance-bambancen cututtukan cututtukan Guillain-Barre bayan maganin Vaxzevria COVID-19: https://pubmed.ncbi.nlm.nih.gov/34261746/
  83. Ciwon Guillain-Barre bayan allurar farko ta ChAdOx1 nCoV-19: rahoton farko: https://pubmed.ncbi.nlm.nih.gov/34217513/.
  84. Halin ciwon ataxic na Guillain-Barre tare da rigakafi na immunoglobulin G anti-GM1 bayan kashi na farko na COVID-19 BNT162b2 mRNA rigakafin (Pfizer): https://pubmed.ncbi.nlm.nih.gov/34871447/
  85. Bayar da rahoton cututtukan neuropathy masu kumburi tare da rigakafin COVID-19: ƙididdigar rashin daidaituwa na rukuni a cikin VigiBase: https://pubmed.ncbi.nlm.nih.gov/34579259/
  86. Bambancin ciwon Guillain-Barré bayan rigakafin SARS-CoV-2: AMSAN: https://pubmed.ncbi.nlm.nih.gov/34370408/.
  87. Baƙaƙen bambancin ciwon Guillain-Barré bayan alurar riga kafi tare da Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34703690/.
  88. Ciwon Guillain-Barré bayan rigakafin SARS-CoV-2 a cikin mara lafiyar da ke da alaƙa da cutar Guillain-Barré ta baya: https://pubmed.ncbi.nlm.nih.gov/34810163/
  89. Ciwon Guillain-Barré a cikin jihar Ostiraliya ta amfani da mRNA da adenovirus-vector SARS-CoV-2 rigakafin: https://onlinelibrary.wiley.com/doi/10.1002/ana.26218.
  90. M myelitis mai saurin kamuwa da cuta bayan rigakafin SARS-CoV-2: rahoton shari'a da bita na wallafe-wallafe: https://pubmed.ncbi.nlm.nih.gov/34482455/.
  91. Bambancin ciwon Guillain-Barré yana faruwa bayan rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34114269/.
  92. Ciwon Guillian-Barre tare da bambance-bambancen axonal na ɗan lokaci mai alaƙa da rigakafi na tushen SARS-CoV-2 na zamani: https://pubmed.ncbi.nlm.nih.gov/34722067/
  93. Ciwon Guillain-Barre bayan kashi na farko na rigakafin SARS-CoV-2: abin da ya faru na ɗan lokaci, ba ƙungiyar da ke da alaƙa ba: https://pubmed.ncbi.nlm.nih.gov/33968610/
  94. Magungunan SARS-CoV-2 na iya zama masu rikitarwa ba kawai ta cutar Guillain-Barré ba har ma ta hanyar ƙananan ƙwayoyin fiber neuropathy: https://pubmed.ncbi.nlm.nih.gov/34525410/
  95. Bambanci na asibiti na ciwo na Guillain-Barré tare da fitaccen fuskar diplegia bayan AstraZeneca 2019 rigakafin cutar coronavirus: https://pubmed.ncbi.nlm.nih.gov/34808658/
  96. Rahoto mara kyau da haɗarin palsy na Bell bayan rigakafin COVID-19: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext.
  97. Ciwon jijiyoyi na fuska biyu da kuma rigakafin COVID-19: sanadi ko daidaituwa: https://pubmed.ncbi.nlm.nih.gov/34522557/
  98. Ciwon Hagu na Bell bayan kashi na farko na rigakafin mRNA-1273 SARS-CoV-2: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34763263/.
  99. Bell's palsy bayan rigakafin da ba a kunna ba tare da COVID-19 a cikin mara lafiya da ke da tarihin ciwon gurguwar Bell: rahoton shari'a: https://pubmed.ncbi.nlm.nih.gov/34621891/
  100. Rikicin jijiyoyi bayan kashi na farko na rigakafin COVID-19 da kamuwa da cutar SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34697502/
  101. Nau'in I interferon a matsayin yuwuwar hanyar da ke haɗa allurar rigakafin mRNA na COVID-19 tare da palsy Bell: https://pubmed.ncbi.nlm.nih.gov/33858693/
  102. m transverse myelitis mai saurin kamuwa da cutar COVID-19 da ba a kunna ba: https://pubmed.ncbi.nlm.nih.gov/34370410/
  103. m transverse myelitis bayan COVID-19 alurar riga kafi: https://pubmed.ncbi.nlm.nih.gov/34579245/.
  104. Halin da ke tattare da myelitis mai tsayi mai tsayi mai tsayi bayan rigakafin Covid-19: https://pubmed.ncbi.nlm.nih.gov/34182207/
  105. Bayan COVID-19 transverse myelitis; rahoton shari'a tare da nazarin wallafe-wallafe: https://pubmed.ncbi.nlm.nih.gov/34457267/.
  106. Hattara da cutar neuromyelitis optica spectrum cuta bayan alurar riga kafi tare da ƙwayar cuta mara aiki don COVID-19: https://pubmed.ncbi.nlm.nih.gov/34189662/
  107. Neuromyelitis optica a cikin mace mai lafiya bayan alurar riga kafi game da matsanancin ciwo na numfashi na coronavirus 2 mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34660149/
  108. Mummunan neuritis na gani na biyu / chiasm mai tsayi mai tsayi mai tsayi a cikin tsayayyen barga mai yawa sclerosis bayan allurar tushen vector daga SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34131771/
  109. Jerin shari'ar m pericarditis bayan allurar rigakafi tare da COVID-19 a cikin mahallin rahotannin kwanan nan daga Turai da Amurka: https://pubmed.ncbi.nlm.nih.gov/34635376/
  110. M pericarditis da tamponade na zuciya bayan allurar rigakafi tare da Covid-19: https://pubmed.ncbi.nlm.nih.gov/34749492/
  111. Myocarditis da pericarditis a cikin samari bayan allurai na farko da na biyu na rigakafin COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34849667/
  112. Perimyocarditis a cikin samari bayan Pfizer-BioNTech COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34319393/
  113. Babban myopericarditis bayan rigakafin COVID-19 a cikin samari: https://pubmed.ncbi.nlm.nih.gov/34589238/
  114. Pericarditis bayan gudanar da maganin rigakafi na BNT162b2 mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34149145/
  115. Rahoton shari'ar: alamar pericarditis bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34693198/.
  116. Barkewar cutar har yanzu bayan rigakafin COVID-19 a cikin majiyyaci mai shekaru 34: https://pubmed.ncbi.nlm.nih.gov/34797392/
  117. Hemophagocytic lymphohistiocytosis bayan rigakafin COVID-19 (ChAdOx1 nCoV-19): https://pubmed.ncbi.nlm.nih.gov/34862234/
  118. Myocarditis bayan rigakafin SARS-CoV-2 mRNA, jerin lokuta: https://pubmed.ncbi.nlm.nih.gov/34396358/.
  119. Ciwon Miller-Fisher da Ciwon Guillain-Barré sun mamaye ciwo a cikin mara lafiya bayan Oxford-AstraZeneca SARS-CoV-2 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34848426/.
  120. Barkewar cutar ta hanyar rigakafi ko sabuwar cuta a cikin batutuwa 27 bayan rigakafin mRNA/DNA akan SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33946748/
  121. Binciken bayan mutuwa na mace-mace bayan allurar rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34591186/
  122. Raunin koda tare da macroscopic hematuria da IgA nephropathy bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34352309/
  123. Komawar thrombocytopenia na rigakafi bayan rigakafin covid-19 a cikin majinyata mara lafiya: https://pubmed.ncbi.nlm.nih.gov/34804803/.
  124. Immune thrombocytopenic purpura mai alaƙa da COVID-19 mRNA rigakafin Pfizer-BioNTech BNT16B2b2: https://pubmed.ncbi.nlm.nih.gov/34077572/
  125. Zubar da jini bayan SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34884407/.
  126. Rahoton shari'ar: anti-neutrophil cytoplasmic antibody-hade vasculitis tare da mummunan gazawar koda da zubar jini na huhu na iya faruwa bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34859017/
  127. Zubar da jini na intracerebral saboda vasculitis biyo bayan rigakafin COVID-19: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34783899/
  128. Peduncular, alamar zub da jini na cavernous bayan rigakafin thrombocytopenia-induced SARS-CoV-2 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34549178/.
  129. Mutuwar kwakwalwa a cikin mara lafiyar da aka yiwa alurar riga kafi tare da kamuwa da COVID-19: https://pubmed.ncbi.nlm.nih.gov/34656887/
  130. Gabaɗaya purpura annularis telangiectodes bayan rigakafin SARS-CoV-2 mRNA: https://pubmed.ncbi.nlm.nih.gov/34236717/.
  131. Hemorrhage na Lobar tare da fashewar ventricular jim kadan bayan kashi na farko na rigakafin SARS-CoV-2 mRNA na tushen SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34729467/.
  132. Wani lamari na fashewa na macroscopic hematuria da IgA nephropathy bayan rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33932458/
  133. Hemorrhage na Acral bayan gudanar da kashi na biyu na rigakafin SARS-CoV-2. Halin bayan allurar: https://pubmed.ncbi.nlm.nih.gov/34092400/742.
  134. Tsananin rigakafin thrombocytopenic purpura bayan rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34754937/
  135. Babban hematuria bayan mummunan cututtukan numfashi na coronavirus 2 allurar rigakafi a cikin marasa lafiya 2 tare da IgA nephropathy: https://pubmed.ncbi.nlm.nih.gov/33771584/
  136. Autoimmune encephalitis bayan ChAdOx1-S SARS-CoV-2 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34846583/
  137. Alurar rigakafin COVID-19 da mutuwa: algorithm na haddasawa bisa ga tantance cancantar WHO: https://pubmed.ncbi.nlm.nih.gov/34073536/
  138. Cutar sankarau ta Bell bayan alurar riga kafi tare da mRNA (BNT162b2) da marasa aiki (CoronaVac) rigakafin SARS-CoV-2: jerin shari'o'i da binciken kula da shari'a: https://pubmed.ncbi.nlm.nih.gov/34411532/
  139. Epidemiology na myocarditis da pericarditis bin allurar mRNA a cikin Ontario, Kanada: ta samfurin rigakafin, jadawalin, da tazara: https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1
  140. Anaphylaxis bin maganin Covid-19 a cikin mara lafiya tare da urticaria cholinergic: https://pubmed.ncbi.nlm.nih.gov/33851711/
  141. Anaphylaxis wanda CoronaVac COVID-19 ya jawo: fasali na asibiti da sakamakon sakewa: https://pubmed.ncbi.nlm.nih.gov/34675550/.
  142. Anaphylaxis bayan rigakafin COVID-19 na zamani: https://pubmed.ncbi.nlm.nih.gov/34734159/.
  143. Ƙungiya na tarihin kai rahoton kai na rashin lafiyar haɗari mai haɗari tare da alamun rashin lafiyar bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34698847/
  144. Bambance-bambancen jima'i a cikin abin da ya faru na anaphylaxis zuwa allurar LNP-mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34020815/
  145. Abubuwan rashin lafiyar jiki, gami da anaphylaxis, bayan sun karɓi kashi na farko na rigakafin Pfizer-BioNTech COVID-19 - Amurka, Disamba 14 zuwa 23, 2020: https://pubmed.ncbi.nlm.nih.gov/33641264/
  146. Rashin lafiyar jiki, gami da anaphylaxis, bayan an karɓi kashi na farko na rigakafin COVID-19 na zamani - Amurka, Disamba 21, 2020 zuwa Janairu 10, 2021: https://pubmed.ncbi.nlm.nih.gov/33641268/
  147. Anaphylaxis na tsawon lokaci zuwa Pfizer 2019 rigakafin cutar coronavirus: rahoton shari'a da tsarin aiki: https://pubmed.ncbi.nlm.nih.gov/33834172/
  148. Halin anaphylaxis ga Pfizer BNT162b2 rigakafin: rahoton lokuta 3 na anaphylaxis biyo bayan allurar rigakafi tare da Pfizer BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34579211/
  149. Biphasic anaphylaxis bayan kashi na farko na 2019 manzo RNA coronavirus maganin rigakafin cutar tare da ingantaccen sakamakon gwajin fata na polysorbate 80: https://pubmed.ncbi.nlm.nih.gov/34343674/
  150. Myocardial infarction da myocarditis bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34586408/
  151. Ciwon Takotsubo bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34539938/.
  152. Takotsubo cardiomyopathy bayan rigakafin coronavirus 2019 a cikin haƙuri akan kiyaye hemodialysis: https://pubmed.ncbi.nlm.nih.gov/34731486/.
  153. Ciwon zuciya na zuciya da wuri ko illar maganin COVID-19: https://pubmed.ncbi.nlm.nih.gov/33824804/
  154. Ciwon zuciya, bugun jini, da ciwon huhu bayan BNT162b2 mRNA COVID-19 a cikin mutane masu shekaru 75 ko fiye: https://pubmed.ncbi.nlm.nih.gov/34807248/
  155. Nau'in ciwon Kounis na 1 wanda aka jawo ta hanyar rigakafin SARS-COV-2 da ba a kunna ba: https://pubmed.ncbi.nlm.nih.gov/34148772/
  156. Myocardial infarction a cikin sa'o'i 24 bayan COVID-19 alurar riga kafi: Kounis ciwo ne mai laifi: https://pubmed.ncbi.nlm.nih.gov/34702550/
  157. Mutuwar da ke da alaƙa da rigakafin SARS-CoV-2 da aka ƙaddamar kwanan nan (Comirnaty®): https://pubmed.ncbi.nlm.nih.gov/33895650/
  158. Mutuwar da ke da alaƙa da ƙaddamar da rigakafin SARS-CoV-2 kwanan nan: https://pubmed.ncbi.nlm.nih.gov/34425384/
  159. Wani lamari na m encephalopathy da marasa ST-segment daga myocardial infarction bayan alurar riga kafi tare da mRNA-1273: yiwuwar mummunan sakamako: https://pubmed.ncbi.nlm.nih.gov/34703815/
  160. Urticarial vasculitis wanda ke haifar da rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34369046/.
  161. vasculitis mai alaƙa da ANCA bayan Pfizer-BioNTech COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34280507/.
  162. Sabon-farko leukocytoclastic vasculitis bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34241833/
  163. Cutaneous ƙananan jirgin ruwa vasculitis bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34529877/.
  164. Barkewar leukocytoclastic vasculitis bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/33928638/
  165. Leukocytoclastic vasculitis bayan kamuwa da cutar ta COVID-19: https://pubmed.ncbi.nlm.nih.gov/34836739/
  166. Vasculitis da bursitis a cikin [18 F] FDG-PET/CT bayan COVID-19 mRNA rigakafin: post hoc ergo propter hoc?; https://pubmed.ncbi.nlm.nih.gov/34495381/.
  167. Cutaneous lymphocytic vasculitis bayan gudanar da rigakafin COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34327795
  168. Cutaneous leukocytoclastic vasculitis wanda Sinovac COVID-19 ya haifar: https://pubmed.ncbi.nlm.nih.gov/34660867/.
  169. Rahoton shari'ar: vasculitis mai alaƙa da ANCA wanda ke gabatarwa tare da rhabdomyolysis da Pauci-Inmune glomerulonephritis bayan alurar riga kafi tare da Pfizer-BioNTech COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34659268/
  170. Sake kunna IgA vasculitis bayan alurar riga kafi tare da COVID-19: https://pubmed.ncbi.nlm.nih.gov/34848431/
  171. Varicella-zoster ƙwayar cuta mai alaƙa da ƙananan vasculitis bayan Pfizer-BioNTech COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34310759/.
  172. Hoto a cikin maganin jijiyoyin jini: leukocytoclastic vasculitis bayan COVID-19 mai ƙarfafa rigakafin: https://pubmed.ncbi.nlm.nih.gov/34720009/
  173. Wani lamari mai wuya na Henoch-Schönlein purpura bayan rahoton shari'ar rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34518812/
  174. Cutaneous vasculitis bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34611627/.
  175. Matsala mai yuwuwar COVID-19 mRNA rigakafin-jawo ƙananan-jigi vasculitis: https://pubmed.ncbi.nlm.nih.gov/34705320/.
  176. IgA vasculitis biyo bayan allurar COVID-19 a cikin manya: https://pubmed.ncbi.nlm.nih.gov/34779011/
  177. Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-hade vasculitis bayan allurar rigakafi tare da COVID-19: https://pubmed.ncbi.nlm.nih.gov/34451967/
  178. Alurar rigakafin cutar Coronavirus 2019 (COVID-19) a cikin tsarin lupus erythematosus da neutrophil anti-cytoplasmic antibody-Associated vasculitis: https://pubmed.ncbi.nlm.nih.gov/33928459/
  179. Sake kunna IgA vasculitis bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34250509/
  180. Bakan na asibiti da na tarihi na jinkirin halayen fata bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34292611/.
  181. Bayanin farko na hadaddun vasculitis na rigakafi bayan rigakafin COVID-19 tare da BNT162b2: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34530771/.
  182. Ciwon Nephrotic da vasculitis bayan rigakafin SARS-CoV-2: ƙungiya ta gaskiya ko yanayi: https://pubmed.ncbi.nlm.nih.gov/34245294/.
  183. Faruwar de novo cutaneous vasculitis bayan allurar rigakafin cutar coronavirus (COVID-19): https://pubmed.ncbi.nlm.nih.gov/34599716/.
  184. Asymmetric cutaneous vasculitis bayan COVID-19 alurar riga kafi tare da sabon abu na eosinophils: https://pubmed.ncbi.nlm.nih.gov/34115904/.
  185. Henoch-Schönlein purpura yana faruwa bayan alurar riga kafi tare da COVID-19: https://pubmed.ncbi.nlm.nih.gov/34247902/.
  186. Henoch-Schönlein purpura yana bin kashi na farko na COVID-19 rigakafin vector: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34696186/.
  187. Granulomatous vasculitis bayan maganin AstraZeneca anti-SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34237323/.
  188. Mummunan necrosis na retinal saboda sake kunnawar ƙwayar cuta ta varicella zoster bayan alurar riga kafi tare da BNT162b2 COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34851795/.
  189. Wani shari'ar gama-gari ta Sweet's ciwo tare da vasculitis ta haifar da rigakafin kwanan nan tare da COVID-19: https://pubmed.ncbi.nlm.nih.gov/34849386/
  190. Ƙananan vasculitis vasculitis yana bin Oxford-AstraZeneca allurar rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34310763/
  191. Komawa na microscopic polyangiitis bayan rigakafin COVID-19: rahoton shari'ar: https://pubmed.ncbi.nlm.nih.gov/34251683/.
  192. Cutaneous vasculitis bayan mummunan cututtukan numfashi na coronavirus 2: https://pubmed.ncbi.nlm.nih.gov/34557622/.
  193. Herpes zoster na yau da kullun bayan rigakafin COVID-19 a cikin marasa lafiya tare da urticaria na yau da kullun akan maganin cyclosporine - Rahoton lokuta 3: https://pubmed.ncbi.nlm.nih.gov/34510694/
  194. Leukocytoclastic vasculitis bayan rigakafin cutar coronavirus 2019: https://pubmed.ncbi.nlm.nih.gov/34713472/803
  195. Barkewar gauraye cryoglobulinemia vasculitis bayan allurar rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34819272/
  196. Cutaneous small-vesel vasculitis bayan allurar rigakafi tare da kashi ɗaya na Janssen Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34337124/
  197. Shari'ar immunoglobulin A vasculitis bayan allurar rigakafin cutar coronavirus 2019: https://pubmed.ncbi.nlm.nih.gov/34535924/
  198. Ci gaba da sauri na angioimmunoblastic T-cell lymphoma bayan BNT162b2 mRNA maganin rigakafi: rahoton shari'ar: https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/
  199. COVID-19 mRNA rigakafin cutar lymphadenopathy ya haifar da ci gaban lymphoma akan FDG PET / CT: https://pubmed.ncbi.nlm.nih.gov/33591026/
  200. Lymphadenopathy a cikin masu karɓar alurar rigakafin COVID-19: matsalar rashin lafiya a cikin marasa lafiyar oncology: https://pubmed.ncbi.nlm.nih.gov/33625300/
  201. Hypermetabolic lymphadenopathy bayan gudanar da maganin alurar rigakafi na BNT162b2 mRNA Covid-19: abin da ya faru da [18 F] FDG PET-CT da kuma dacewa don fassarar binciken: https://pubmed.ncbi.nlm.nih.gov/33774684/
  202. Lymphadenopathy bayan rigakafin COVID-19: nazarin binciken hoto: https://pubmed.ncbi.nlm.nih.gov/33985872/
  203. Juyin Halittar hypermetabolic axillary hypermetabolic lymphadenopathy akan FDG PET/CT bayan allurar COVID-2-19-XNUMX: https://pubmed.ncbi.nlm.nih.gov/34735411/
  204. Lymphadenopathy mai alaƙa da rigakafin COVID-19 akan FDG PET/CT: bambance-bambancen fasali a cikin rigakafin adenovirus-vectored: https://pubmed.ncbi.nlm.nih.gov/34115709/.
  205. Cutar sankara ta COVID-19 ta haifar da rigakafin cutar lymphadenopathy a cikin wani ƙwararren asibitin hoton nono a Isra'ila: nazarin shari'o'i 163: https://pubmed.ncbi.nlm.nih.gov/34257025/.
  206. Cutar sankara ta COVID-19 da ke da alaƙa da axillary lymphadenopathy a cikin masu cutar kansar nono: jerin shari'o'i tare da bitar wallafe-wallafe: https://pubmed.ncbi.nlm.nih.gov/34836672/.
  207. Alurar rigakafin cutar Coronavirus 2019 yana mimics metastases na ƙwayar lymph a cikin marasa lafiya da ke jurewa cutar sankara ta fata: nazarin tsakiya guda: https://pubmed.ncbi.nlm.nih.gov/34280870/
  208. COVID-19 lymphadenopathy bayan allurar rigakafi: rahoton kyakkyawan buri na cytologic biopsy: https://pubmed.ncbi.nlm.nih.gov/34432391/
  209. Lymphadenopathy na yanki bayan rigakafin COVID-19: bita na wallafe-wallafe da la'akari don gudanar da haƙuri a cikin kula da kansar nono: https://pubmed.ncbi.nlm.nih.gov/34731748/
  210. Subclinical axillary lymphadenopathy hade da COVID-19 allurar rigakafin mammography: https://pubmed.ncbi.nlm.nih.gov/34906409/
  1. Mummunan al'amuran da ke faruwa na allurar COVID da ka iya faruwa a cikin yara. Mummunan farkon farkon supraclavicular lymphadenopathy daidai da allurar mRNA na intramuscular da COVID-19 na iya kasancewa da alaƙa da fasahar allurar rigakafin, Spain, Janairu da Fabrairu 2021: https://pubmed.ncbi.nlm.nih.gov/33706861/
  2. Supraclavicular lymphadenopathy bayan COVID-19 alurar riga kafi a Koriya: jeri-bi-bi-bi-biyu ta ultrasonography: https://pubmed.ncbi.nlm.nih.gov/34116295/
  3. Oxford-AstraZeneca COVID-19 rigakafin cutar ta haifar da lymphadenopathy akan [18F] choline PET / CT, ba kawai binciken FDG ba: https://pubmed.ncbi.nlm.nih.gov/33661328/
  4. Biphasic anaphylaxis bayan fallasa zuwa kashi na farko na Pfizer-BioNTech COVID-19 mRNA maganin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34050949/
  5. Axillary adenopathy mai alaƙa da rigakafin COVID-19: binciken hoto da shawarwarin biyo baya a cikin mata 23: https://pubmed.ncbi.nlm.nih.gov/33624520/
  6. Wani lamari na lymphadenopathy na mahaifa bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34141500/
  7. Binciken hoto na musamman na neurologic phantosmia bayan Pfizer-BioNtech rigakafin COVID-19: rahoton shari'a: https://pubmed.ncbi.nlm.nih.gov/34096896/
  8. Abubuwan da ba su da kyau na Thrombotic da aka ruwaito don Moderna, Pfizer, da Oxford-AstraZeneca COVID-19 rigakafin: kwatankwacin abin da ya faru da sakamakon asibiti a cikin bayanan EudraVigilance: https://pubmed.ncbi.nlm.nih.gov/34835256/
  9. Unilateral lymphadenopathy bayan COVID-19 alurar riga kafi: tsarin gudanarwa mai amfani don masu aikin rediyo na kowane fanni: https://pubmed.ncbi.nlm.nih.gov/33713605/
  10. Unilateral axillary adenopathy a cikin saitin rigakafin COVID-19: biyo baya: https://pubmed.ncbi.nlm.nih.gov/34298342/
  11. Bita na tsari na shari'o'in CNS demyelination biyo bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34839149/
  12. Supraclavicular lymphadenopathy bayan rigakafin COVID-19: ƙarin gabatarwa a cikin asibitin jiran wuyan mako biyu: https://pubmed.ncbi.nlm.nih.gov/33685772/
  13. COVID-19 da ke da alaƙa da axillary da lymphadenopathy na mahaifa a cikin marasa lafiya tare da ciwon nono na yanzu ko na baya da sauran muggan laifuka: Sakamakon binciken hoto akan MRI, CT da PET-CT: https://pubmed.ncbi.nlm.nih.gov/34719892/
  14. Adenopathy bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/33625299/.
  15. Abubuwan da ke faruwa na axillary adenopathy akan hoton nono bayan alurar riga kafi tare da COVID-19: https://pubmed.ncbi.nlm.nih.gov/34292295/.
  16. Alurar riga kafi na COVID-19 da ƙananan ƙwayar cuta na mahaifa a cikin asibiti na mako biyu na wuyan wuyansa: duban bin diddigi: https://pubmed.ncbi.nlm.nih.gov/33947605/.
  17. Cervical lymphadenopathy bayan rigakafin cutar coronavirus 2019: fasali na asibiti da abubuwan da ke tattare da ayyukan kansa da wuyansa: https://pubmed.ncbi.nlm.nih.gov/34526175/
  18. Lymphadenopathy mai alaƙa da maganin COVID-19: https://pubmed.ncbi.nlm.nih.gov/33786231/
  19. Juyin Halitta na lymphadenopathy akan PET/MRI bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/33625301/.
  20. Autoimmune hepatitis ya jawo ta hanyar rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34332438/.
  21. Sabon-farko ciwon nephrotic bayan Janssen COVID-19 rigakafin: rahoton shari'a da bitar wallafe-wallafe: https://pubmed.ncbi.nlm.nih.gov/34342187/.
  22. Babban lymphadenopathy na mahaifa bayan allurar rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34601889/
  23. ANCA glomerulonephritis yana bin rigakafin COVID-19 na zamani: https://pubmed.ncbi.nlm.nih.gov/34081948/
  24. Faɗakarwar myelitis mai tsayi mai tsayi da ke bin AstraZeneca COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34507942/.
  25. Ciwon ƙwayar cuta na tsarin capillary bayan allurar rigakafi tare da ChAdOx1 nCOV-19 (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34362727/
  26. Unilateral axillary lymphadenopathy da ke da alaƙa da rigakafin COVID-19: tsari akan gwajin nono MRI yana ƙyale ƙima mara kyau: https://pubmed.ncbi.nlm.nih.gov/34325221/
  27. Axillary lymphadenopathy a cikin marasa lafiya tare da rigakafin Covid-19 na baya-bayan nan: wani sabon matsalar bincike: https://pubmed.ncbi.nlm.nih.gov/34825530/.
  28. Karancin canjin cuta da raunin koda bayan Pfizer-BioNTech COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34000278/
  29. COVID-19 adenopathy unilateral axillary adenopathy ya haifar da alurar rigakafi: kimantawa mai zuwa a cikin Amurka: https://pubmed.ncbi.nlm.nih.gov/34655312/.
  30. Gastroparesis bayan Pfizer-BioNTech COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34187985/.
  31. Mummunan farawar supraclavicular lymphadenopathy wanda ya yi daidai da allurar mRNA na intramuscular daga COVID-19 na iya kasancewa yana da alaƙa da fasahar allurar rigakafin, Spain, Janairu da Fabrairu 2021: https://pubmed.ncbi.nlm.nih.gov/33706861/
  32. Supraclavicular lymphadenopathy bayan COVID-19 alurar riga kafi a Koriya: jeri-bi-bi-bi-biyu ta ultrasonography: https://pubmed.ncbi.nlm.nih.gov/34116295/
  33. Oxford-AstraZeneca COVID-19 rigakafin cutar ta haifar da lymphadenopathy akan [18F] choline PET / CT, ba kawai binciken FDG ba: https://pubmed.ncbi.nlm.nih.gov/33661328/
  34. Biphasic anaphylaxis bayan fallasa zuwa kashi na farko na Pfizer-BioNTech COVID-19 mRNA maganin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34050949/
  35. Axillary adenopathy mai alaƙa da rigakafin COVID-19: binciken hoto da shawarwarin biyo baya a cikin mata 23: https://pubmed.ncbi.nlm.nih.gov/33624520/
  36. Wani lamari na lymphadenopathy na mahaifa bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34141500/
  37. Binciken hoto na musamman na neurologic phantosmia bayan Pfizer-BioNtech rigakafin COVID-19: rahoton shari'a: https://pubmed.ncbi.nlm.nih.gov/34096896/
  38. Abubuwan da ba su da kyau na Thrombotic da aka ruwaito don Moderna, Pfizer, da Oxford-AstraZeneca COVID-19 rigakafin: kwatankwacin abin da ya faru da sakamakon asibiti a cikin bayanan EudraVigilance: https://pubmed.ncbi.nlm.nih.gov/34835256/
  39. Unilateral lymphadenopathy bayan COVID-19 alurar riga kafi: tsarin gudanarwa mai amfani don masu aikin rediyo na kowane fanni: https://pubmed.ncbi.nlm.nih.gov/33713605/
  40. Unilateral axillary adenopathy a cikin saitin rigakafin COVID-19: biyo baya: https://pubmed.ncbi.nlm.nih.gov/34298342/
  41. Bita na tsari na shari'o'in CNS demyelination biyo bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34839149/
  42. Supraclavicular lymphadenopathy bayan rigakafin COVID-19: ƙarin gabatarwa a cikin asibitin jiran wuyan mako biyu: https://pubmed.ncbi.nlm.nih.gov/33685772/
  43. COVID-19 da ke da alaƙa da axillary da lymphadenopathy na mahaifa a cikin marasa lafiya tare da ciwon nono na yanzu ko na baya da sauran muggan laifuka: Sakamakon binciken hoto akan MRI, CT da PET-CT: https://pubmed.ncbi.nlm.nih.gov/34719892/
  44. Adenopathy bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/33625299/.
  45. Abubuwan da ke faruwa na axillary adenopathy akan hoton nono bayan alurar riga kafi tare da COVID-19: https://pubmed.ncbi.nlm.nih.gov/34292295/.
  46. Alurar riga kafi na COVID-19 da ƙananan ƙwayar cuta na mahaifa a cikin asibiti na mako biyu na wuyan wuyansa: duban bin diddigi: https://pubmed.ncbi.nlm.nih.gov/33947605/.
  47. Cervical lymphadenopathy bayan rigakafin cutar coronavirus 2019: fasali na asibiti da abubuwan da ke tattare da ayyukan kansa da wuyansa: https://pubmed.ncbi.nlm.nih.gov/34526175/
  48. Lymphadenopathy mai alaƙa da maganin COVID-19: https://pubmed.ncbi.nlm.nih.gov/33786231/
  49. Juyin Halitta na lymphadenopathy akan PET/MRI bayan rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/33625301/.
  50. Autoimmune hepatitis ya jawo ta hanyar rigakafin SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34332438/.
  51. Sabon-farko ciwon nephrotic bayan Janssen COVID-19 rigakafin: rahoton shari'a da bitar wallafe-wallafe: https://pubmed.ncbi.nlm.nih.gov/34342187/.
  52. Babban lymphadenopathy na mahaifa bayan allurar rigakafin COVID-19: https://pubmed.ncbi.nlm.nih.gov/34601889/
  53. ANCA glomerulonephritis yana bin rigakafin COVID-19 na zamani: https://pubmed.ncbi.nlm.nih.gov/34081948/
  54. Faɗakarwar myelitis mai tsayi mai tsayi da ke bin AstraZeneca COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34507942/.
  55. Ciwon ƙwayar cuta na tsarin capillary bayan allurar rigakafi tare da ChAdOx1 nCOV-19 (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34362727/
  56. Unilateral axillary lymphadenopathy da ke da alaƙa da rigakafin COVID-19: tsari akan gwajin nono MRI yana ƙyale ƙima mara kyau: https://pubmed.ncbi.nlm.nih.gov/34325221/
  57. Axillary lymphadenopathy a cikin marasa lafiya tare da rigakafin Covid-19 na baya-bayan nan: wani sabon matsalar bincike: https://pubmed.ncbi.nlm.nih.gov/34825530/.
  58. Karancin canjin cuta da raunin koda bayan Pfizer-BioNTech COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34000278/
  59. COVID-19 adenopathy unilateral axillary adenopathy ya haifar da alurar rigakafi: kimantawa mai zuwa a cikin Amurka: https://pubmed.ncbi.nlm.nih.gov/34655312/.
  60. Gastroparesis bayan Pfizer-BioNTech COVID-19 rigakafin: https://pubmed.ncbi.nlm.nih.gov/34187985/.
  61. Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, PR, Klein, K., . . . Danielides, S. (2021). Cikakken myocarditis da kumburin tsari na ɗan lokaci suna da alaƙa da rigakafin BNT162b2 mRNA COVID-19 a cikin marasa lafiya biyu. Int J Cardiol, 340, 119-121. doi:10.1016/j.ijcard.2021.08.018. https://www.ncbi.nlm.nih.gov/pubmed/34416319
  62. Abu Mouch, S., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L., . . . Berar Yanay, N. (2021). Myocarditis biyo bayan rigakafin COVID-19 mRNA. Alurar riga kafi, 39 (29), 3790-3793. doi:10.1016/j.alurar rigakafi.2021.05.087. https://www.ncbi.nlm.nih.gov/pubmed/34092429
  63. Albert, E., Aurigemma, G., Saucedo, J., & Gerson, DS (2021). Myocarditis bayan allurar COVID-19. Rediyol Case Rep, 16 (8), 2142-2145. doi:10.1016/j.radcr.2021.05.033. https://www.ncbi.nlm.nih.gov/pubmed/34025885
  64. Aye, YN, Mai, AS, Zhang, A., Lim, OZH, Lin, N., Ng, CH, . . . Tauna, NWS (2021). Myocardial Infarction da Myocarditis bayan Alurar rigakafin COVID-19. QJM. doi:10.1093/qjmed/hcab252. https://www.ncbi.nlm.nih.gov/pubmed/34586408
  65. Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI Mimic: Focal Myocarditis a cikin Matashi Mara lafiya Bayan mRNA COVID-19 Alurar. J Emerg Med, 61 (6), e129-e132. doi:10.1016/j.jemermed.2021.09.017. https://www.ncbi.nlm.nih.gov/pubmed/34756746
  66. Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., . . . Balicer, RD (2021). Amintaccen rigakafin BNT162b2 mRNA Covid-19 a cikin Saitin Ƙasa baki ɗaya. N Engl J Med, 385 (12), 1078-1090. doi:10.1056/NEJMoa2110475. https://www.ncbi.nlm.nih.gov/pubmed/34432976
  67. Bhandari, M., Pradhan, A., Vishwakarma, P., & Sethi, R. (2021). Coronavirus da bayyanar cututtukan zuciya - samun zuwa zuciyar al'amarin. Duniya J Cardiol, 13 (10), 556-565. doi:10.4330/wjc.v13.i10.556. https://www.ncbi.nlm.nih.gov/pubmed/34754400
  68. Bozkurt, B., Kamat, I., & Hotez, PJ (2021). Myocarditis Tare da COVID-19 mRNA Vaccines. Kewayawa, 144 (6), 471-484. doi:10.1161/CIRCULATIONAHA.121.056135. https://www.ncbi.nlm.nih.gov/pubmed/34281357
  69. Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J., & Heidecke, H. (2021). Sakin Autoantibody a cikin Yara bayan Cutar Corona Virus mRNA Alurar riga kafi: Halin Hatsari na Ciwon kumburin Multisystem? Alurar rigakafi (Basel), 9 (11). doi: 10.3390/alurar rigakafi9111353. https://www.ncbi.nlm.nih.gov/pubmed/34835284
  70. Calcaterra, G., Bassareo, PP, Barilla, F., Romeo, F., & Mehta, JL (2022). Game da yanayin prothrombotic da ba zato ba tsammani bayan wasu cututtukan coronavirus 2019. J Cardiovasc Med (Hagerstown), 23(2), 71-74. doi:10.2459/JCM.0000000000001232. https://www.ncbi.nlm.nih.gov/pubmed/34366403
  71. Calcaterra, G., Mehta, JL, de Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassareo, PP (2021). Alurar COVID 19 ga Matasa. Damuwa game da myocarditis da pericarditis. Wakilin Pediat, 13 (3), 530-533. doi: 10.3390 / likitan yara13030061. https://www.ncbi.nlm.nih.gov/pubmed/34564344
  72. Chai, Q., Nygaard, U., Schmidt, RC, Zaremba, T., Moller, AM, & Thorvig, CM (2022). Ciwon kumburin tsarin Multisystem a cikin matashin saurayi bayan maganin sa na biyu na Pfizer-BioNTech COVID-19. Acta Paediatr, 111 (1), 125-127. doi:10.1111/apa.16141. https://www.ncbi.nlm.nih.gov/pubmed/34617315
  73. Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., . . . Yilmaz, A. (2021). Faɗuwar myocarditis mai tsanani mai kama da cutar ta biyo bayan allurar COVID-19: kawai haɗarin haɗin gwiwa ne ko kuma mai alaƙa da allurar rigakafin cutar myocarditis? Clin Res Cardiol, 110 (11), 1850-1854. doi:10.1007/s00392-021-01916-w. https://www.ncbi.nlm.nih.gov/pubmed/34333695
  74. Chang, JC, & Hawley, HB (2021). Thrombocytopenia da Thrombosis mai Haɗin Alurar rigakafi: Venous Endotheliopathy yana kaiwa ga Haɗewar Micro-Macrothrombosis. Medicina (Kaunas), 57(11). doi:10.3390/magunguna57111163. https://www.ncbi.nlm.nih.gov/pubmed/34833382
  75. Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Binciken MRI na zuciya na Myocarditis Bayan COVID-19 mRNA Alurar rigakafi a cikin Matasa. AJR Am J Roentgenol. doi:10.2214/AJR.21.26853. https://www.ncbi.nlm.nih.gov/pubmed/34704459
  76. Choi, S., Lee, S., Seo, JW, Kim, MJ, Jeon, YH, Park, JH, . . . Yau, NS (2021). Mutuwar Kwatsam ta haifar da Myocarditis bayan BNT162b2 mRNA COVID-19 Alurar riga kafi a Koriya: Rahoton Case Mai da hankali kan Binciken Tarihi. J Korean Med Sci, 36(40), e286. doi:10.3346/jkms.2021.36.e286. https://www.ncbi.nlm.nih.gov/pubmed/34664804
  77. Chouchana, L., Blet, A., Al-Khalaf, M., Kafil, TS, Nair, G., Roblee, J., . . . Liu, PP (2021). Siffofin Maganganun Zuciya Masu Kumburi Bayan mRNA COVID-19 Alurar riga kafi a Matsayin Duniya. Clin Pharmacol Ther. doi:10.1002/cpt.2499. https://www.ncbi.nlm.nih.gov/pubmed/34860360
  78. Chua, GT, Kwan, MYW, Chui, CSL, Smith, RD, Cheung, EC, Tian, T., . . . Ip, P. (2021). Annobar Cutar Myocarditis/Pericarditis a cikin Matasa na Hong Kong Bayan Alurar riga kafi. Clin Infect Dis. doi:10.1093/cid/ciab989. https://www.ncbi.nlm.nih.gov/pubmed/34849657
  79. Clarke, R., & Ioannou, A. (2021). Shin ya kamata a yi amfani da taswirar T2 a lokuta na maimaita myocarditis don bambanta tsakanin kumburi mai tsanani da tabo na yau da kullum? J Pediatr. doi:10.1016/j.jpeds.2021.12.026. https://www.ncbi.nlm.nih.gov/pubmed/34933012
  80. Colaneri, M., De Filippo, M., Licari, A., Marseglia, A., Maiocchi, L., Ricciardi, A., . . . Bruno, R. (2021). Alurar riga kafi na COVID da haɓakar asma: shin za a iya samun hanyar haɗi? Int J Infect Dis, 112, 243-246. doi:10.1016/j.ijid.2021.09.026. https://www.ncbi.nlm.nih.gov/pubmed/34547487
  81. Das, BB, Kohli, U., Ramachandran, P., Nguyen, HH, Greil, G., Hussain, T., . . . Khan, D. (2021). Myopericarditis bayan manzon RNA Coronavirus Cutar 2019 Alurar riga kafi a cikin Matasa 12 zuwa 18 Shekaru. J Pediatr, 238, 26-32 e21. doi:10.1016/j.jpeds.2021.07.044. https://www.ncbi.nlm.nih.gov/pubmed/34339728
  82. Das, BB, Moskowitz, WB, Taylor, MB, & Palmer, A. (2021). Myocarditis da Pericarditis Bin mRNA COVID-19 Alurar rigakafi: Me Muka Sani Ya zuwa yanzu? Yara (Basel), 8 (7). doi: 10.3390 / yara8070607. https://www.ncbi.nlm.nih.gov/pubmed/34356586
  83. Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Raunin Ciwon Zuciya Mai Mutuwa Bayan Alurar COVID-19: Rahoton Harka da Bitar Shaida ta Yanzu Daga Tushen Bayar da Rahoton Abubuwan Al'amuran Alurar. J Prim Care Community Health, 12, 21501327211029230. doi:10.1177/21501327211029230. https://www.ncbi.nlm.nih.gov/pubmed/34219532
  84. Dickey, JB, Albert, E., Badr, M., Laraja, KM, Sena, LM, Gerson, DS,. . . Aurigemma, GP (2021). Jerin Marasa lafiya Masu fama da Myocarditis Bin SARS-CoV-2 Alurar rigakafin mRNA-1279 da BNT162b2. JACC Hoton Cardiovasc, 14 (9), 1862-1863. doi:10.1016/j.jcmg.2021.06.003. https://www.ncbi.nlm.nih.gov/pubmed/34246585
  85. Dimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, MN, & Maritsi, DN (2021). Amincewa da juriya na COVID-19 mRNA-alurar rigakafi a cikin samari masu fama da cututtukan cututtukan cututtukan cututtukan cututtukan yara kan jiyya tare da masu hana TNF. Arthritis Rheumatol. doi:10.1002/art.41977. https://www.ncbi.nlm.nih.gov/pubmed/34492161
  86. Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M., & Maritsi, D. (2021). Immunogenicity na maganin COVID-19 mRNA a cikin samari masu fama da cututtukan wariyar launin fata na yara akan jiyya tare da masu hana TNF. Ann Rheum Dis. doi:10.1136/annrheumdis-2021-221607. https://www.ncbi.nlm.nih.gov/pubmed/34844930
  87. Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Huttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). Biopsy-tabbatar da lymphocytic myocarditis biyo bayan mRNA COVID-19 na farko rigakafin a cikin namiji mai shekaru 40: rahoton shari'a. Clin Res Cardiol, 110 (11), 1855-1859. doi:10.1007/s00392-021-01936-6. https://www.ncbi.nlm.nih.gov/pubmed/34487236
  1. El Sahly, HM, Baden, LR, Essink, B., Doblecki-Lewis, S., Martin, JM, Anderson, EJ, . . . Rukuni, CS (2021). Ingantacciyar rigakafin mRNA-1273 SARS-CoV-2 a Kammala Matakin Makafi. N Engl J Med, 385(19), 1774-1785. doi:10.1056/NEJMoa2113017. https://www.ncbi.nlm.nih.gov/pubmed/34551225
  2. Facetti, S., Giraldi, M., Vecchi, AL, Rogiani, S., & Nassiacos, D. (2021). [Myocarditis mai tsanani a cikin wani matashi baligi kwana biyu bayan allurar Pfizer]. G Ital Cardiol (Rome), 22 (11), 891-893. doi:10.1714/3689.36746. https://www.ncbi.nlm.nih.gov/pubmed/34709227
  3. Fazlollahi, A., Zahmatyar, M., Noori, M., Nejadghaderi, SA, Sullman, MJM, Shekarriz-Foumani, R., . . . Safiri, S. (2021). Rikicin zuciya bayan mRNA COVID-19 alluran rigakafi: Tsare-tsare bita na rahotannin shari'a da jerin shari'o'i. Rev Med Virol, e2318. doi:10.1002/rmv.2318. https://www.ncbi.nlm.nih.gov/pubmed/34921468
  4. Fazolo, T., Lima, K., Fontoura, JC, de Souza, PO, Hilario, G., Zorzetto, R., . . . Bonorino, C. (2021). Marasa lafiya na COVID-19 na yara a Kudancin Brazil suna nuna ɗimbin ƙwayar cuta ta mRNA da takamaiman martani na rigakafin cutar. Nat Commun, 12 (1), 6844. doi: 10.1038/s41467-021-27120-y. https://www.ncbi.nlm.nih.gov/pubmed/34824230
  5. Fikenzer, S., & Laufs, U. (2021). Gyara zuwa: Martani ga Wasiƙa ga masu gyara suna magana akan Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U. (2020). Tasirin tiyata da FFP2/N95 abin rufe fuska akan karfin motsa jiki na zuciya. Bincike na asibiti a cikin ilimin zuciya: jarida na hukuma na Jamus Cardiac Society, 1-9. Bugawa kan layi gaba. https://doi.org/10.1007/s00392-020-01704-y. Clin Res Cardiol, 110 (8), 1352. doi: 10.1007/s00392-021-01896-x. https://www.ncbi.nlm.nih.gov/pubmed/34170372
  6. Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., . . . Montstruc, F. (2021). Myocarditis da Pericarditis a cikin Matasa bayan allurai na farko da na biyu na rigakafin mRNA COVID-19. Eur Heart J Qual Care Clin Sakamakon. doi:10.1093/ehjqcco/qcab090. https://www.ncbi.nlm.nih.gov/pubmed/34849667
  7. Forgacs, D., Jang, H., Abreu, RB, Hanley, HB, Gattiker, JL, Jefferson, AM, & Ross, TM (2021). Rigar SARS-CoV-2 mRNA tana Haɓaka Amsoshi Daban-daban a cikin Immunologically Naive da Pre-Immune Humanan Adam. Gaban Immunol, 12, 728021. doi:10.3389/fimmu.2021.728021. https://www.ncbi.nlm.nih.gov/pubmed/34646267
  8. Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., . . . Elkayam, O. (2021). Immunogenicity da amincin rigakafin BNT162b2 mRNA COVID-19 a cikin manya marasa lafiya tare da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan hai da kuma sauran jama'a. Ann Rheum Dis, 80 (10), 1330-1338. doi:10.1136/annrheumdis-2021-220647. https://www.ncbi.nlm.nih.gov/pubmed/34127481
  9. Galindo, R., Chow, H., & Rongkavilit, C. (2021). COVID-19 a cikin Yara: Bayyanar Asibiti da Matsalolin Magunguna gami da Gwajin Alurar riga kafi. Pediatr Clin North Am, 68(5), 961-976. doi:10.1016/j.pcl.2021.05.004. https://www.ncbi.nlm.nih.gov/pubmed/34538306
  10. Gargano, JW, Wallace, M., Hadler, SC, Langley, G., Su, JR, Oster, ME, . . . Oliver, SE (2021). Amfani da MRNA COVID-19 Vaccine Bayan Rahoton Myocarditis Daga Cikin Masu Samun Alurar: Sabuntawa daga Kwamitin Ba da Shawarwari kan Ayyukan rigakafi - Amurka, Yuni 2021. MMWR Morb Mortal Wkly Rep, 70(27), 977-982. doi:10.15585/mmwr.mm7027e2. https://www.ncbi.nlm.nih.gov/pubmed/34237049
  11. Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., & Diemberger, I. (2021). Alurar riga-kafin mura da Myo-Pericarditis a cikin Marasa lafiya Masu Karɓi Masu hana Kayayyakin Tsaro na rigakafi: Binciken Yiwuwar Ma'amala ta Tsarin Bayar da Bala'i na Alurar rigakafi da VigiBase. Alurar rigakafi (Basel), 9 (1). doi: 10.3390/alurar rigakafi9010019. https://www.ncbi.nlm.nih.gov/pubmed/33406694
  12. Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T., & Al'Aref, S. (2021). Batun Gabatarwa na COVID-19 Myocarditis da ke haifar da rigakafin cutar. Cureus, 13 (9), e17890. doi:10.7759/cureus.17890. https://www.ncbi.nlm.nih.gov/pubmed/34660088
  13. Gellad, WF (2021). Myocarditis bayan allurar rigakafin covid-19. BMJ, 375, n3090. doi:10.1136/bmj.n3090. https://www.ncbi.nlm.nih.gov/pubmed/34916217
  14. Greenhawt, M., Abrams, EM, Shaker, M., Chu, DK, Khan, D., Akin, C., . . . Golden, DBK (2021). Haɗarin Rashin Lafiyar Ra'ayin Ga Rigakafin SARS-CoV-2 da Shawarar Kima da Gudanarwa: Bita na Tsari, Nazarin Meta, Ƙimar GRADE, da Hanyar Yarjejeniya ta Duniya. J Allergy Clin Immunol Pract, 9 (10), 3546-3567. doi:10.1016/j.jaip.2021.06.006. https://www.ncbi.nlm.nih.gov/pubmed/34153517
  15. Haaf, P., Kuster, GM, Mueller, C., Berger, CT, Monney, P., Burger, P., . . . Tanner, FC (2021). Ƙananan haɗarin myocarditis da pericarditis bayan rigakafin mRNA COVID-19 bai kamata ya hana rigakafin ba. Swiss Med Wkly, 151, w30087. doi:10.4414/smw.2021.w30087. https://www.ncbi.nlm.nih.gov/pubmed/34668687
  16. Hasnie, AA, Hasnie, UA, Patel, N., Aziz, MU, Xie, M., Lloyd, SG, & Prabhu, SD (2021). Perimyocarditis bin kashi na farko na rigakafin mRNA-1273 SARS-CoV-2 (Moderna) a cikin saurayi mai koshin lafiya: rahoton shari'a. BMC Ciwon Zuciya, 21 (1), 375. doi: 10.1186/s12872-021-02183-3. https://www.ncbi.nlm.nih.gov/pubmed/34348657
  17. Hause, AM, Gee, J., Baggs, J., Abara, WE, Marquez, P., Thompson, D., . . . Shayi, DK (2021). Amintaccen Alurar rigakafin COVID-19 a cikin Matasa Masu Shekaru 12-17 - Amurka, Disamba 14, 2020-Yuli 16, 2021. MMWR Morb Mortal Wkly Rep, 70(31), 1053-1058. doi:10.15585/mmwr.mm7031e1. https://www.ncbi.nlm.nih.gov/pubmed/34351881
  18. Helms, JM, Ansteatt, KT, Roberts, JC, Kamatam, S., Foong, KS, Labayog, JS, & Tarantino, MD (2021). Tsanani, Mai Rage Immune Thrombocytopenia yana faruwa Bayan rigakafin SARS-CoV-2. J Jinin Med, 12, 221-224. doi:10.2147/JBM.S307047. https://www.ncbi.nlm.nih.gov/pubmed/33854395
  19. Hippisley-Cox, J., Patone, M., Mei, XW, Saatci, D., Dixon, S., Khunti, K., . . . Coupland, CAC (2021). Hadarin thrombocytopenia da thromboembolism bayan rigakafin covid-19 da ingantaccen gwajin SARS-CoV-2: nazarin jerin shari'o'in sarrafa kai. BMJ, 374, n1931. doi:10.1136/bmj.n1931. https://www.ncbi.nlm.nih.gov/pubmed/34446426
  20. Ho, JS, Sia, CH, Ngiam, JN, Loh, PH, Chew, NW, Kong, WK, & Poh, KK (2021). Bita na rigakafin COVID-19 da bayyanar cututtukan zuciya da aka ruwaito. Singapore Med J. doi:10.11622/smedj.2021210. https://www.ncbi.nlm.nih.gov/pubmed/34808708
  21. Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Rahoto Masu Tarukan Tattaunawa na Anaphylaxis Bayan mRNA COVID-19 Alurar rigakafi (Pfizer-BioNTech) allura a Japan: Rahoton Watan Farko. Drug Saf, 44 (11), 1209-1214. doi:10.1007/s40264-021-01104-9. https://www.ncbi.nlm.nih.gov/pubmed/34347278
  22. A takaice: Myocarditis tare da Pfizer/BioNTech da Moderna COVID-19. (2021). Med Lett Drugs Ther, 63(1629), e9. An dawo daga https://www.ncbi.nlm.nih.gov/pubmed/34544112https://www.ncbi.nlm.nih.gov/pubmed/3454412
  23. Ioannou, A. (2021). Ya kamata a yi la'akari da myocarditis a cikin waɗanda ke da hawan troponin da jijiyoyin jini marasa toshe bayan Pfizer-BioNTech COVID-19 rigakafin. QJM. doi:10.1093/qjmed/hcab231. https://www.ncbi.nlm.nih.gov/pubmed/34463755
  24. Ioannou, A. (2021b). Ya kamata a yi amfani da taswirar T2 a lokuta da ake zargin myocarditis don tabbatar da wani mummunan tsari mai kumburi. QJM. doi:10.1093/qjmed/hcab326. https://www.ncbi.nlm.nih.gov/pubmed/34931681
  25. Isaak, A., Feisst, A., & Luetkens, JA (2021). Myocarditis Bayan Alurar COVID-19. Radiology, 301 (1), E378-E379. doi:10.1148/radiol.2021211766. https://www.ncbi.nlm.nih.gov/pubmed/34342500
  26. Istampoulouoglou, I., Dimitriou, G., Sipaniya, S., Christ, A., Zimmermanns, B., Koechlin, S., . . . Leuppi-Taegtmeyer, AB (2021). Myocarditis da pericarditis a cikin haɗin gwiwa tare da COVID-19 mRNA-alurar rigakafi: lokuta daga cibiyar kula da magunguna na yanki. Glob Cardiol Sci Pract, 2021(3), e202118. doi:10.21542/gcsp.2021.18. https://www.ncbi.nlm.nih.gov/pubmed/34805376
  27. Jaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S., . . . La Scola, B. (2021). Babban Bambance-bambancen ɗaiɗaikun ɗaiɗaikun Ayyukan Neutralizing a kan Asali na Asali da Bambance-bambancen tara na SARS-CoV-2. Kwayoyin cuta, 13(11). doi:10.3390/v13112177. https://www.ncbi.nlm.nih.gov/pubmed/34834983
  28. Jain, SS, Steele, JM, Fonseca, B., Huang, S., Shah, S., Maskatia, SA,. . . Grosse-Wortmann, L. (2021). Myocarditis mai alaƙa da rigakafin COVID-19 a cikin Matasa. Likitan Yara, 148(5). doi:10.1542/peds.2021-053427. https://www.ncbi.nlm.nih.gov/pubmed/34389692
  29. Jhaveri, R., Adler-Shohet, FC, Blyth, CC, Chiotos, K., Gerber, JS, Green, M., . . . Zaoutis, T. (2021). Yin Auna Hadarin Perimyocarditis Tare da Fa'idodin rigakafin SARS-CoV-2 mRNA a cikin Matasa. J Ciwon Yara na Yara Dis Soc, 10 (10), 937-939. doi:10.1093/jpids/piab061. https://www.ncbi.nlm.nih.gov/pubmed/34270752
  30. Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Saurayi Namiji Tare da Myocarditis Bayan MRNA-1273 Alurar rigakafin Cutar Coronavirus-2019 (COVID-19). Circ J. doi:10.1253/circj.CJ-21-0818. https://www.ncbi.nlm.nih.gov/pubmed/34744118
  31. Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., . . . Panza, JA (2021). Myocarditis bayan allurar COVID-19. Int J Cardiol Zuciya Vasc, 36, 100872. doi:10.1016/j.ijcha.2021.100872. https://www.ncbi.nlm.nih.gov/pubmed/34568540
  32. Khogali, F., & Abdelrahman, R. (2021). Gabatarwar da ba a saba da shi ba na Mugun Perimyocarditis Bayan SARS-COV-2 mRNA-1237 Moderna Alurar riga kafi. Cureus, 13 (7), e16590. doi:10.7759/cureus.16590. https://www.ncbi.nlm.nih.gov/pubmed/34447639
  33. Kim, HW, Jenista, ER, Wendell, DC, Azevedo, CF, Campbell, MJ, Darty, SN, . . . Kim, RJ (2021). Marasa lafiya da Myocarditis Mai Mutuwar MRNA COVID-19 Alurar riga kafi. JAMA Cardiol, 6 (10), 1196-1201. doi:10.1001/jamacardio.2021.2828. https://www.ncbi.nlm.nih.gov/pubmed/34185046
  34. Kim, IC, Kim, H., Lee, HJ, Kim, JY, & Kim, JY (2021). Hoton Zuciya na Myocarditis Mai Mutuwar Ciwon Cutar COVID-19 mRNA. J Korean Med Sci, 36(32), e229. doi:10.3346/jkms.2021.36.e229. https://www.ncbi.nlm.nih.gov/pubmed/34402228
  35. King, WW, Petersen, MR, Matar, RM, Budweg, JB, Cuervo Pardo, L., & Petersen, JW (2021). Myocarditis bayan rigakafin mRNA daga SARS-CoV-2, jerin shari'o'i. Am Heart J Plus, 8, 100042. doi:10.1016/j.ahjo.2021.100042. https://www.ncbi.nlm.nih.gov/pubmed/34396358
  36. Klein, NP, Lewis, N., Goddard, K., Fireman, B., Zerbo, O., Hanson, KE, . . . Weintraub, ES (2021). Sa ido don Mummunan Al'amuran Bayan COVID-19 mRNA Alurar riga kafi. JAMA, 326 (14), 1390-1399. doi:10.1001/jama.2021.15072. https://www.ncbi.nlm.nih.gov/pubmed/34477808
  37. Klimek, L., Bergmann, KC, Brehler, R., Pfutzner, W., Zuberbier, T., Hartmann, K., . . . Tsutsa, M. (2021). Haɓaka aikin rashin lafiyan ga allurar COVID-19: Takardar matsayi daga Jamusanci da Allergy Societies AeDA, DGAKI, GPA da OGAI. Allergo J Int, 1-17. doi:10.1007/s40629-021-00165-7. https://www.ncbi.nlm.nih.gov/pubmed/33898162
  38. Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., . . . Tsutsa, M. (2021). Mummunan halayen rashin lafiyan bayan allurar COVID-19 tare da allurar Pfizer/BioNTech a cikin Burtaniya da Amurka: Bayanin matsayi na Ƙungiyoyin Allergy na Jamus: Ƙungiyar Likitoci na Jamusawa Allergologists (AeDA), Ƙungiyar Jama'a don Allergology da Clinical Immunology (DGAKI) da Society for Pediatric Allergology da Muhalli (GPA Medicine). Allergo J Int, 30 (2), 51-55. doi:10.1007/s40629-020-00160-4. https://www.ncbi.nlm.nih.gov/pubmed/33643776
  39. Kohli, U., Desai, L., Chowdhury, D., Harahsheh, AS, Yonts, AB, Ansong, A., . . . Kuma, JY (2021). mRNA Coronavirus-19 Myopericarditis mai alaƙa da Alurar rigakafi a cikin Matasa: Nazarin Bincike. J Pediatr. doi:10.1016/j.jpeds.2021.12.025. https://www.ncbi.nlm.nih.gov/pubmed/34952008
  40. Kostoff, RN, Calina, D., Kanduc, D., Briggs, MB, Vlachoyiannopoulos, P., Svistunov, AA, & Tsatsakis, A. (2021a). Erratum zuwa "Me yasa muke yiwa yara rigakafin COVID-19?" [Toxicol. Wakili 8C (2021) 1665-1684 / 1193]. Toxicol Rep, 8, 1981. doi:10.1016/j.toxrep.2021.10.003. https://www.ncbi.nlm.nih.gov/pubmed/34642628
  41. Kostoff, RN, Calina, D., Kanduc, D., Briggs, MB, Vlachoyiannopoulos, P., Svistunov, AA, & Tsatsakis, A. (2021b). Me yasa muke yiwa yara rigakafin COVID-19? Toxicol Rep, 8, 1665-1684. doi:10.1016/j.toxrep.2021.08.010. https://www.ncbi.nlm.nih.gov/pubmed/34540594
  42. Kremsner, PG, Mann, P., Kroidl, A., Leroux-Roels, I., Schindler, C., Gabor, JJ, . . . Rukunin, C.-N.-S. (2021). Aminci da rigakafi na ɗan takarar rigakafi na mRNA-lipid nanoparticle a kan SARS-CoV-2: gwaji na asibiti bazuwar lokaci na 1. Wien Klin Wochenschr, 133 (17-18), 931-941. doi:10.1007/s00508-021-01922-y. https://www.ncbi.nlm.nih.gov/pubmed/34378087
  43. Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., . . . Stern, A. (2021). Shaida don haɓaka ƙimar bambance-bambancen SARS-CoV-2 na damuwa a cikin mutanen da aka yiwa BNT162b2-mRNA. Nat Med, 27 (8), 1379-1384. doi:10.1038/s41591-021-01413-7. https://www.ncbi.nlm.nih.gov/pubmed/34127854
  44. Kwan, MYW, Chua, GT, Chow, CB, Tsao, SSL, To, KKW, Yuen, KY, . . . Ip, P. (2021). mRNA COVID maganin rigakafi da myocarditis a cikin samari. Hong Kong Med J, 27 (5), 326-327. doi:10.12809/hkmj215120. https://www.ncbi.nlm.nih.gov/pubmed/34393110
  1. Lee, E., Chew, NWS, Ng, P., & Yeo, TJ (2021). Amsa ga "Wasika zuwa ga edita: Ya kamata a yi la'akari da Myocarditis a cikin waɗanda ke da hawan troponin da jijiyoyin jijiyoyin jini ba tare da toshe su ba bayan PfizerBioNTech COVID-19 rigakafin". QJM. doi:10.1093/qjmed/hcab232. https://www.ncbi.nlm.nih.gov/pubmed/34463770
  2. Lee, EJ, Cines, DB, Gernsheimer, T., Kessler, C., Michel, M., Tarantino, MD, . . . Bussel, JB (2021). Thrombocytopenia yana bin Pfizer da Moderna SARS-CoV-2 allurar rigakafi. Am J Hematol, 96 (5), 534-537. doi:10.1002/ajh.26132. https://www.ncbi.nlm.nih.gov/pubmed/33606296
  3. Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., . . . Gordon, B. (2021). Myocarditis biyo bayan allurar COVID-19 - Jerin shari'a. Alurar riga kafi, 39 (42), 6195-6200. doi:10.1016/j.alurar rigakafi.2021.09.004. https://www.ncbi.nlm.nih.gov/pubmed/34535317
  4. Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H., . . . Zhu, F. (2021). Aminci da rigakafi na rigakafin SARS-CoV-2 BNT162b1 mRNA a cikin matasa da manya na kasar Sin: bazuwar, sarrafa wuribo, nazarin kashi biyu na makafi. Nat Med, 1 (27), 6-1062. doi:1070/s10.1038-41591-021-01330. https://www.ncbi.nlm.nih.gov/pubmed/33888900
  5. Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, ZK (2021). Myocarditis da Pericarditis suna bin rigakafin COVID-19: Rashin daidaito a cikin Shekaru da Nau'in Alurar riga kafi. J Pers Med, 11 (11). doi:10.3390/jpm11111106. https://www.ncbi.nlm.nih.gov/pubmed/34834458
  6. Lim, Y., Kim, MC, Kim, KH, Jeong, IS, Cho, YS, Choi, YD, & Lee, JE (2021). Rahoton Case: Myocarditis Mai Ciki Mai Ciki da Ciwon Jiki Bayan Manzo RNA Coronavirus Cutar 2019 Rigakafin Bukatar Farfaɗowar Ciwon Zuciya na Extracorporeal. Gaban Cardiovasc Med, 8, 758996. doi:10.3389/fcvm.2021.758996. https://www.ncbi.nlm.nih.gov/pubmed/34778411
  7. Dogon, SS (2021). Muhimman bayanai cikin Myopericarditis bayan Pfizer mRNA COVID-19 Alurar rigakafi a cikin Matasa. J Pediatr, 238, 5. doi:10.1016/j.jpeds.2021.07.057. https://www.ncbi.nlm.nih.gov/pubmed/34332972
  8. Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., . . . McDonald, M. (2021). Myocarditis da Pericarditis Bayan COVID-19 Alurar rigakafin mRNA: La'akari da Mahimmanci don Masu Ba da Kulawa. Can J Cardiol, 37 (10), 1629-1634. doi:10.1016/j.cjca.2021.08.001. https://www.ncbi.nlm.nih.gov/pubmed/34375696
  9. Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, DO,. . . Eberhardt, CS (2021). Amsoshin ƙwayoyin ƙwayoyin T masu ƙarfi a cikin anti-CD20 da aka yi wa marasa lafiya biyo bayan rigakafin COVID-19: nazarin ƙungiyar masu zuwa. Clin Infect Dis. doi:10.1093/cid/ciab954. https://www.ncbi.nlm.nih.gov/pubmed/34791081
  10. Mangat, C., & Milosavljevic, N. (2021). BNT162b2 Alurar riga kafi a lokacin daukar ciki Yana Kare duka Uwa da Jariri: Anti-SARS-CoV-2 S Antibodies dawwama a cikin Jariri a cikin Watanni 6. Case Rep Pediatr, 2021, 6901131. doi:10.1155/2021/6901131. https://www.ncbi.nlm.nih.gov/pubmed/34676123
  11. Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A., . . . Alexander, S. (2021). Amintaccen gudanarwa na BNT162b2 mRNA (Pfizer-BioNTech) rigakafin COVID-19 a cikin matasa da matasa masu tarihin cutar sankarar bargo ta lymphoblastic da rashin lafiyar PEG-asparaginase. Pediatr Ciwon Jini, 68(11), e29295. doi:10.1002/pbc.29295. https://www.ncbi.nlm.nih.gov/pubmed/34398511
  1. Martins-Filho, PR, Quintans-Junior, LJ, de Souza Araujo, AA, Sposato, KB, Souza Tavares, CS, Gurgel, RQ, . . . Santos, VS (2021). Rashin daidaiton zamantakewa da tattalin arziki da cutar COVID-19 da mace-mace a cikin yaran Brazil: nazari na tushen rajista na ƙasa baki ɗaya. Kiwon Lafiyar Jama'a, 190, 4-6. doi:10.1016/j.puhe.2020.11.005. https://www.ncbi.nlm.nih.gov/pubmed/33316478
  2. McLean, K., & Johnson, TJ (2021). Myopericarditis a cikin wani saurayi mai koshin lafiya a baya bayan rigakafin COVID-19: Rahoton shari'a. Acad Emerg Med, 28 (8), 918-921. doi:10.1111/acem.14322. https://www.ncbi.nlm.nih.gov/pubmed/34133825
  3. Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, EJ, Nadir, E., . . . Alroy-Preis, S. (2021). Myocarditis bayan BNT162b2 mRNA Alurar rigakafin Covid-19 a cikin Isra'ila. N Engl J Med, 385(23), 2140-2149. doi:10.1056/NEJMoa2109730. https://www.ncbi.nlm.nih.gov/pubmed/34614328
  4. Minocha, PK, Better, D., Singh, RK, & Hoque, T. (2021). Maimaita Cutar Myocarditis Mai Haɗawa Na ɗan lokaci tare da Karɓi Cutar Cutar MRNA Coronavirus 2019 (COVID-19) a cikin Matasa Namiji. J Pediatr, 238, 321-323. doi:10.1016/j.jpeds.2021.06.035. https://www.ncbi.nlm.nih.gov/pubmed/34166671
  5. Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Perez, G., Ben-Tov, A., . . . Patlon, T. (2021). Haɗin kai na SARS-CoV-2-cututtukan ci gaba zuwa lokaci-daga-alurar rigakafi. Nat Commun, 12 (1), 6379. doi: 10.1038/s41467-021-26672-3. https://www.ncbi.nlm.nih.gov/pubmed/34737312
  6. Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C., & Malley, R. (2021). Binciken Staphylococcus aureus Transcriptome a cikin Ƙunƙarar Nama mai laushi na Yara da Kwatanta da Cututtukan Murine. Kamuwa da Immun, 89(4). doi:10.1128/IAI.00715-20. https://www.ncbi.nlm.nih.gov/pubmed/33526560
  7. Mohamed, L., Madsen, AMR, Schaltz-Buchholzer, F., Ostenfeld, A., Netea, MG, Benn, CS, & Kofoed, PE (2021). Sake kunna tabo na rigakafin BCG bayan alurar riga kafi tare da mRNA-Covid-vaccines: rahotanni guda biyu. BMC Infect Dis, 21 (1), 1264. doi: 10.1186/s12879-021-06949-0. https://www.ncbi.nlm.nih.gov/pubmed/34930152
  8. Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., . . . Cooper, LT, Jr. (2021). Myocarditis Bayan Alurar rigakafin mRNA COVID-19 a cikin Membobin Sojojin Amurka. JAMA Cardiol, 6 (10), 1202-1206. doi:10.1001/jamacardio.2021.2833. https://www.ncbi.nlm.nih.gov/pubmed/34185045
  9. Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., . . . Ikeda, T. (2021). Myocarditis Bin COVID-19 Messenger RNA Alurar riga kafi: Jerin shari'ar Jafananci. Intern Med. doi:10.2169/maganin ciki.8731-21. https://www.ncbi.nlm.nih.gov/pubmed/34840235
  10. Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., . . . Kaneko, Y. (2021). Myocarditis mai Myocarditis mai Haɗewa da Alurar COVID-19: Rahoton Case. J Cardiol Cases. doi:10.1016/j.jccase.2021.11.006. https://www.ncbi.nlm.nih.gov/pubmed/34876937
  1. Ntouros, PA, Vlachogiannis, NI, Pappa, M., Nezos, A., Mavragani, CP, Tektonidou, MG, . . . Sfikakis, PP (2021). Ingantacciyar amsawar lalata DNA bayan ƙalubalen ƙalubalen rigakafi na yau da kullun ba: rigakafin SARS-CoV-2 tare da Lupus Erythematosus Systemic. Clin Immunol, 229, 108765. doi:10.1016/j.clim.2021.108765. https://www.ncbi.nlm.nih.gov/pubmed/34089859
  2. Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, LS, Hartling, UB, . . . Stensball, LG (2022). Abubuwan da suka faru na tushen yawan jama'a na Myopericarditis Bayan rigakafin COVID-19 a cikin Matasan Danish. Cutar da Pediatr Dis J, 41(1), e25-e28. doi:10.1097/INF.0000000000003389. https://www.ncbi.nlm.nih.gov/pubmed/34889875
  3. Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S., . . . Hofmann, M. (2021). Gaggawa da kwanciyar hankali na sel CD8(+) T ta rigakafin SARS-CoV-2 mRNA. Yanayin, 597 (7875), 268-273. doi:10.1038/s41586-021-03841-4. https://www.ncbi.nlm.nih.gov/pubmed/34320609
  4. Park, H., Yun, KW, Kim, KR, Song, SH, Ahn, B., Kim, DR, . . . Kim, YJ (2021). Epidemiology da Siffofin Asibiti na Myocarditis/Pericarditis kafin Gabatar da rigakafin mRNA COVID-19 a cikin Yaran Koriya: Nazari Multicenter. J Korean Med Sci, 36(32), e232. doi:10.3346/jkms.2021.36.e232. https://www.ncbi.nlm.nih.gov/pubmed/34402230
  5. Park, J., Brekke, DR, & Bratincsak, A. (2021). Myocarditis mai iyakance kansa wanda ke nunawa tare da ciwon kirji da haɓaka sashin ST a cikin samari bayan alurar riga kafi tare da maganin BNT162b2 mRNA. Cardiol Young, 1-4. doi:10.1017/S1047951121002547. https://www.ncbi.nlm.nih.gov/pubmed/34180390
  6. Patel, YR, Louis, DW, Atalay, M., Agarwal, S., & Shah, NR (2021). Abubuwan da aka gano na maganadisu na zuciya da jijiyoyin jini a cikin matasa marasa lafiya marasa lafiya tare da myocarditis mai saurin kamuwa da cutar mRNA COVID-19: jerin shari'o'i. J Cardiovasc Magn Reson, 23 (1), 101. doi: 10.1186/s12968-021-00795-4. https://www.ncbi.nlm.nih.gov/pubmed/34496880
  7. Patone, M., Mei, XW, Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., . . . Hippisley-Cox, J. (2021). Hadarin myocarditis, pericarditis, da arrhythmias na zuciya da ke da alaƙa da rigakafin COVID-19 ko kamuwa da cutar SARS-CoV-2. Na Med. doi:10.1038/s41591-021-01630-0. https://www.ncbi.nlm.nih.gov/pubmed/34907393
  8. Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Myocarditis mai muni biyo bayan allurar rigakafin Comirnaty a cikin mutum mai lafiya tare da kamuwa da cutar SARS-CoV-2 da ta gabata. Rediyol Case Rep, 16 (11), 3321-3325. doi:10.1016/j.radcr.2021.07.082. https://www.ncbi.nlm.nih.gov/pubmed/34367386
  9. Perez, Y., Levy, ER, Joshi, AY, Virk, A., Rodriguez-Porcel, M., Johnson, M., . . . Swift, MD (2021). Myocarditis Yana bin COVID-19 mRNA Alurar: Jerin shari'a da Ƙayyadaddun Ƙimar Haɗuwa. Clin Infect Dis. doi:10.1093/cid/ciab926. https://www.ncbi.nlm.nih.gov/pubmed/34734240
  10. Perrotta, A., Biondi-Zoccai, G., Saade, W., Miraldi, F., Morelli, A., Marullo, AG, . . . Peruzzi, M. (2021). Hoton bincike na duniya game da illar rigakafin COVID-19 tsakanin kwararrun kiwon lafiya da sojoji tare da mai da hankali kan ciwon kai. Panminerva Med, 63 (3), 324-331. doi:10.23736/S0031-0808.21.04435-9. https://www.ncbi.nlm.nih.gov/pubmed/34738774
  1. Pinana, JL, Lopez-Corral, L., Martino, R., Montoro, J., Vazquez, L., Perez, A., . . . Magungunan Kwayoyin cuta, G. (2022). Ganowar rigakafin SARS-CoV-2-mai amsawa bayan rigakafin SARS-CoV-2 a cikin masu karɓan ƙwayar hematopoietic stem cell: Bincike mai zuwa daga Spain Hematopoietic Stem Cell Transplantation and Cell Therapy Group. Am J Hematol, 97 (1), 30-42. doi:10.1002/ajh.26385. https://www.ncbi.nlm.nih.gov/pubmed/34695229
  2. Revon-Riviere, G., Ninove, L., Min, V., Rome, A., Coze, C., Verschuur, A., . . . Andre, N. (2021). Alurar rigakafin BNT162b2 mRNA COVID-19 a cikin matasa da matasa masu fama da cutar kansa: Kwarewar monocentric. Eur J Ciwon daji, 154, 30-34. doi:10.1016/j.ejca.2021.06.002. https://www.ncbi.nlm.nih.gov/pubmed/34233234
  3. Sanchez Tijmes, F., Thavendiranathan, P., Udell, JA, Seidman, MA, & Hanneman, K. (2021). Cardiac Mri game da kumburi na rashin daidaituwa: Yanayin bita da sabuntawa akan myocarditis hade da alurar riga kafi-19. Hoton Radiol Cardiothorac, 3(6), e210252. doi:10.1148/ryct.210252. https://www.ncbi.nlm.nih.gov/pubmed/34934954
  4. Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Mallenahalli Chikkabyrappa, S., & Portman, MA (2021). Myopericarditis Bayan Pfizer Messenger Ribonucleic Acid Coronavirus Cutar Cutar A cikin Matasa. J Pediatr, 238, 317-320. doi:10.1016/j.jpeds.2021.06.083. https://www.ncbi.nlm.nih.gov/pubmed/34228985
  5. Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, HU, Kuhnen, C., . . . Schmeling, A. (2021). Binciken bayan mutuwa na mace-mace biyo bayan allurar rigakafin COVID-19. Int J Legal Med, 135 (6), 2335-2345. doi:10.1007/s00414-021-02706-9. https://www.ncbi.nlm.nih.gov/pubmed/34591186
  6. Schramm, R., Costard-Jackle, A., Rivinius, R., Fischer, B., Muller, B., Boeken, U., . . . Gummert, J. (2021). Amsa mara kyau na barkwanci da T-cell zuwa kashi biyu na SARS-CoV-2 messenger RNA allurar BNT162b2 a cikin masu karɓar dasawa na cardiothoracic. Clin Res Cardiol, 110 (8), 1142-1149. doi:10.1007/s00392-021-01880-5. https://www.ncbi.nlm.nih.gov/pubmed/34241676
  7. Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Sakamakon Gawarwaki da Dangantakar Dalili tsakanin Mutuwa da Alurar COVID-19: Bita na Tsari. J Clin Med, 10 (24). doi:10.3390/jcm10245876. https://www.ncbi.nlm.nih.gov/pubmed/34945172
  8. Sharif, N., Alzahrani, KJ, Ahmed, SN, & Dey, SK (2021). Inganci, Immunogenicity da Tsaron rigakafin COVID-19: Bita na Tsari da Nazarin Meta. Gaban Immunol, 12, 714170. doi:10.3389/fimmu.2021.714170. https://www.ncbi.nlm.nih.gov/pubmed/34707602
  9. Shay, DK, Gee, J., Su, JR, Myers, TR, Marquez, P., Liu, R., . . . Shimabukuro, TT (2021). Sa ido kan Tsaro na Janssen (Johnson & Johnson) rigakafin COVID-19 - Amurka, Maris-Afrilu 2021. MMWR Morb Mortal Wkly Rep, 70(18), 680-684. doi:10.15585/mmwr.mm7018e2. https://www.ncbi.nlm.nih.gov/pubmed/33956784
  10. Shazley, O., & Alshazley, M. (2021). Wani Mutumi Mai Shekara 52 Mai Kyau Wanda Aka Gabatar Tare da Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar ta Ciki da Yaduwa a cikin Jiki Bayan Alurar Johnson & Johnson: Nazari-Nazari. Cureus, 13 (7), e16383. doi:10.7759/cureus.16383. https://www.ncbi.nlm.nih.gov/pubmed/34408937
  11. Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., . . . Hamdan, A. (2021). Myocarditis yana bin rigakafin COVID-19: nazarin hoton maganadisu. Eur Zuciyar J Cardiovasc Hoto. doi:10.1093/ehjci/jeab230. https://www.ncbi.nlm.nih.gov/pubmed/34739045
  12. Simone, A., Herald, J., Chen, A., Gulati, N., Shen, AY, Lewin, B., & Lee, MS (2021). Myocarditis Myocarditis Mai Mutuwa Yana bin COVID-19 mRNA Alurar rigakafi a cikin Manya Masu Shekaru 18 ko Sama. JAMA Intern Med, 181 (12), 1668-1670. doi:10.1001/jamainternmed.2021.5511. https://www.ncbi.nlm.nih.gov/pubmed/34605853
  13. Singer, ME, Taub, IB, & Kaelber, DC (2021). Hadarin Myocarditis daga kamuwa da cutar COVID-19 a cikin Mutanen da ke ƙasa da Shekaru 20: Nazari na tushen yawan jama'a. medRxiv. doi:10.1101/2021.07.23.21260998. https://www.ncbi.nlm.nih.gov/pubmed/34341797
  14. Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., . . . Fraser, LK (2021). Mutuwar yara da matasa a Ingila bayan kamuwa da cutar SARS-CoV-2 a farkon shekarar cutar ta farko. Na Med. doi:10.1038/s41591-021-01578-1. https://www.ncbi.nlm.nih.gov/pubmed/34764489
  15. Snapiri, O., Rosenberg Danziger, C., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., . . . Bilavsky, E. (2021). Raunin Ciwon Zuciya Mai Wuya a Matasa Suna Karɓar Alurar rigakafin BNT162b2 mRNA COVID-19. Cutar da Pediatr Dis J, 40(10), e360-e363. doi:10.1097/INF.0000000000003235. https://www.ncbi.nlm.nih.gov/pubmed/34077949
  16. Spinner, JA, Julien, CL, Olayinka, L., Dreyer, WJ, Bocchini, CE, Munoz, FM, & Devaraj, S. (2021). SARS-CoV-2 anti-spike antibodies bayan alurar riga kafi a cikin dashen zuciya na yara: Rahoton farko. J Zuciya Juya. doi:10.1016/j.healun.2021.11.001. https://www.ncbi.nlm.nih.gov/pubmed/34911654
  17. Starekova, J., Bluemke, DA, Bradham, WS, Grist, TM, Schiebler, ML, & Reeder, SB (2021). Myocarditis Haɗe da mRNA COVID-19 Alurar riga kafi. Radiology, 301 (2), E409-E411. doi:10.1148/radiol.2021211430. https://www.ncbi.nlm.nih.gov/pubmed/34282971
  18. Sulemankhil, I., Abdelrahman, M., & Negi, SI (2021). Ƙungiyar ɗan lokaci tsakanin COVID-19 Ad26.COV2.S maganin alurar riga kafi da myocarditis mai tsanani: Rahoton shari'a da nazarin wallafe-wallafe. Cardiovasc Revasc Med. doi:10.1016/j.carrev.2021.08.012. https://www.ncbi.nlm.nih.gov/pubmed/34420869
  19. Tailor, PD, Feighery, AM, El-Sabawi, B., & Prasad, A. (2021). Rahoton shari'ar: myocarditis mai tsanani yana bin kashi na biyu na rigakafin mRNA-1273 SARS-CoV-2. Eur Heart J Case Rep, 5(8), ytab319. doi:10.1093/ehjcr/ytab319. https://www.ncbi.nlm.nih.gov/pubmed/34514306
  20. Takeda, M., Ishio, N., Shoji, T., Mori, N., Matsumoto, M., & Shikama, N. (2021). Eosinophilic Myocarditis Bayan Cutar Coronavirus 2019 (COVID-19) Alurar riga kafi. Circ J. doi:10.1253/circj.CJ-21-0935. https://www.ncbi.nlm.nih.gov/pubmed/34955479
  21. Ƙungiya, CC-R., Abinci, & Magunguna, A. (2021). Maganganun Allergic Haɗe da Anaphylaxis Bayan Karɓar Kashi na Farko na Pfizer-BioNTech COVID-19 Vaccine - Amurka, Disamba 14-23, 2020. MMWR Morb Mortal Wkly Rep, 70(2), 46-51. doi:10.15585/mmwr.mm7002e1. https://www.ncbi.nlm.nih.gov/pubmed/33444297
  22. Thompson, MG, Burgess, JL, Naleway, AL, Tyner, H., Yoon, SK, Meece, J., . . . Gaglani, M. (2021). Rigakafin da Attenuation na Covid-19 tare da BNT162b2 da mRNA-1273 Alurar riga kafi. N Engl J Med, 385(4), 320-329. doi:10.1056/NEJMoa2107058. https://www.ncbi.nlm.nih.gov/pubmed/34192428
  23. Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., . . . Lourenco, A. (2021). Perimyocarditis Bayan Alurar COVID-19. Clin Med Insights Cardiol, 15, 11795468211056634. doi:10.1177/11795468211056634. https://www.ncbi.nlm.nih.gov/pubmed/34866957
  24. Truong, DT, Dionne, A., Muniz, JC, McHugh, KE, Portman, MA, Lambert, LM, . . . Newburger, JW (2021). Myocarditis da ake zargi na asibiti na ɗan lokaci yana da alaƙa da rigakafin COVID-19 a cikin Matasa da Manya Manyan. Zagayawa. doi:10.1161/CIRCULATIONAHA.121.056583. https://www.ncbi.nlm.nih.gov/pubmed/34865500
  25. Tutor, A., Unis, G., Ruiz, B., Bolaji, OA, & Bob-Manuel, T. (2021). Spectrum na Cardiomyopathy da ake zargi Saboda COVID-19: Jerin shari'a. Curr Probl Cardiol, 46 (10), 100926. doi: 10.1016/j.cpcardiol.2021.100926. https://www.ncbi.nlm.nih.gov/pubmed/34311983
  26. Umei, TC, Kishino, Y., Shiraishi, Y., Inohara, T., Yuasa, S., & Fukuda, K. (2021). Maimaitawar myopericarditis biyo bayan allurar mRNA COVID-19 a cikin samari. Farashin CJC. doi:10.1016/j.cjco.2021.12.002. https://www.ncbi.nlm.nih.gov/pubmed/34904134
  27. Vidula, MK, Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, VA, & Han, Y. (2021). Myocarditis da Sauran Rikicin Zuciya na Magungunan COVID-19 na tushen mRNA. Cureus, 13 (6), e15576. doi:10.7759/cureus.15576. https://www.ncbi.nlm.nih.gov/pubmed/34277198
  28. Visclosky, T., Theyyunni, N., Klekowski, N., & Bradin, S. (2021). Myocarditis Bayan mRNA COVID-19 Allurar. Kulawar Yara na gaggawa, 37 (11), 583-584. doi:10.1097/PEC.0000000000002557. https://www.ncbi.nlm.nih.gov/pubmed/34731877
  29. Warren, CM, Snow, TT, Lee, AS, Shah, MM, Heider, A., Blomkalns, A., . . . Nadeau, KC (2021). Ƙimar Allergic and Anaphylactic Reactions zuwa mRNA COVID-19 Alurar rigakafin tare da Tabbataccen Gwaji a cikin Tsarin Kiwon Lafiya na Yanki na Amurka. JAMA Netw Buɗe, 4(9), e2125524. doi:10.1001/jamanetworkopen.2021.25524. https://www.ncbi.nlm.nih.gov/pubmed/34533570
  30. Watkins, K., Griffin, G., Septaric, K., & Simon, EL (2021). Myocarditis bayan allurar BNT162b2 a cikin namiji mai lafiya. Am J Emerg Med, 50, 815 e811-815 e812. doi:10.1016/j.ajem.2021.06.051. https://www.ncbi.nlm.nih.gov/pubmed/34229940
  31. Weitzman, ER, Sherman, AC, & Levy, O. (2021). Halin rigakafin SARS-CoV-2 mRNA kamar yadda aka bayyana a cikin Sharhin Jama'a na FDA: Buƙatar Haɗin gwiwar Jama'a da Masu zaman kansu a cikin Tsarin rigakafin Koyo. Gaban Kiwon Lafiyar Jama'a, 9, 695807. doi:10.3389/fpubh.2021.695807. https://www.ncbi.nlm.nih.gov/pubmed/34336774
  32. Welsh, KJ, Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia ciki har da thrombocytopenia na rigakafi bayan samun mRNA COVID-19 alluran rigakafin da aka ruwaito zuwa Tsarin Bayar da Rahoton Alurar rigakafin Alurar (VAERS). Alurar riga kafi, 39 (25), 3329-3332. doi:10.1016/j.alurar rigakafi.2021.04.054. https://www.ncbi.nlm.nih.gov/pubmed/34006408
  33. Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., . . . Kornowski, R. (2021). Myocarditis bayan Alurar rigakafin Covid-19 a cikin Babban Kungiyar Kula da Lafiya. N Engl J Med, 385(23), 2132-2139. doi:10.1056/NEJMoa2110737. https://www.ncbi.nlm.nih.gov/pubmed/34614329
  34. Zimmermann, P., & Curtis, N. (2020). Me yasa COVID-19 ba shi da ƙarfi a cikin yara? Bita na hanyoyin da aka gabatar da ke haifar da bambance-bambancen da suka shafi shekaru cikin tsananin cututtukan SARS-CoV-2. Arch Dis Child. doi:10.1136/archild-2020-320338. https://www.ncbi.nlm.nih.gov/pubmed/33262177

###

Yi wa abokanka, danginka da abokan aikinka alheri don tabbatar da cewa sun kasance masu wayo na Sino: 

LATSA, TV da RADIO

Akai na: https://radiosinoland.com/about-the-author/
Bidiyon Bichute: https://www.bitchute.com/channel/REzt6xmcmCX1/
Littattafai: https://radiosinoland.com/2018/06/18/praise-for-the-china-trilogy-the-votes-are-in-it-r-o-c-k-s-what-are-you-waiting-for/
Bidiyon Brighteon: https://www.brighteon.com/channels/jeffjbrown
itunes: https://itunes.apple.com/cn/podcast/44-days-radio-sinoland/id1018764065?l=en
Ivoox: https://us.ivoox.com/es/podcast-44-days-radio-sinoland_sq_f1235539_1.html
Labari: https://radiosinoland.com/blog-2/
Dalili.fm: https://reason.fm/podcast/china-rising-radio-sinoland-fluNNZY68
RUvid: https://ruvid.net/w/radio+sinoland
Sautin Cloud: https://soundcloud.com/44-days
Stitcher Radio: http://www.stitcher.com/podcast/44-days-publishing-jeff-j-brown/radio-sinoland?refid=stpr
YouTube: https://www.youtube.com/channel/UCS4h04KASXUQdMLQObRSCNA
Sautin Vurbl: https://vurbl.com/station/1Vc6XpwEWbe/
Shafukan yanar gizo: http://www.chinarising.puntopress.com ; www.bioweapontruth.com ; www.chinatechnewsflash.com

Social Media

email: [email kariya]
Facebook: https://www.facebook.com/44DaysPublishing
Mai Girma: https://www.flickr.com/photos/98158626@N07/
Getr: https://gettr.com/user/44_days
Instagram: https://www.instagram.com/jeffjbrown_44days/
Layin App/Waya/Signal/Telegram/WhatsApp: +33-6-12458821
Linkedin: https://cn.linkedin.com/in/jeff-j-brown-0517477
Pinterest: https://www.pinterest.com/jeffjb/
Parler: https://parler.com/profile/jeffjbrown
Sinawa: http://weibo.com/u/5859194018
Skype: live:.cid.de32643991a81e13
TikTok: chinarissingradioland
Tumblr: http://jjbzaibeijing.tumblr.com/
Twitter: https://twitter.com/44_Days
VK: http://vk.com/chinarisingradiosinoland
WeChat: + 86-19806711824

Me ya sa kuma yadda kasar Sin ke aiki: Tare da madubi zuwa Tarihinmu


Kwanaki 44 na Komawa a China: Masarautar Tsakiya a cikin karni na 21, tare da Amurka, Turai da makomar Duniya a cikin Gilashinsa.

Tashin kasar Sin: Hanyoyi na jari-hujja, wuraren gurguzu

 

 

 

 

 

 

BABBAN Jajayen Littafin Sin: Tarihin Sinawa, Al'adu da Juyin Juyin Halitta

GAME DA JEFF BROWN

jeffBusyatDesktop

JEFF J. BROWN, Edita, Tashin China, kuma Babban Editan & Wakilin China, Aiko daga Beijing, The Greanville Post

Jeff J. Brown masanin nazarin yanayin ƙasa ne, ɗan jarida, malami kuma marubucin The China Trilogy . Ya ƙunshi kwanaki 44 na Backpacking a China – The Middle Kingdom in the 21st Century, tare da Amurka, Turai da Fate of the World in Its Looking Glass (2013); Punto Press ta fitar da China Rising – Capitalist Roads, Socialist Destinations (2016); da kuma BIG Red Book on China (2020). Haka kuma, ya buga littafin karatu, Treasure Trove to Great English na Doctor WriteRead (2015). Jeff babban Edita ne kuma Wakilin China ga The Greanville Post , inda yake riƙe da shafi, Dispatch daga Beijing kuma Shugaban Ra'ayin Duniya ne a ƙarni na 21. Hakanan yana rubuta shafi ga The Saker , wanda ake kira Moscow-Beijing Express . Jeff yana rubutu, yana yin tambayoyi da podcasts akan shirinsa, China Rising Radio Sinoland , wanda kuma ana samunsa a YouTube , Stitcher Radio , iTunes, Ivoox da RUvid . Baƙi sun haɗa da Ramsey Clark , James Bradley , Moti Nissani , Godfree Roberts , Hiroyuki Hamada , The Saker da sauransu da yawa.

Ana iya samun Jeff a China Rising , [email protected] , Facebook , Twitter , Wechat (+86-19806711824/Mr_Professor_Brown, da Layi/Signal/Telegram/Whatsapp: +33-612458821.

Karanta shi cikin harshenku • Lealo en su idioma • Lisez-le dans votre langue • Lies es in deniner Sprache • Прочитайte это на вашem яzyke • 用你的语言阅读

[google-translator]

 

Rukunin Wechat: bincika lambar waya +8619806711824 ko ID dina, Mista_Professor_Brown, buƙatar abokina kuma ka nemi Jeff ya shiga rukunin Wechat na Sinoland Rediyon Sinoland. Zai ƙara ku a matsayin memba, don ku iya shiga cikin tattaunawar da ke gudana.

Kuɗin ya tsaya tare da ku. Idan baku raba wannan ba, wa zaiyi?
         
Categories: Hukumar Gaskiya ta Bioweapon (BWTC), Kasa mai zurfi, Rokan kudi, Jeff J. Brown, podcast, Rediyon kasar Sin, Daular Amurka